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Abstract 
Further development of the 2.2-b/s (4' -nitrophenyl)ethoxycarbonyl (Bnpeoc) 
group, recently introduced as an N a- protecting group in peptide synthesis, is 
presented. Comparison between this moiety and the analogous Fmoc protecting 
group has led to a greater understanding of its protection and deprotection 
requirements. 
The use of this group is exemplified by the preparation of a tripeptide, 
b/s (4 '- nitropheny1)ethoxycarbonyl] - alanylphenylalanylglycine, by two 
syntheses in solution. A solid phase synthesis was also carried Out manually, at 
the same time re-introducing acid-chloride coupling methodology to the field. 
The 	preparation 	of 	N - (benzyloxycarbonyl)alanylaIanylserine 	(0-2,3,4,6- 
tetra -0 -benzyl - ct/B -glucopyranosyl)benzyl ester has shown that Bnpeoc may also 
have a useful role in the new area of glycopeptide synthesis. 
A novel coupling reagent, diphenylphosphinic anhydride, useful in the mediation 
of both amide and ester bond formation is introduced. Several ittempts at the 
preparation of the reagent are discussed. Phosphorus n.m.r. is shown to be an 
excellent method for monitoring its long-term stability and its reactivity towards 
nucleophiles. 
These new protection and activation/coupling methodologies have been fitted 
into the automated solid phase synthesis protocol, alongside more conventional 
methods (e.g carbodiimide/HOBt), enabling several test peptides to be prepared. 
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Ubiquitin, a 76 a-amino acid polyfunctional protein, was first reported as being 
present in bovine thymus by Goldstein et al 1  in 1975, during studies on the 
isolation of the thymic polypeptide hormone, thymopoietin. 
Its presence in animal cells, yeast, bacteria and higher plants led the author to 
postulate that the protein was in fact a universal constituent of living cells. 
Subsequent radioimmunoassay studies have shown ubiquitin to be present, 
either free or covalently bound, in the nucleus, cytoplasm and at the cell surface of 
all eukaryotic cells. 
The primary amino acid sequence of ubiquitin (Figure 1.1) is the most 
evolutionarily conserved of all known proteins 2 ' 3, with variations confined to four 
residues over all species studied to date, namely residues 19, 24, 28 and 51 (Figure 
1.2). - 
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Figurel.1 Primary amino acid sequence of human erythrocytic ubiquitin. 
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Ubiquitin source 
Residue An i ma la Plant  Yeast 
19 Pro Ser Ser 
24 Glu Asp Asp 
28 Ala Ala Ser 
57 Ser Ala Ser 
animal refers to that isolated from man, cattle, mouse, 
chicken, toad and fly. 
plant refers to that isolated from oat and barley. 
Figure 1.2 Primary sequence variations of ubiquitin. 
These observations clearly suggest that ubiquitin has a fundamental role in 
basic cellular chemistry, and recent investigations into the polyfunctional nature of 
ubiquitin, together with the elucidation of its crystal structure (see below), have led 
to a greater understanding of its physiological significance. 
1.1.2. Biological significance of ubiquitin 
Ubiquitin-coding DNA sequences have been cloned from a number of 
eukaryotes4567. These investigations have shown ubiquitin-coding genes to be 
organised into head-to-tail repeat units with no internal spacers. Thus suggesting 
mature ubiquitin is produced by selective proteolytic processing of the precursor 
protein, polyubiquitin. 
In the case of yeast ubiquitin 4, six consecutive ubiquitin monomers are bound 
directly via Gly-Met peptide bonds of the first and last residues of adjacent 
ubiquitin molecules, with a final non-ubiquitin amino acid, asparagine, also present. 
A study of the crystal structure of ubiquitin (see below) shows the amino 
terminal methionine residue to be buried within the molecule. Thus considerable 
conformational change must take place, after cleavage of the polyubiquitin, in 
order to produce the mature ubiquitin monomer. 
However the number of consecutive repeats per gene is not conserved over all 
species, for example, human ubiquitin has been shown to have nine. Another 
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feature which is not species conserved is the identity of the final, non-ubiquitin 
amino acid; it being asparagine in yeast 4, valine in human 5 and tyrosine in chicken 
ubiquitin 6. However this is not thought essential to the precursor protein, due to 
the discovery that the clone isolated from the toad Xenopus /aevis had no 
additional amino acid present 7 . 
Ubiquitin demonstrates a fundamental and perhaps diverse role in the life of 
the cell, and has been identified as present in the nucleus, in the cytoplasm and 
on the cell-surface membrane of eukaryotic cells (for review 8 ). 
Its major function is thought to be the targetting of ubiquitin-protein 
conjugates. for degradation by non-lysosomal ATP-dependent proteolysis 
systems 9,10,11 i.e. ubiquitin may act as a signal for the attack of proteinases 
specific to ubiquitin-protein conjugates. Protein breakdown by this pathway 
requires the formation of a covalent bond between the carboxyl terminus of 
ubiquitin and the target protein. Two distinct classes of ubiquitin-protein 
conjugate have been identified to date: the first displays an isopeptide bond 
formed with the c-NH 2 group of a protein lysine residue 10 ' 11 ' 12, the other formed 
by ubiquitination of the terminal -NH 2 group of the acceptor protein 13 . 
Selective in vitro modification of the terminal 	-NH 2 groups of proteins 
prevents degradation, thus suggesting degradation requires the NH 
2 -terminal
ubiquitination of proteolytic substrates. Investigations have shown that a reduced 
rate of degradation by the ubiquitin pathway exists for proteins with blocked 
c-NH 2 groups, but free -NH 2 groups 13 . 
There appear to be a number of highly specific enzymes which mediate the 
concerted reactions that result in the formation of ubiquitinated proteins (Figure 
1.38). The resulting conjugates, which may contain more than one ubiquitin 
molecule, are either degraded or simply deubiquitinated. 
The existence of at least two distinct enzymes, with different specificities for 
the non-ubiquitin moiety, which catalyse the deubiquitination process, has also 
been shown 145 . 
The four stages in the formation of ubiquitin- protein conjugates (and the 
enzymes of the ubiquitin ligase system) are: 
1. ubiquitin carboxy-terminal adenylation (ubiquitin activating enzyme, El) 
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Figure 1.3 Pathways of the ubiquitin system. 
The first such ubiquitin- protein conjugate reported displayed the formation of 
an isopeptide bond, between the F_-NH 2 group of lysine-1 19 of histone H2A, and 
the carboxyl terminus of ubiquitin 161718. The function of this conjugate is as yet 
unproved, but it is believed that this 'branched ubiquitin-H2A (uH2A) semi-histone 
may result in specific degradation at transcriptionally active chromosome sites, and 
that ubiquitination may indirectly influence the cell-cycle by regulating the lifetime 
of 'cyclins'. 
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The first example of a protein at the cell-surface being covalently ubiquitinated 
was reported by Weissman et al 19.20 who discovered a 90 kDa glycoprotein 
lymphocyte homing receptor bound to ubiquitin. 
Biochemical investigations of the lymphocyte cell-surface receptor involved in 
this homing were made possible by the development of a monoclonal antibody 
(MEL-14) which detects the receptor on only the lymphocytes that home in on the 
peripheral lymph node high endothelial venules (HEVs). It is known that a large 
number of circulating lymphocytes enter the bloodstream through this specialized 
endothelium. Subsequent screening of Agt 11 expression libraries with MEL-14, 
revealed the ubiquitin sequence, in several reactive clones 21 . Further studies 
confirmed the obtained glycoprotein to be ubiquitinated at the c-NH 2 group of a 
lysine residue analogous to the ubiquitination of the histone H2A. 
The discovery of ubiquitin at the cell surface merits further investigation to 
determine, for example, the mode of transport of ubiquitin to that location and 
what difference, if any, in function, there is between cell-surface ubiquitin and its 
intracellular counterpart. 
1.1.3. Structure of ubiquitin 
Apart from the physiological significance and the unparalleled sequence 
• conservation of ubiquitin, its structure has been of some interest due to the 
remarkable stability of this relatively small polypeptide. 
It is noteworthy that the molecule is extremely resistent to tryptic digestion 
despite the presence of seven lysine and four arginine residues, as well as being 
stable to a wide range of pH and temperature. Nuclear magnetic resonance studies 
have demonstrated no apparent denaturation - over a pH range of 1.18-8.48 and a 
temperature range of 23-80 °C, whilst predicting a compact, globular structure 22 . 
More recently the three dimensional structure by X-ray analysis at 2.8 
resolution of human erythrocytic ubiquitin 23, together with a further refinement to 
1.8424, have been reported. 
These studies have shown ubiquitin to be extremely compact, with a 
pronounced hydrophobic core (of the 21 valine, leucine, isoleucine and methionine 
residues, 16 are buried within the interior of the molecule), and tightly 
hydrogen-bonded - with approximately 87% of the polypeptide chain involved in 
hydrogen-bonded secondary structure. 
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Noteworthy secondary structure features include three and one-half turns of a 
a-helix, a short piece of 3 10 -helix, a mixed B -sheet that contains five strands, and 
seven reverse turns. The molecule also displays a number of unusual secondary 
structure features, namely a parallel Gi 13-bulge, two reverse Asx turns, and a 
symmetrical hydrogen-bonding region that involves the two helices and two of the 
reverse turns. 
A comparison of the three dimensional crystal structures of yeast and oat 
ubiquitin 25  has shown both to have a similar structure to that of human ubiquitin, 
with all amino acid variations contained in two small sections on one surface of 
the molecule. It is therefore concluded that this surface Js .  not involved in 
conjugation with proteins destined for ATP-dependent ubiquitin proteolysis. 
As previously stated, the conjugates formed between ubiquitin and other 
proteins involves the formation of isopeptide bonds between the carboxyl terminus 
of ubiquitin and the E-NH 2  groups of lysine residues of other proteins. In the only 
fully characterised ubiquitin-protein complex to date, ubiquitin-histone H2A, it has 
been reported that there are probably no allosteric, noncovalent interactions 
between ubiquitin and histone H2A 26. This is consistent with the crystal 
structure 24 , in that the carboxyl terminus protrudes from, and therefore does not 
interact with, the rest of the molecule by way of hydrogen bonding or hydrophobic 
interactions. Thus, this portion of the molecule has considerable freedom of 
motion (confirmed by the poorer definition of the electron density maps for this 
region 24) and should be accessible to enzymes involved with the formation or 
cleavage of the isopeptide bond. 
Conversely the amino-terminal methionine is buried in the interior of the 
molecule, with the sulphur atom hydrogen bonded to the backbone nitrogen atom 
of lysine-63. This inaccessibility shields the terminus from solvent and prevents 
the proteolysis of the mature ubiquitin by its own pathway. 
1.1.4. Synthesis and fragment synthesis of ubiquitin 
In 1978, Schlesinger at al 27 synthesised and purified a hexadecapeptide, 
corresponding to positions 59-74 of ubiquitin, by the solid phase strategy of 
Merrifield 28  using Boc N-protection 29 and DCCI 30 activation. The peptide was 
shown to possess approximately 40% of the activity of the native ubiquitin in each 
of three in vitro biological assays. More recently, Abiko and Sekino 31 chose 
solution phase methodology to synthesise the same fragment, employing a 
I 
FA 
combination of activation strategies which included the azide method 32 
DCCI-HOBt 33 and active ester methodology 34 . Again the fragment was shown to 
have considerable biological activity. 
It was at about this time that ubiquitin, which had been thought of as a 74 
residue protein, was confirmed as actually containing 76 residues - with a 
C-terminus of Gly-Gly-0H 35. Subsequent structural and activity studies of ubiquitin 
have suggested that the C-terminus, which protrudes from the bulk of the 
molecule, is fundamental to its activity. This somewhat contradicts the discovery 
that small fragments of ubiquitin have significant activity i.e. suggesting that there 
is no need for (1) the complete tertiary structure of the molecule or (2) the 
C-terminal Gly-Gly region. These more recent investigations, together with the 
knowledge of ubiquitin's unique structure conservation, must therefore cast some 
doubt on the representativeness of the earlier fragment activity experiments. 
Recent work in this research group has led to the synthesis and purification of 
a number of fragments of ubiquitin (for example, residues 1_3536, 36-53, 60_76 38 ) 
as well as the total synthesis of human ubiquitin itself 39. This was undertaken 
using the Merrifield solid phase strategy 40, based on the Fmoc group designed by 
Carpino 41 , and developed by Sheppard 42. 
1.2. Solid Phase Peptide Synthesis 
1.2.1. Introduction 
The importance of peptides and proteins, substances upon which the primary 
functions Of. the living cell depend, is now well established and is the subject of 
much research. 
The area of peptide and protein chemistry is a vast one, with the many types 
of molecule exhibiting a large and varied range of functions e.g. as enzymes, 
oxygen carriers, electron-transfer agents, hormones, hormone precursors, 
antibiotics and growth factors. 
There is no distinct division between the terms peptide and protein, however 
the former term is generally reserved for species of more than 100 amino acids, 
whereas 'peptide' is reserved for those substances of a lesser number. Hence, 
whereas protein chemistry has largely been thought of as a subdiscipline of 
biochemistry, peptide chemistry has been of more interest to organic chemists. 
Fischer 43  synthesised, and coined the name of, the first peptide at the 
beginning of this century. His results were impressive but not practical, due largely 
to his to his failure to discover a suitable reversible protecting group for the amine 
function. However one of his former students, Bergmann, with Zervas, was 
successsful and in 1932 the benzyloxycarbonyl or Z- group was introduced 44 . The 
design of this urethane-type protecting group led to a new era in peptide 
chemistry. 
The methodology of peptide synthesis has progressed quickly since that 
introduction, with improvements and modifications in all the relevent areas of 
synthesis frequently reported. However the most conspicuous milestone was the 
move away from solution phase synthesis and the introduction of Solid Phase 
Peptide Synthesis (SPPS) by Merrifield 28  in 1963, for which he was later awarded 
the Nobel Prize 40 
His plan to synthesise peptides in a stepwise manner while one end was 
attached to an insoluble support revolutionized the entire peptide field, and its 
influence has since spread to other areas of chemical synthesis e.g. 
oligonucleotide synthesis 45, with equally dramatic results; 
1.2.2. 'Classical' Solid Phase Peptide Synthesis 
Standard solution phase synthesis of peptides containing more than just a few 
amino acids is a demanding task. 
The introduction of protecting groups, coupling and deprotection reactions 
involves a large number of physical operations, such as neutralising the r'eaction 
mixture after coupling, precipitation or crystallisation of intermediates, collection of 
solid products by filtration etc These manipulations lead to a great deal of 
mechanical loss of product during a synthesis. Add to these the problems of 
purification and increasing lack of solubility of the growing peptide chain, and it 
becomes apparent why the solution phase synthesis of a 20 amino acid peptide is 
indeed a heroic effort. 
Merrifield 28, and others, were aware of the repetitiveness of the procedures 
involved in peptide synthesis when he introduced the method whereby the first 
amino acid was attached to an insoluble support, and the peptide synthesised by a 
stepwise procedure of repetitive activation, coupling and deprotection cycles 
(Scheme 1.1). 
The insoluble support is a synthetic polymer (a 'resin') which bears reactive 
groups (X). A 0-protected derivative of the first amino acid which will form the 
C-terminal residue of the peptide is activated by the appropriate chemistry (A) and 
coupled to the reactive polymer. 
The nature of this labile N a-protection (L) must be such that it can be removed 
by the addition of a reagent which must not either harm the link formed between 
the polymer and the C-terminal residue or remove any stable (semi-permanent) 
protecting groups (S) which are employed in masking the side-chain functionality 
of the initial, or subsequent, residues. 
The orthogonal nature of the protecting groups and reagents involved permits 
this deprotection-coupling cycle to continue until all the amino acids have been 
incorporated into the chain. 
Finally the fully side-chain-protected peptide is cleaved from the resin and 
taken into solution using a reagent of a different class. The semi-permanent 
protecting groups must also be removed, and are usually chosen such that they 
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Scheme 1.1 'Classical' solid phase peptide synthesis. 
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Merrifield demonstrated that once the amino acid or peptide was attached to 
the insoluble matrix, it too would be insoluble and hence in a suitable physical 
form to permit rapid filtration and washing. 
The advantages of such a system are numerous: 
The multi-step synthesis is greatly simplified by the use of a 
single reaction vessel and hence the mechanical losses 
associated with the repeated transfer of material is avoided. 
It avoids the large losses which are encountered :d•uring the 
isolation and purification of intermediates. 
Excess starting materials and reagents can be used to force 
individual reactions to completion and hence increase overall 
yield of the product. 
Excess starting materials and reagents, as well as deprotection 
products and byproducts from the reactions, can be removed 
by simply washing the peptidyl polymer with appropriate 
solvents such as DCM and DMF. 
The repetitive nature of the cycles lends SPPS to automation. 
Increased speed of synthesis; modern automated synthesisers 
assemble peptides at a rate of one residue every four hours or 
so. 
1.2.3. The Polymer Support 
The fundamental requirements for a suitable insoluble support for SPPS are as 
follows: 
The polymer must Consist of particles of a physical size and 
shape to permit ready manipulation and rapid filtration from 
liquids. 
The polymer must undergo sufficient chemical modification to 
permit attachment of the first amino acid, and yet be inert to 
all subsequent reagents and solvents used in the synthesis. 
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3. The polymer must swell in the appropriate solvents 
- the 
greater the swelling, the more efficiently the reactants will 
penetrate the polymer matrix by diffusion. 
The support (2) developed initially by Merrifield 28 was prepared by the 
chloromethylation of a copolymer (1) obtained from 2% divinylbenzene in styrene. 
The first Na_protected amino acid (the C-terminal residue of the peptide) was then 
attached by the reaction of its triethylammonium salt with the chloromethylated 
resin (2) (Scheme 1.2). 
	
CH3-0-CH2-Cl 	 + 	
0__E~ 
1 (1) 
CH30H + CI-CH2  _0~ 
(2) 
I 	- 	 + 
L -NH-CH-0O2 Et3HN 
L -NH-CH-CO2  -CH2 -Q_.(POLYUE1 
dsprot.ctJon ate 
Scheme 1.2 Development of the chloromethyl resin (2). 
If benzyloxycarbonyl Na_protected amino acids are used, a solution of HBr in 
acetic acid is required for the subsequent deprotection. 
The next step is the removal of the temporary Na_protecting  group. While it is 
possible to do this without cleaving to a significant extent the benzyl ester-like 
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linkage between the support and the C-terminal residue, this selectivity is simply 
not sufficient for practical purposes. With each deprotection cycle a small, but not 
negligible amount, of peptide is cleaved from the support. While this could be 
tolerated in the synthesis of short peptides, it is unacceptable in larger ones. 
Nitration and bromination 28 of the aromatic nuclei of the polymer were 
considered as two possible methods of increasing the electron-withdrawing effect 
on the benzylic position and thus improving this selectivity. However while both 
products exhibited an increased stability towards acidolysis, the nitrated derivative 
yielded a peptide-resin link that was resistant to acidolysis with HBr and HF, and 
required the somewhat unsatisfactory method of saponification for removal, the 
brominated resin, although used successfully in some instances, suffers from a 
reduction in swelling properties in both DCM and DMF, and hence has not been 
adopted extensively. 
Merrifield 46 therefore 	sought an 	improvement by introducing 	the 
tert.butyloxycarbonyl (Boc) N a-protecting group 29,47 to replace the Z- group in his 
revised strategy in 1964. 
The milder deprotection conditions for this more acid-labile group, namely 1M 
HCI in acetic acid or trifluoroacetic acid in DCM, were shown to degrade the 
peptide-resin bond to a lesser extent during the course of the synthesis. 
An alternative development has been the modification of the Merrifield 
copolymer itself. 
A reduction in the divinylbénzene content from 2% to 1% has resulted in a 
resin with greater swelling characteristics in both 0CM and DMF 2848. This 
improvement permits more efficient delivery of the reagents to the reactive sites 
by increasing the penetration of the acylating agents etc. around the amino sites, 
but also 4the 1% cross-linked polymer will have fewer sites hidden in areas 
inaccessible to hindered amino acid derivatives e.g those of valine and isoleucine. 
The cost of this increased 'reactivity' is a reduction in the mechanical stability of 
the polymer. 
If less than 1% divinylbenzene is used, Birr 49 has shown that although the 
resulting resin can be used, it is very soft and filtration can no longer be used as a 
means of separation. On the other hand, Merrifield also reported that 8 and 16% 
cross-linked supports resulted in a matrix that was too rigid to allow easy 
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penetration of reagents, and therefore caused a reduction in both reaction rate and 
yield 28 . 
In addition to the physical 	developments, the chemistry of the 
chloromethylated resin (2) has also been improved. 
CI-CH2 - QHPOLYUER I 
(2) 




c N2 H4 
- 	: 	 HO-CH2 - 	-IP0LflIER I 
(3) 
Scheme 1.3 Synthesis of the hydroxymethyf resin (3). 
The heating of the resin in a solution of potassium acetate in a high boiling 
alcohol results in the displacement of the chloride by the acetate ion. Subsequent 
saponification 50, ammonolysis in methanol 50 or treatment with hydrazine 51 yields 
the hydroxymethyl resin (3) (Scheme 1.3). 
One of the problems associated with the original resin (2) is that the 
chloromethyl group may alkylate nucleophilic side chain amino acid functions e.g 
the imidazole nucleus of histidine and the thioether sulphur atom of methionine, 
during incorporation of the C-terminal amino acid. The hydroxymethyl resin (3) 
avoids this problem, due to the possibility of employing a number of milder 
coupling reagents for the first (and subsequent) amino acids - the most commonly 
30 used being 0CC1. 
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In the early years after the introduction of SPPS a number of peptide 
sequences were encountered that proved essentially impossible to synthesise in 
good yield e.g the decapeptide corresponding to residues 65-74 of acyl carrier 
protein (ACP) 52 . 
Sheppard 53  suggested that this was a result of the incompatability between the 
nature of the polymer support and the peptide chain, that is the hydrophobic 
support is in marked contrast to the essentially hydrophilic chain. Therefore a 
solvent such as DCM, while it sufficiently swells the resin, causes the collapse of 
the peptide chain and renders it unreactive. The use of DMF, which solvates both 
the peptide chain and the support (but to a lesser extent), partially alleviates the 
problem. However DMF, while usefully promoting nucleophilic reactions, does give 
rise to other problems in SPPS (see Discussion). 
Sheppard therefore sought to develop cross-linked polyamide resin S53,54,55, 
which are fundamentally very similar in nature to the chain itself. 
While these resins are being used increasingly in synthesis, as yet they have 
been shown to exhibit no general fundamental advantage over the traditional 
polystyrene support - for although Sheppard 53 has successfully synthesised the 
ACP 65-74 peptide using polyamide resins, Merrifield 56  has also more recently 
adapted the polystyrene strategy to obtain this same product. 
Sheppard has however introduced polyamide resin supported on Kieselguhr 57 , 
and has been using this resin as the basis for his successful Continuous flow 
peptide synthesis strategy. 
1.2.4. The Peptide-Resin Unk 
• Unfortunately the introduction of the Boc group as the transient N a-protection 
in SPPS did not end the problems of peptide-resin bond cleavage during 
deprotection. 
It has been reported that the standard SPPS conditions employed for the 
repetitive removal of Boc, namely 50% TFA in 0CM, results in the loss of 
approximately 1% of the peptide per deprotection cycle. As was discussed in the 
previous section, increasing the stability of the peptide-resin link by the 
introduction of electron-withdrawing groups to the aromatic nuclei of the resin 
was shown to be unsatisfactory for general application. 
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The phenylacetamidomethyl (Pam) resin (6) of Merrifield et al 58 increased the 
stability of this link by a factor of 100 over the classical system through the 
inclusion of a 'handle' between the peptide and the resin. Merrifield's original 
synthesis of the Pam resin 58  was a time-consuming process, and stimulated the 
introduction of a much improved synthesis 59. This involves the acylation of the 
aminomethyl resin (5) (generated by the treatment of the chloromethyl support (2) 
with potassium phthalimide then hydrazine 60) with p -acetoxymethylphenylacetjc 
acid (4) using 0CC1 30. The acetyl group is subsequently removed by hydrazinolysis 
to yield the hydroxymethyl Pam resin (6) (Scheme 1.4). 
CH3CO-.0_CH2-_CH2_CO2H 	+ 	H2N-CH2 
(4) 	 (5) 
DCCI 
CH3CO-0-CH2 -K:::i-- CH2 -CONH-CH2 --fYUER 
N2H4 
HO-CH2 	 CH2-CONH-CH2 
(8) 
Scheme lÀ Syntheis of the hydrôxymethyl Pam resin (6). 
The increased stability of the peptide-resin linkage in the Pam resin is due to the 
electron-withdrawing effect of the acetamido group in the para position of the 
phenyl ring to which the peptide is attached. 
A further advantage gained by the inclusion of a 'handle' attached to the resin 
is that a 'spacer' is also introduced i.e. the distance between the peptide chain and 
the solid support is increased - hence there is a reduction in crowding of the 
polymer-bound amine sites and a greater accessibility for reagents. 
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However there is a problem with this type of resin. As peptides become larger 
and more complex, they become less stable towards the reagents used for the 
final cleavage of the peptide from the support, namely HE Therefore although the 
Pam resin has been used to synthesise large peptides, researchers have 
considered the possibility of more labile peptide-resin linkages being used in SPPS. 
The most successful such resin to date is the p-alkoxybenzyl alcohol resin (8), 
introduced by Wang 61 which was developed primarily for the synthesis of 
protected peptide fragments. 
The synthesis of (8) involves the treatment of the chioromethyl resin (2) with 
4-hydroxy-benzyl alcohol (7) and sodium methoxide (Scheme 1.5). Merrifield later 
improved this synthesis by more rigorously controlling the reaction conditions 62 






HO-CH2 	 O-CH2 
(8) 
Scheme 1.5 Synthesis of the Wang resin (8). 
The 	-alkoxy substituent of the benzyl alcohol moiety of this resin enhances the 
acid lability of the ester linkage by electron-donation - hence a solution of TFA in 
0CM 	can 	be 	used 	for 	the final 	cleavage of 	the peptide 	from 	the 	resin. 
Consequently the Na_protecting group chosen for a synthesis involving the Wang 
resin 	must be 	either more 	acid-labile (e.g. the 	Bpoc group 63 ), 	or 	alternatively, 
base-labile (e.g. the Fmoc group 41 ) (see section 1.2.5). 
An alternative approach to the development of a suitable handle was reported 
by Barany 64, when he introduced a fluoride-labile linker (9). The advantages of a 
SPPS strategy involving such a handle include the possibility of the final 
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peptide-resin cleavage being performed at neutral pH (i.e. using TBAF in DMF) and 
also it would enable a fully protected peptide to be cleaved and purified - hence a 










Investigations in this research group have led to the introduction of the 
2- (4-hydroxymethylphenyl)-2-trimetnylsilyl-propanojc acid group 65 (10) as an 
alternative fluoride-labile handle, with more recent work yielding a fully protected 
peptide corresponding to residues 1-35 of ubiquitin 36 . 
HO-CH2- - CH-CH2-0O2H 
s1(CH3)3 
 
Other handles and strategies have also been reported, for example, while both 
Rich66 and Tjoeng 67 have produced photolabile handles, Tam 68  has developed a 
multi-detachable linker for peptide synthesis, where careful selection of reagents 
has resulted in the possibility of cleavage at more than one site of the resin 
during the synthesis. 
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1.2.5. N a_Protection 
The most Commonly used amine protecting groups in peptide synthesis are of 
the urethane-type (11) due to their relatively mild deprotection requirements and 
the suppression of racemization during the activation and coupling of the amino 





Z protecting group 
The first such urethane group, the benzyloxycarbonyl or Z-protecting group 44 
(12), was introduced in 1932 and still has a key role in peptide synthesis. The 
Z-derivatives of amino acids are stable and readily prepared. 
CH2-04— 
 
Removal of the group may be achieved by a number of methods; hydrogenolysis 
and acid-catalysed solvolysis using HBr being by far the most widely used 
procedures. However the use of this group has significant limitations, for example, 
catalytic hydrogenolysis of sulphur-containing amino acids usually fails due to 
catalytic poisoning, difficulties may result in the hydrogenation of aromatic amino 
acids (particularily tryptophan), and premature peptide-resin cleavage may occur 
during repetitive Na_deprotection by acidolysis in SPPS. 
The principle alternatives to the Z- group are: 
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The tertbutyloxycarbonyl. (Boc) group 29.47  (13) is the most commonly used 
acid-labile N a-protecting group in SPPS - this is due to the ready availability of 
its derivatives and its satisfactory lability- stability characteristics (this is only the 
case in SPPS if used in conjunction with a suitable resin e.g. the Pam resin). 
Cleavage is usually performed by 50% TFA in DCM. 
0 	R 
II 
CH3 - C-O- C- NH-CH-0O2 H 
CH3 
CH3 
- CH3 -0+ + 
CH3 
TFA 	 CH3 t OH 	R 
CH3 - C-;- C- NH-CH-0O2 H 








Scheme 1.6 Cleavage of the Boc protecting group. 
A disadvantage of the Boc group is the generation of reactive intermediate 
carbonium ions (Scheme 1.6) during deprotection which may participate in side 
reactions with sulphur containing amino acids (methionine and cysteine) or the 
aromatic ring systems of tyrosine and tryptophan which readily undergo 
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electrophilic substitution. In the case of small peptides this can be overcome by 
the use of cation scavengers e.g. anisole or dimethyl sulphide 70, however, these 
may reduce the desired selectivity of cleavage and thus lower the yield of the 
product. 
Bpoc protecting group 
The 2-(4-biphenyl)isopropyloxycarbonyl (Bpoc) group (14) was introduced by 
Sieber and Iselin 71  in 1968 and displays a significantly greater acid-lability than 
that of the the Boc group. 
CH3 oo 1 11 C— 0—C-- CH3 
(14) 
Bpoc urethanes are 2000-9000 times more labile to acidolysis that Boc urethanes - 
therefore Na_deprotection  conditions of 0.2-0.5% TFA in 0CM can be employed. 
As with Boc derivatives, deprotection yields stable carbonium ions and hence 
scavengers are required. 
Although Bpoc-amino acids exhibit near ideal lability characteristics, they are 
not in general use due to their instability as free acids i.e. they must be stored as 
their acid salts and liberated before use. 
Other urethane-type protecting groups of intermediate acid-lability include the 
Ddz group of Birr72, the Tmz group of Matsueda and Stewart 73 and the Poc group 
of Ragnarsson 74. These require 3% TFA in 0CM for adequate deprotection, but due 
to the expensive nature of their synthesis, have not been generally adopted in 
peptide synthesis. 
Fmoc protecting group 
The principle base-labile 0-protecting group, the 9-fluorenylmethoxycarbonyl 
(Fmoc) group (15) was introduced by Carpino 41 , and applied to peptide synthesis 






The use of a base-labile protecting group enables an orthogonal protection 
strategy to be adopted for peptide synthesis, in that acid-labile side chain 
protection and peptide-resin linkage may be used. Hence this group has been 
employed a great deal in SPPS 76 ' 77 . 
Fmoc displays essentially complete acid stability and a quite remarkable lability 
to secondary amines. Therefore deprotection, a 8-elimination process, is generally 
effected by 20% piperidine in DMF and as no intermediate carbonium ions are 
produced with Fmoc, no scavengers are required. 
Bnpeoc protecting group 
More recently an alternative base-labile N e-protecting group, the 2,2-b/s 
(4' -nitrophenyl)ethoxycarbonyl (Bnpeoc) group (16) has been introduced by Ramage 
and Florence 78, and Valentine 79 . 





The synthesis of the protecting group is based on the observation of Kharasch and 
Clapp80  that the opening of styrene oxide with phenylmagnesium bromide to give 
either the expected secondary alcohol (17) (after attack at the least hindered 
centre) or the primary alcohol (18), is dependent on the order of addition of 
reactants i.e. the primary alcohol can be obtained in 80% yield if the oxide is 













Scheme 1.7 Reaction of styrene oxide with phenylmagnesium bromide. 
The subsequent para nitration of the phenyl rings gave 2,2-b/s (4'-nitrophenyl)-
ethanol (19), from which both the chloroformate (20) and the succinimidyl active 
ester (21) derivative can be readily synthesised (Scheme 1.8). The active ester 
derivative (21) has been used to protect the N e -functionality of a number of amino 
acids by the method of Lapatsanis 81 , or more recently by the method of Rich 82 . 
The deprotection of the Bnpeoc group, as with the Fmoc group, was found to 
proceed via a B-elimination mechanism, and is performed by the addition of either 
DBN or DBU. These are strong bases, but importantly, weak nucleophiles, hence 
the possibility of unwanted side reactions is considerably reduced. Also extremes 
of pH can be avoided by the use of a system buffered with acetic acid. 
The authors have reported Bnpeoc to be stable to the following reagents 
commonly used in peptide synthesis: TFA, HCI-methanol, acetic acid, NaOH, 
pyridine, triethylamine, N -methylmorpholine and piperidine. 
o Kc 
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H CH2-0—CO—CH3 	 H CH2 —OH 
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H CH2 —0—COd 
(20) 




Scheme 1.8 Bnpeoc protecting group synthesis. 
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1.2.6. Side Chain Protection 
The use of the acid-labile Boc N e-protection in SPPS necessitates a side chain 
protection strategy based on increased acid stability. The one in general use is 
that which involves benzyl derived protecting groups. 
In the case of serine, threonine and tyrosine, benzyl ethers may be employed. 
However as the tyrosine derivative is not completely stable to the Boc cleavage 
conditions, the 2.6-dichlorobenzyl ether group is more commonly used (an 
unwanted side reaction involves the migration of the unsubstituted benzyl ether to 
the 3 -position of the aromatic ring). 
The acidic side chains of aspartic and glutamic acids are protected using 
benzyl esters, arginine protection employs the nitro or tosyl group, histidine the 
tosyl, and lysine uses a urethane with the Z- or 2 -chlorobenzyloxycarbonyl group. 
As for cystine, the Acm 83  group is being used increasingly in synthesis. Asparagine 
and glutamine are generally left unprotected, as there is no ideal method available 
for their protection. 
If the very acid-labile Bpoc or the base-labile Fmoc protecting groups are used, 
a side chain protection strategy based on tert.butyl is more commonly employed 84 
e.g. serine and threonine are adequately protected as their tert.butyl ethers. 
As for the remaining amino acid residues, a large number of alternative side 
chain protecting groups have been reported (see reviews 85 ' 86), including a novel 
acid-labile arginine protecting group, the Pmc group 87 ' 88, developed recently in this 
research group. 
1.2.7. Coupling Methods 
The standard procedure for peptide bond formation must involve the activation 
of the carboxylic acid component of the incoming N a-protected amino acid to 
nucleophilic attack by the polymer bound amine component i.e. the hydroxyl group 






















N - R* 
H 
Scheme 1.9 Peptide bond formation. 
Ensuring complete coupling of the acid and amine components represents the 
greatest technical difficulty in SPPS at the present time. Hence many alternative 
procedures have been investigated, with the result that there are now many 
different coupling methods and reagents available to the peptide chemist. 
The ideal coupling reagent must exhibit all of the following characteristics: 
It must be easy to handle and use (of particular importance if 
automated synthesisers are to be used). 
It must result in racemization-free couplings. 
It must give rapid and efficient coupling (the degree of 
racemization is increased if the coupling is slow and 
prolonged). 
Some of the most widely used methods and reagents are discussed below: 
The Acid Chloride method 
Perhaps the most obvious choice of an electron-withdrawing group (X) is the 
chlorine atom. The high reactivity of protected amino acid chlorides had been well 
documented before the earliest days of peptide synthesis. However their use in 
peptide chemistry has been limited due to the problem of racemization (via 
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azlactone formation) occurring during the activation procedure, the high incidence 
of unwanted side reactions and the generally difficult deprotection of protecting 
groups which are stable enough to survive the conversion of a carboxylic acid to 
an acid chloride. 
Notwithstanding these drawbacks, the introduction of novel acid-stable 
0- protecting groups has led to a re-evaluation of the acid chloride methodology. 
Bechtolsheimer and Kunz 89  have employed acid chlorides (generated using 
oxalyl chloride in DCM at 0 °C) for the preparation of sterically hindered peptide 
bonds using the extremely acid-stable 2 - (triphenylphosphonio)-ethoxycarbonyl 
(Peoc) N e-protecting group 90 ' 91 . 
More recently, Carpino at al 92 have used thionyl chloride in DCM to generate 
the acid chlorides of several Fmoc-amino acids. Again these have been 
successfully employed in synthesis, and can be isolated and stored indefinitely in a 
dry atmosphere. On the question of racemization, Carpino et a/ 93 have shown that 
theacid chloride couplings of Fmoc-amino acids result in a loss of chirality of less 
than 0.1%. 
The Azide method 
This techique was first introduced in 1902 by Curtius 94 and to this day it 
remains a powerful and practical approach for the synthesis of peptides of high 
optical purity. 
0 	 0 	 0 
ii 	 H2N-N2 H 	I HONO 	II 	+ - 
R-C-0-CH3 	 - R-C-NH-NH2 	 - R-C-N=N=N 
(-cH30H) 	 (-21120) 
(22) 	 (23) 
Scheme 1.10 Preparation of acid azides (23) 
The original method involves the treatment of alkyl esters (often methyl) with 
hydrazine, and the resulting hydrazides (22) are smoothly converted to the 
corresponding acid azides (23) by the addition of nitrous acid (Scheme 1.10). 
More recent improvements have resulted in the use of diphenylphosphonyl 
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azide for the conversion of carboxylic acids to acid azides, and the use of alIkyl 
nitrites, instead of nitrous acid, for the transformation of hydrazides to azides. 
These modifications however, have had little effect on the inherent 
shortcoming of the azide method, that is the side-reaction involving the 
conversion of acid azides to isocyanates by the Curtius rearrangement. Therefore if 
the azide coupling method is to be successful, a number of precautions must be 
taken: the reaction must be performed at low temperature, with a high 
concentration of reactants, and the coupling step must immediately follow the 
preparation of the azide. 
The Carbodiumide Method 
The usefulness of this procedure for peptide bond formation was first 
recognised by Sheehan and Hess 30. Merrifield employed the 
N,N'-dicyclohexylcarbodjimide (DCCI) (24) coupling reagent when he first 
introduced SPPS 28, and it remains the most widely used in peptide synthesis. 
The mechanism of DCCI-mediated coupling reactions was first investigated by 
Khorana 95 ' 96, and more recently discussed by De Tar et al . These studies have 
shown that the ractions pi
. 
 oceed rapidly due to the high activation afforded by 
the O-acyl urea (25) which is formed (Scheme 1.11). 
However this isourea spontaneously rearranges to the unreactive N-acyl urea 
(26), and leads to the loss of N a -protected amino acid from the coupling reaction. 
The rate of this undesirable rearrangement can be troublesome in polar aprotic 
solvents such as DMF, and hence DCCI-mediated couplings require the use of the 
minimum volume of such solvents. 
The high degree of activation afforded by the 0-acyl urea can also lead to the 
formation of azlactones. This is not considered a serious problem if the species 
being activated is a single amino acid with urethane-type N e-protection (hence 
the suitability of DCCI to SPPS), but can result in racemization if used in a 
98 fragment condensation procedure.
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Scheme 1.11 DCCI-mediated coupling mechanism. 
More recently, diisopropylcarbodiimide (Did) 99 has become commercially 
available, and has gained increasing popularity with peptide chemists. This 
carbodiiimide is a liquid and hence much easier to handle than DCCI which is a 
waxy solid. Also the byproducts, diisopropyiurea and the N-acyl ureas, are more 
soluble than their DCCI counterparts, and therefore can be removed more readily 
and efficiently from the reaction system (of particular importance in SPPS). 
One further point to note is that DCCI (and DICI) cannot be used to couple 
asparagine and giutamine that have no side chain protection, as this results in the 
100 dehydraton of the side chain amide to the corresponding nitrile.
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The Preformed Symmetrical Anhydride Method 
Preformed Boc-amino acid symmetrical anhydrides (27 )95 have been reported 
as resulting in the greatest coupling yields in many difficult sequences. 
Their preparation can be performed using phosgene, but is more usually carried 
Out using condensing agents such as carbodiimides (e.g. DCCI) (Scheme 1.12). 
Boc-amino acid symmetrical anhydrides are not stable and therefore they must 
be prepared immediately before use. While this is of little inconvenience in 
solution phase peptide synthesis and manual SPPS, it causes significant problems 
with storage, transfer etc. in automated synthesisers. In contrast Fmoc-amino acid 
symmetrical anhydrides have been reported as being stable and hence can be 
prepared in advance and stored until they are required. 
Q 
R 0 	 R 0 	NH 
DCCI 	 I 	I I 




ii 	 R 
Boc-NH-CH-C-OH 	 I 	/ 






Scheme 1.12 Preparation of symmetrical anhydrides. 
Disadvantages associated with the use of such anhydrides include the slow and 
incomplete couplings experienced when anhydrides of hindered amino acids (such 
as valine, isoleucine and threonine) are reacted with sterically hindered 
polymer-bound amine sites, and also the wastefulness of the symmetrical 
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anhydride procedure in that it requires 2 moles of (expensive!) Na_protected amino 
acid to generate 1 mole of the symmetrical anhydride. 
The Active Ester method 
At the very beginning of synthetic peptide chemistry, peptide bonds were 
prepared using amino acid methyl and ethyl esters as acylating agents. Both 
Fischer 101 and Curtius 102 prepared peptides by this approach. 
However Schwyzer at a! 103 recognised that by increasing the 
electron-withdrawing effect of the alcohol component of the ester, the 
electrophilic character of the carbon atom is increased and therefore becomes 
more susceptible to attack by nucleophiles e.g the amino group of the amine 
component. Thus he introduced the cyanomethyl esters (28) for use in peptide 
synthesis. However although used with limited success, they have not been 
generally adopted as satisfactory reaction rates are only obtained if the reactants 
are applied in high concentration. 
Aryl esters proved to be more promising, with the most popular derivative 
being that reported by Bodanszky 104 , the p-nitrophenyl active ester (29). 
0 
I' 




These esters (29) can be prepared by treatment of the Na_protected amino 
acid with either p-nitrophenyl sulphite or phosphite 105, or by condensation with 
g-nitrophenol using 0CC1 106 . They are easily purified, crystalline solids and couple 
under mild conditions (although the reaction rate is dependent on the nature of 
the solvent and some racemization difficulties have been reported 107 ). 
However these esters were largely superceeded by the introduction of the 
active esters of 1-hydroxybenzotriazole (HOBt) (30) of Konig and Geiger 108, and 











Following the dramatic improvement in the rate of solution phase coupling 
reactions involving HOBt active esters, whether in catalytic (with p-nitrophenyl 
active esters) or equimolar quantities, this procedure was successfully applied to 
SPPS. These esters may be preformed or generated in Situ, and in the example of 
coupling asparagine and glutamine, HOBt esters have been commonly adopted 
without the need for protection on the side chain amide. 
N-hydroxysuccinimide esters have attained increasing practical importance and 
successful application in both solution and solid phase peptide synthesis. Their 
high reactivity results in the preparation of the desired peptides with the expected 
ease - however their application is not without problems; the succinimide 
carbonyls are not entirely inert toward the amine component. An attractive feature 
of the use of this method, however, is that the byproduct formed, 
N-hydroxysuccinimide, is water soluble and readily removed from the reaction 
system. 
This is by no means an exhaustive list of the active esters available for use in 
peptide synthesis - for example, the trichlorophenyl 110 and the 
pentachloro(fluoro)phenyl 111  esters have also been employed extensively. 
I 
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The Mixed Anhydride method 
The use of mixed or unsymmetrical anhydrides (32) for peptide bond formation 





One of the first examples investigated involved the use of benzoyl chlorides 
(R'= Ph) 112,113 
0 	 0 
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Scheme 1.13 An example of the use of mixed anhydrides in peptide synthesis. 
• However these were found to be 	unsatisfactory 	due to the 
electron-withdrawing effect of the phenyl group. This effect renders the adjacent 
carbonyl carbon sufficiently electrophilic to compete in the acylation reaction. 
More satisfactory results were obtained when electron-donating R' groups were 
used e.g mixed anhydrides formed from isovaleric 114 and trimethylacetic 
(pivalic) 115 acid chlorides (33) were shown to couple in excellent yield (Scheme 
1.13). 
This is not only due to the electron-donating effect, of the R' groups, but also 
the increased steric bulk of these groups promote the attack at the carbonyl 






Mixed carbonic anhydrides (34) have also been introduced. Examples of these 
now commonly employed include the ethylcarbonic 116117 and the improved 
isobuty1carbonic 18 acid mixed anhydrides, and they remain a valuble asset to the 
peptide chemist. 
The problems with mixed anhydrides are their tendency towards 
disproportionation to symmetrical anhydrides 117, and the possibility of 
racemization. The former can largely be avoided by employing low temperatures 
for the anhydride preparation and the latter by the use of short activation times 118 
(less than 10 minutes) with the minimum quantity of tertiary amine present during 
their generation. 
Mixed anhydrides with organophosphorus acids have more recently received a 
great deal of attention and will be discussed in Section 1.3. 
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1.3. Organophosphorus coupling reagents in peptide synthesis 
1.3.1. Introduction 
Mixed carboxylic anhydrides of N a-protected amino acids (34), as discussed in 
the previous section, have been employed extensively in both solution and solid 
phase peptide synthesis 119 . 
0 0 
II 	Ii 
R — C—O—C—O—R' 
ft 
a 	b 
R -- NI-12  
(34) 
The choice of group (X), based on a consideration of steric and electronic 
factors, is an important one. It must promote attack by the amine component 
(R"NH 2) at position a therefore yielding the desired peptide bond, rather than at 
position A which would result in reduced yields and unwanted byproducts. 
The advantages of this methodology, not least of which is the relatively fast 
nature of the couplings involved (important if the amine component has a limited 
lifetime e.g if it is a dipeptide ester favourably disposed toward cyclisation to a 
piperazine-2,5-dione), have resulted in the repetitive excess mixed anhydride 
(REMA) method becoming increasingly popular with peptide chemists. 
Problems with this method include the facile thermal disproportionation of the 
mixed anhydrides and the occurence of racemization. However a further limitation 
concerns the size of the groups R' and R", for if they are bulky, the unwanted 
reaction at position b may become competitive 120 . 
Researchers, have therefore sought a class of anhydrides that would not only 
be more stable to disproportionation but which would react with nucleophiles only 
at the desired carbonyl. It was also noted that stability and crystallinity of the 
anhydrides would be an added advantage. 
One approach that has been studied extensively in recent years is the use of 
anhydrides derived from organophosphorus acids. The role of such reagents in 
34 
carbonyl activation has been reviewed 121  and continuing developments in this area 
are periodically collated 122 . 
1.3.2. Anhydrides with Phosphoric acid derivatives 
Research in this area was stimulated by ihe early hypothesis by Lipmann 123 
that the formation of the peptide bond in living cells may be ascribed to 
energy-rich acyl phosphates derived from amino acids. This led to Chantrenne 124 
and, later, Sheehan 125  studying the potentialities of the mixed anhydrides (35) and 
(36) respectively, in peptide synthesis. 
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The reaction of phthaloylglycyl chloride and dibenzylphosphate afforded (36) in 
good yield, and peptide derivatives were prepared using this acyl phosphate at pH 
7.4 and 37 0C i.e. approaching physiological conditions. 
Cramer and Gartner 126  found that the reaction of acylamino acids with the enol 
phosphate (37) provided the 0,0-diethylphosphoric mixed anhydride (38) and that 
this could be used in peptide synthesis (Scheme 1.14). Interestingly, no 
disproportionation to the symmetrical anhydrides was observed despite the initial 
reaction being carried out at 70 ° C. 
An alternative strategy was introduced by Zervas et a! 127  when he employed 
diphenyl phosphorochioridate to form the mixed anhydride (39) which gave 
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Diphenylphosphorazidate 	(40)' 28 	(prepared 	by 	the 	reaction 	of 
diphenyiphosphoric chloride and sodium azide in acetone) and 
di ethyl- phosphorocyanidate (41) 129 (from an Arbusov reaction between triethyl 
phosphite and cyanogen bromide) were introduced as coupling reagents by Shiori 












These reagents were shown to be effective in peptide bond formation in both 
solution and solid phase synthesis. However using (40) in the Young test 130, that is 
the formation of B2-Leu-Gly-OEt in which the oxazalone might be expected to be 
an intermediate, the optical purity of the product was found to be only 89%. The 
lzumiya test 131 , involving the condensation of Boc-Gly-Ala-OH with H-Leu-(resin), 
was employed to determine the viability of this reagent for fragment couplings in 
solid phase work. After deprotection to give H-Gly-Ala-Leu-OH, it was shown that 
the extent of racemization was 2.5% at 20 °C and 2.0% at 0 °C. No difficulties were 
encountered with functional side chains such as serine, threonine, asparagine, 
glutamine, histidine, methionine, tyrosine and tryptophan. 
With reagent (41) even less racemization was observed in the Young test (96% 
optically pure) and in the lzumiya test (1.0% racemization at 20 °C and 0.5% at 0 °C). 
However, whilst the anhydrides derived from 0,0-dialkyl and 0,0-diaryl 
phosphoric acids have previously been employed in peptide synthesis, they have 
failed to gain widespread acceptance. 
1.3.3. Anhydrides with Phosphinic acid derivatives 
More recently researchers have turned their attentions toward the analogous 
phosphinic-carboxylic mixed anhydrides. The following considerations suggested 
that these anhydrides may be useful intermediates in peptide synthesis: 
1. The cyclic system (42) (Scheme 1.15) undergoes aminolysis at 
the carbonyl group a but alcoholysis occurs by attack at 
phosphorus b 132  This change in regiospecificity depending on 
the nature of the nucleophile is entirely compatible with the 





















Dimethylphosphoryl chloride (43) has been shown to be less 
reactive toward oxygen nucleophiles than dimethylphosphinyl 
chloride (44)133• The rate of solvolysis of (44) in absolute 
alcohol is 300 times as fast as that of (43), which would 
suggest that phosphinyl chlorides should react with carboxylate 
anions to form mixed anhydrides 134 very much faster than 
phosphoryl chlorides. 
0 	 0 
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Published evidence suggested that phosphinic-carboxylic mixed 
anhydrides are more stable to disproportionation than mixed 
carboxylic anhydrides 135 . 
It was with this limited knowledge that Ramage et a! 136,137 introduced the readily 
available diphenylphosphinyl chloride (Dpp-CI) (45)1 38 as a means of preparing 
phosphinic-carboxylic mixed anhydrides (46). 
In an attempt to determine the relative reactivity of mixed carboxylic 
anhydrides and phosphinic-carboxylic mixed anhydrides 136, the lzumiya test 
sequence 131 was applied using both pivalic 115 and Dpp mixed anhydrides. Since 
this test is a measure of the racemization derived from an oxazolone intermediate, 
it gives a measure of the electron density on the terminal peptide carbonyl group. 
The extent of racemization found for Dpp (5.7%) and pivalic (2.6%) mixed 
anhydrides indicated a greater activation in the phosphinic example. 
The standard conditions for the use of Dpp-Cl (45) in stepwise peptide 
synthesis involves the initial formation of the mixed anhydride at -20 °C in DCM (or 
EtOAc) using NMM as base. After 20 minutes the amino component is added and 
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Scheme 1.16 Diphenylphosphinic anhydrides in peptide synthesis. 
The yields of crystalline products and the ease of purification were shown to 
be generally superior to those involving mixed carboxylic anhydrides. 
Subsequent 31 P n.m.r. studies 134 found that the rates of disproportionation of a 
series of phosphinic-carboxylic mixed anhydrides were insignificant from a 
preparative point of view in comparison with aminolysis at 0 °C. 
Also these studies, as well as proving that mixed anhydride formation with 
Dpp-Cl was almost instantaneous, confirmed that the resulting anhydrides react 
rapidly with a nucleophilic amine to form the desired peptide bond i.e. because the 
amino group has a greater affinity for the carbonyl group rather than the 
phosphorus centre, attack occurs regiospecifically at the carbonyl centre. 
The initial investigations with diphenylphosphinic mixed anhydrides had shown 
that the extent of racemization that had occured during the coupling of 
Z-GIy-Ala-OH to H-Leu-OBzl (i.e. the Izumiya test sequence) was 5.7%. 
Galpin et a/ 139  chose to study further this racemization process by considering 
the activation and coupling of N-methylated amino acids. Some research has 
found these to be particularly susceptible to racemization during coupling with 
DCC1 140 ' 141  (it should be noted that Benoitin has reported exceptions to this 142 ), 
however with HOBt and HONSu as additives, problematic oxazolone formation has 
been minimised. The researchers found that within the limits of the proton n.m.r. 
method 141 ' 143 they employed, no racemization was observed when urethane 
protection was used for the N-methylated amino acids. However if the benzoyl 
group was employed for protection, this led to extensive racemization. 
The use of diphenyiphosphinic mixed anhydrides in manual SPPS was initially 
reported by Galpin et al 144.145 
The researchers confirmed that there were no problems with 'wrong-way' 
opening (in SPPS, attack by the amine component at P=O instead of C=O would 
result in chain termination, whereby the extending amino terminus would become 
blocked as the corresponding diphenylphosphinamide) or thermal 
disproportionation. In fact, 31 P and 13 C n.m.r. studies had shown that the 
Z-Gly-ODpp mixed anhydride was stable for at least 48 hours at room temperature 
in CD3CN, and after that time, the mixed anhydride had retained its potential for 
promoting acylation (e.g it reacted immediately with benzylamine). This is in 
marked contrast to the related pivalic anhydride of the same amino acid derivative, 
which displayed some disproportionation after 30 minutes at 0 °C. 
Galpin at a/ subsequently employed diphenylphosphinic mixed anhydrides in the 
synthesis of the protected and unprotected derivatives of the Bombesin-like 
peptide sequence (47), using a phenolic resin 146 ' 147 and Bpoc Na_p rotec tion it . 
H —Ala— Pro—Vol —Ser—Val —Gly—Tyr—OH 
(47) 
Results in this research group on the application of diphenyiphosphinic mixed 
anhydrides to SPPS 18, have suggested that the byproduct from the coupling 
reaction, diphenylphosphinic acid, forms a salt with the liberated amino 
component, thus removing the latter from the reaction and reducing the efficiency 
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of the coupling. To counteract this, one further equivalent of base was added to 
the reaction mixture after the activated amino acid and the NMM had been added 
to the amine component. The base used was 2,6-lutidine (2,6 - dimethylpyridine) 
which was thought sufficiently weak so as not to abstract an cz-proton from the 
amino acid residues, but strong enough to neutralise any diphenyiphosphinic acid. 
Although Dpp-CI has been successfully employed in both solution and in 
manual SPPS, the search continued for a phosphinic chloride with all the 
aforementioned advantages of Dpp-Cl, but whose corresponding acid - formed as 
a byproduct of the acylation reaction - would be water soluble, thereby permitting 
its ready removal from the final reaction mixture. Diphenyiphosphinic acid 
(Dpp-OH) has occasionally proved troublesome in this respect. 
One possible alternative, 1 -oxo-1-chlorophospholane (Cpt-Cl) (48), was 




Me2 -../ "ci 
(49) 
Cpt-Cl was shown to be an efficient promotor of peptide bond formation 
through phosphinic-carboxylic mixed anhydrides, with the byproduct, Cpt-OH, 
readily removed from the reaction system to leave peptides of high quality and 
requiring the minimum of purification. Regiospecific attack by amine on the mixed 
anhydride and stability to disproportionation at 0 °C were also confirmed. 
Later work had demonstrated that the mixed anhydrides derived from Cpt-Cl 
have greater stability than those of Dpp-CI and to the suitability of this reagent to 
fragment coupling has been postulated. However this reagent is expensive and 
time-consuming to prepare. It is hoped therefore, that the recently introduced 
1-oxo-1-chloro-3,4-dimethyl-3-phospholene (49)38 which is more readily prepared, 
will be of some use in the mediation of amide bond formation. The preliminary 
results 38 appear promising. 
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1.3.4. Anhydrides with Phosphorous acid derivatives 
A great deal of work on this class of anhydride has been reported. Examples 
include diethyl chlorophosphite (50) and tetraethyl pyrophosphite (51) introduced 
by Anderson et al 150, both of which have been employed in peptide synthesis, but 
there are many others. Reagent (51) is preferred to (50) due to its simpler 







For other examples - see aforementioned reviews 121.122 
1.3.5. Other phosphorus reagents useful in peptide synthesis 
+ 	+. 
(Ue2 N)3P-0—P(N Me2)3. 
2 CH3 —aSO3 
(52)  
+ 	/N, 
(Ue2N)3P-0— N 	N PF6 
b 
(53) 
Again, many possible coupling reagents have been reported - see 
reviews 121, Noteworthy examples include the Bates' reagent (52) of Ramage et 
al 151  and the BOP reagent (53) of Castro 152 ' 153 . 
An alternative approach was reported. by Ueki et al 154  when he introduced 
dimethylphosphinott'iioyl chloride (54) (Mpt-Cl) as a reagent for the preparation of 
dimethylphosphinothioic mixed anhydrides (55). 
It was found that the preparation of the mixed anhydrides could be performed 
in polar, protic solvents e.g. MeOH. MeOH cannot be used in traditional peptide 
bond formation reactions due to its high reactivity toward the activated amino acid 
derivatives. The applicability of this reagent has been demonstrated by the 
synthesis of sparingly soluble C-terminal segments of vasoactive intestinal peptide 
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(VIP) up to the heptapeptide stage. 
II 	 I 
(Me)2 P—CI 	 R'—NH—CH—C—Q—P(Mø)2 
[,J 
(54) 	 . 	(55) 
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1.4. Glycopeptides and glycoproteins 
1.4.1. Introduction 
Chemical and biochemical researchers had long considered proteins and 
carbohydrates to be two distinct classes of natural products, and due to the belief 
that biological specificity could be attributed to proteins, with carbohydrates 
largely serving only a secondary role as structural and protective moieties, or as 
energy sources, protein research had enjoyed by far the greater attention. 
It is only since the 1950's that the existence, and the diversity, of a novel class 
of ubiquitous natural products, the glycoproteins, has been proved. These 
substances, in which proteins are bound covalently to carbohydrate units, have 
been found to occur in cells both in soluble and membrane-bound forms, as well 
as in the intercellular matrix and the extracellular fluids. 
In fact, early researchers working on the isolation and determination of protein 
and carbohydrate structures often went to some length to remove what they 
thought were sugar 'impurities' from proteins and protein 'impurities' from 
polysaccharides. Now it seems many proteins (and many polysaccharides) exist in 
vivo as glycoproteins, and far from being biologically insignificant, there is 
evidence to suggest that the carbohydrate moieties perform important biological 
functions, for example, in the stabilisation of protein conformation - hence 
stabilisation of activity, the specification of blood types, the control of the lifetimes 
of glycoproteins in the circulatory system of higher animals, and the control of 
glycoprotein uptake by cells. 
While research has shown there is a vast number of natural glycoproteins, 
there is seemingly little variation in the type of linkage employed between the 
protein and carbohydrate units 155. The principle linkages concern the formation of 
a covalent bond between the anomeric centre of a carbohydrate residue, and the 
amide of the side chain of an asparagine residue, or the side chain hydroxyl 
functions of serine and threonine residues. The former are collectively known as 
N-glycoproteins, the latter as 0-glycoproteins. 
There are at least 200 monosaccharides known to occur in nature, however, 
only a limited number of these (about 20) have been shown to be present in 
glycoproteins. These are mostly hexoses or their simple derivatives, such as 
N-acetylhexosamines and uronic acids. In addition to these some animal 
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glycoproteins have been shown to contain the more complex sugars, the sialic 
acids. More than 20 different sialic acids (derived from the nine-carbon 
straight-chain sugar, neuraminic acid 156) have been identified, including 
N-acetylneuraminic (the most common) and N-glycolylneuraminic acid. 
The carbohydrate moiety need not just be a monosaccharide unit, 
oligosaccharides and polysaccharides, in which the carbohydrate moieties are 
linked through 0 -glycosidic bonds, are also found in abundance. In glycoproteins 
such as serum glycoproteins, the carbohydrate unit is an oligosaccharide 
consisting of up to 20 monosaccharides, generally arranged in branched sequences 
with no repeating structures. The proteoglycans, such as chrondroitin sulphate and 
dermatan sulphate, contain linear units of 50 to 100 carbohydrate residues made 
up of repeating disaccharide structures. 
One point to note is that carbohydrate moieties which cross-link protein chains 
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The most common N-glycoprotein involves asparagine bound through a 
-N-glycosidic linkage to N-acetylglucosamine (56). Examples in nature of this 
linkage include immunoglobulins, hormones (e.g chorionic gonadotropin); hormone 
precursors (e.g. thyroglobulin) and membrane glycoproteins (e.g. glycosyl 
tra n sfe ra $ es). 
The biosynthesis of these N-glycoproteins (56) has been investigated at some 
length 157, and it has been found that they are further characterised by a common 
sequence in the connecting region: N-glycosylated asparagine appears to be 
always followed by a serine or threonine residue at the next but one C-terminal 
amino acid. It is thought that the hydroxyl function of this residue catalyses the 
158 . glycosyl transfer 
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Recent studies have confirmed the existence of alternatives to the type (56) 
N-glycosiciic linkage. Investigations of cell surface 'glycoproteins of halobacteria 
have shown that they contain N-glucosyl- 159 and N -galactosaminylasparagine 160  
and also the involvement of glutamine as a binding partner has been postulated 161 . 
Proteoglycans of the extracellular matrix and connective tissue display a 
characteristic B-O--glycosidic protein to carbohydrate linkage between xylose and 
serine (57). On the other hand, the linkage between N -acetylgalactosamine and 
serine (and threonine) (58), is commonly an a-O-glycosidic bond. Although this 
connecting element was first reported as present in mucous glycoproteins 
(mucins) 155, it is characteristic of many other membrane and serum glycoproteins, 
including the blood group glycoproteins 162, human glycophorin 163, and the 
glycoproteins of the tumor-associated T N  and T antigens 164 . 
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In glycoproteins which contain more than one N-glycosidic unit, several amino 
acids separate the points of attachment of the carbohydrate moieties. In contrast, 
0-glycosidic chains may be attached , at adjacent amino acid residues. In 
glycophorin 163, for example, residues 2 to 4 and 10 to 15 are all hydroxyamino 
acids with attached carbohydrate units, and residues threonine-25 and 
asparagine-26 are 0- and N-glycosylated respectively. 
The highest concentration of serine and threonine residues with attached 
carbohydrate units is found in two classes of substance. One is the class of 
glycoproteins known as antifreeze glycoproteins (AFGPs) 16566 (see below). These 
are polymers of the monomer unit, Ala-Ala-Thr, with all the threonine residues 
substituted with the galactosyl- 81 - '3-N-acetylgalactosamine disaccharide. The 
other is ovine submaxillary mucin, in which one in every three residues is either 
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serine or threonine with an attached N -acetylneuraminyl-c2--6-N-acetyl-
galactosamine unit. 
The large variation in both size and number of otigosaccharide chains has 
resulted in glycoproteins with very different proportions of carbohydrate present 
i.e. from 1% (e.g collagen) to 85% (soluble blood group substances) carbohydrate. 
1.4.2. Glycoprotein biosynthesis 
The polypeptide chains of glycoproteins are produced in the same manner as 
non-glycosylated proteins. Their structure is therefore determined by information 
contained in the genetic code and as a result all the molecules of a given protein 
are chemically identical. Oligo- and polysaccharides, on the other hand, whether 
free or covalently bound to polypeptide chains in glycoproteins, are not primary 
gene products. 
The attachment of carbohydrate moieties to polypeptide chains is a 
co-translational event, catalysed by enzymes that permit the transfer of saccharide 
units from nucleotides, known as glycosyltransferases. These glycosyltransferases, 
for example, sialyltransf erases and galactosyltransferases, act in a stepwise 
manner, with the product of one enzymically controlled process acting as a 
substrate for the following one. The identity of the carbohydrate sequence is 
therefore controlled indirectly by the properties of the glycosyltransferases, which 
are themselves primary gene products. However, this method of synthesis results 
in micro heterogeneity within the carbohydrate unit 167, and thus renders the 
isolation and characterisation of natural glycoproteins difficult. 
One further point to note is that examples of carbohydrate units being added 
nonenzymically to proteins in viva are known 168 . 
Until the. 1970's it was thought that all the carbohydrate units of glycoproteins 
were produced by this stepwise transfer of monosaccharides from nucleotides to 
the growing oligosaccharide structures. White this appears to be the case in the 
synthesis of 0-glycosidic units, researchers 168 have demonstrated an alternative 
mechanism for the process of N-glycosylation. The existence of a lipid-linked 
oligosaccharide or "G-oligosaccharide" precursor, central to the in viva process, 
has been discovered. 
The formation of this G-oligosaccharide, which consists of two residues of 
N-acetylglucosamine, nine residues of mannose, and two or three residues of 
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glucose, is controlled by the dolichol phosphate cycle. The function of these 
lipid-linked saccharides appears to involve the transfer of the hydrophilic 
carbohydrates into or through the hydrophobic membrane to a position where the 
formation of glycoproteins occurs. 
The G-oligosaccharide is attached to the side chain of an asparagine residue of 
the growing polypeptide chain. The subsequent removal of some of the 
carbohydrate units of the oligosaccharide, by -glycosidases and -mannosidases, 
and incorporation of additional saccharide residues, by glycosyltransf erases, results 
in the formation of the required glycoproteins. 
This is by no means a lengthy consideration of the extensive process of 
glycoprotein biosynthesis. Reviews 168 ' 169 can furnish the reader with much greater 
detail. 
Biological significance of g lycoproteins 
Cellular biological and biochemical investigations have clearly demonstrated the 
fundamental biological functions that glycoproteins perform. 
Although glycoproteins are widely distributed, both as soluble and 
membrane-bound forms, perhaps their most important roles are in 
post-translational biological selectivity, particularly in biological recognition 170, and 
in cell differentiation and the regulation of cell growth 171 . 
Studies of human erythrocytes and lymphocytes have demonstrated the 
amphiphatic nature of cell-membrane glycoproteins, that is, in addition to the 
hydrophilic sections commonly present in soluble proteins, they contain a 
hydrophobic region that anchors them to the lipid bilayer. Biological selection 
processes, which occur predominately on the intracellular and outer-cell 
membranes, are responsible for the transportation of a recently synthesised 
protein to its required location. In eukaryotic cells at least, glycoproteins perform 
an important function in this post-translational biological selectivity which is 
clearly based on a receptor-effector interaction 155 . 
Researchers have investigated at some length the functions of the 
carbohydrate moieties of both soluble and membrane-bound glycoproteins - for 
some examples, see above. 
It is important to be aware that the glycosylation of proteins is an expensive 
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procedure for an organism to perform. It requires a considerable amount of 
genetic information, the synthesis of enzymes, cofactors and intermediates, and 
the expenditure of much energy. Hence the inclusion of a carbohydrate unit must 
be of considerable value to the cell. 
Carbohydrates in soluble glycoproteins apppear to perform a variety of 
functions. In particular, they may alter the physicochemical properties of the 
protein by changing its hydrophobicity, electrical charge, mass and size. However, 
although the sugar rarely affects the biological activites of the protein 172 , it may 
act as a recognition marker on soluble glycoproteins. This has been demonstrated 
by the control of the lifetime of serum glycoproteins in the circulatory system and 
their uptake into liver cells. 
Glycoproteins, especially if they are carbohydrate rich, are more resistant to 
proteolysis in vitro than are non-glycoslated proteins 172 . Also if the sugar content 
is very high (particularly if considerable amounts of sialic acid are present), the 
conformation of the protein may be altered. 
Cell-surface glycoprotein carbohydrate units have been shown to perform roles 
in intercellular adhesion, which is an important stage in fundamental biological 
processes such as fertilization and cellular differentiation 167, as well as serving as 
initial attachment sites for viruses 173 . 
1.4.4. Antifreeze glycoproteins 
A unique class of serum proteins, the antifreeze glycoproteins (AFGPs) 16566 , 
are found in some Antarctic and Arctic fish species and overwintering insects. 
These glycoproteins depress the freezing point of the aqueous body fluids (and of 
water) by means of a non-colligative mechanism 17475, without significantly 
lowering the melting temperature 176. One third of the freezing temperature 
depression in the blood sera of the Antarctic fish species, Trematomus 
borchgrevinkL is attributed to the presence of these antifreeze glycoproteins 177 . 
To date eight closely related glycoproteins and glycopeptides have been 
identified, numbered 1 to 8 (AFGP 1 to 8) in order of decreasing size according to 
their relative migrations on gel electrophoresis. AFGP 1 to 5 (m. wt. 10500 to 
32000) have similar antifreeze capabilities and are polymers of the monomer, 
Ala-Ala-Thr, with each threonine residue substituted with a galactosyl 
- B1 - 3-N-acetylgalactosamine disaccharide unit. AFGP 6 to 8 have basically the 
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same repeating monomer, except that proline residues are often present after the 
threonines. They have smaller molecular weights (2600 to 10000), are found in 
larger quantities than AFGP 1 to 5 and by themselves exhibit lower antifreeze 
activities 178 
Research has shown, however, that the largest freezing point depression values 
are obtained with mixtures of AFGP 1 .  to 5 and 6 to 8 i.e. there appears to be a 
cooperative function between the two different components 179 . 
It should be noted that a class of nongylcoprotein polypeptides (AFPs) 180181 
exist, which, although containing no carbohydrate, also depress the freezing. 
temperature of water non-colligatively. They display a unique compositional 
similarity to AFGP, in that approximately two thirds of their amino acid content is 
alan i ne. 
1.45. Glycopeptide synthesis 
Introduction 
Perhaps the most attractive strategy for the synthesis of glycopeptides would 
involve the coupling of the peptide and carbohydrate moieties following their 
separate preparation by established methods. However, this method has been 
hampered by the lack of reliable methods for the stereoselective introduction of 
the glycosidic linkage and by the limited solubility of peptides in solvents which in 
turn determine the outcome of the glycosylation reaction. Therefore the most 
practical approach to date involves the preparation of adequately protected N- and 
0-glycosyl amino acid derivatives, followed by extension from either or both of 
the C- and N-terminals. One advantage of this method is that the final 
glycopeptide may contain both glycosyl and non-glycosylated serine, threonine 
and asparagine residues. 
Glycopeptide synthesis requires protecting groups in order to direct the site of 
required reaction, that is, in the case of the carbohydrate moiety, the anomeric 
centre must be selectively exposed and functionalised, and with the amino acids, 
protecting groups must be chosen in order to selectively protect and deprotect 
both the amine and carboxyl terminals. In short, the problems of peptide and 
carbohydrate chemistry merge in the syntheis of such polvfurtctional molecules. 
The requirements of glycopeptide synthesis can therefore be summarised as 
follows: 
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deprotection of peptide residues to permit coupling at the C-
and N-terminals must be both selective 'and compatible with 
the traditional carbohydrate hydroxyl protecting groups (i.e. 
benzyl ethers and acetates). 
protecting group and coupling methodology must permit the 
glycosidic linkage to be formed stereoselectively and to be 
retained unchanged during the course of the synthesis. 
amino acid protecting groups must be acid stable due to the 
acid-catalysed nature of the glycosidation reaction. 
The stability of the glycosidic linkage itself must also be considered. The 
N-glycosidic linkage is relatively stable to mild acid, but is hydrolysed under harsh 
conditions. The various 0-glycosidic linkages are also acid-labile, and differ 
markedly in their sensitivity to base 182 (they are cleaved by base by a reaction 
known as B-elimination). Recent investigations have shown that the lability of the 
0-glycosidic linkage appears to be dependent on the structure of the glycopeptide 
itself (see review 183 ). 
The synthesis of oligosaccharides represents a separate area of chemistry and 
has been the subject of many recent reviews184185, however, it will not be 
considered further here. The synthesis of N- and 0-glycopeptides has been 
comprehensively reviewed in 1985186  and 1983187 respectively, and again in 
1987183. The work of this project does not involve N-glycopeptide synthesis, and 
therefore only the more significant methods and recent advances in 
0-glycopeptide synthesis will be discussed. 
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The -glucosyl-senne/threonine linkage 
The 8 - glycosidic linkage between carbohydrate residues and serine (and 
threonine) side chain hydroxyl functions is found extensively in the glycoproteins 
of fungi, animals and plants. Xylosylserine derivatives of the type (57), for example, 
are especially characteristic of the animal proteoglycans, and have been prepared 
by Lindberg at a! under Koenigs-Knorr glycosylation reaction conditions 188 ' 189 . 
However, in plants and fungi, other carbohydrates commonly occur as connecting 
partners. 
The use of Koenigs-Knorr 190, or the modified Helferich 191 , conditions has been 
extensive in glycopeptide synthesis, and a number of syntheses are discussed. in 
the aforementioned reviews 186187 . One noteable example concerns the synthesis of 
the glycotripeptide alanyl-(O- B-D -galactopyranosylseryl)-alanine, by van Boom at 
al 192.  The glycosylation of the (9,10-anthraquinon-2-yl)methyl (Maq) ester 193  (see 
below) of Fmoc-serine and threonine (59) with 2,3,4,6-tetra-0-acetyl--D-
galactopyranosyl bromide (Ac 4aGal-Br) (60). was initially attempted using the 
Helferich modification of the classical Koenigs-Knorr method. However, low yields 
of the desired product (61) were obtained even when the mercuric cyanide was 
activated by the addition of mercuric bromide 184 . It was only when pure mercuric 
bromide and two equivalents of the monosaccharide were used that acceptable 
results were obtained (Scheme 1.17). 
Modern variants of the Koenigs-Knorr reaction have also been used in the 
synthesis of 0-glycosylserine (and threonine) linkages. Kunz at at for example, 
have successfully employed the silver trifluoromethanesulphonate (silver triflate) / 
tetramethyl urea method to couple the 2-bromoethyl ester 194  of Z-serine 195 and 
the benzyl ester of Fmoc-serine (62)196 to -D-glucopyranosyl bromides (63) to 
give protected glucosylserine derivatives (64) (Scheme 1.18). 
The trifluoromethanesulphonic (triflic) anhydride method has also been 
employed. Both Gobbo at a! 197  and Lacombe and Pavia 198, have synthesised 
glycosylthreonine derivatives in good yield. However, in both cases the authors 
have reported that a mixture of the a and B anomeric products are obtained, and 
these have to be separated. It is interesting to note that Lacombe and Pavia chose 
threonine, rather than serine, for their glycosylation reactions. This is because of 
the presence of a methyl group on the former, which enables the stereochemistry 
of the anomeric linkage 199 and the racemization at either or both the asymmetric 
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Alternatives to the Koenigs-Knorr method have also been reported. The 
xylopyranose (65), for example, has been treated with the allylic ester of Z-serine 
(66) by means of the trichioroacetimidate method 185,201 to give (67) in good 
yield 202 (Scheme 1.19). This product (67) has also been obtained by the reaction of 
the xylopyranosyl fluoride derivative (68) with the serine ester (66) in the presence 
of boron trifluoride etherate and triethylamine 203  (Scheme 1.19). However, as with 
the triflic anhydride method, both a and B anomers are formed and must be 
separated by chromatography. 
The a-glycosidic serine/threonine-N-acetylgalactosamine linkage 
For many years the preparation of the a-glycosidic linkage between 
N-acetylgalactosamine and serine and threonine residues, which is characteristic of 
many serum and membrane-bound glycoproteins, presented considerable 
problems. Attempts to synthesis these derivatives in the corresponding glucose 
series using Koenigs-Knorr or Helferich methodology had resulted in almost 
exclusively the B-anomer. 
It was only when Paulsen eta! 204  introduced glycosyl chlorides that contained 
the 2-azido function as the reactive carbohydrate moiety that an answer was 
found. By adapting this methodology and applying it with the triflic anhydride 
coupling procedure, Ferrari and Pavia 205_ glycosylated Fmoc-serine and threonine 
active esters (69) (Scheme 1.20) in order to synthesise two antigenic TN 
triglycosylated pentapeptides. 
Advantages of this method include the ready availability of the 
2-azido-gylcosyl halides via the azidonitration route 206, and the possible coversion 
of the azido group to the acetamido group by treatment with 
dimethyl(phenyl)phosphine in glacial acetic acid 207  (Scheme 1.21). 
More recently -glycosides have been reported as being prepared by two 
alternative 	routes. 	While 	one 	involves 	the 	coupling 	of 
2-azido-2-deoxygalactopyranose 	with 	serine 	derivatives 	using 	the 
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Advances in glycosyl amino acid protecting groups 
Na_protecting groups 
Chemists have traditionally made use of the Fmoc N a-protecting group 41 in the 
synthesis of glycopeptides. Its removal, under basic conditions that are sufficiently 
weak, permits the base-labile 0-glycosylserine linkage to remain intact during 
deprotection. While some syntheses have employed the commonly applied 
piperidine in DMF deprotection conditions 198, more recent researchers have turned 
to the weaker base, morpholine, for the selective cleavage of the Fmoc 
moiety 192 ' 196 . 
An alternative protecting group, the triphenylphosphonioethoxycarbonyl 	eoc) 
group (70), was introduced in 1976 by Kunz 9091 . The author employed this group in 
the synthesis of N-glycopeptides in conjunction with the C-terminal benzyl and 
tert.butyl ester groups 183. It was shown to exhibit high acid stability, while being 
cleaved in very mild basic conditions - typically, a solution of morpholine in DCM 
- and hence base-labile 0-glycosylserine linkages remain completely intact during 
deprotection. There are, however, limitations: the bulky nature of the group hinders 
the condensation reaction, the group is so base-labile that the reaction conditions 
must be very carefully controlled, and as the Peoc group is a cationic moiety, its 
halogen counter ion (i.e. chloride) may interfere with gylcosylation reactions 
involving mercury or silver reagents. Hence the Z-group had to be used in the 
glycosylation step (and the Peoc group for subsequent chain extension), and this in 
turn prohibited the use of the benzyl ester carboxyl protecting group. 
Kunz et a/ have also reported the use of the 2 -(2-pyridyl)ethoxycarbonyl 
(2-Pyoc) 210 (71) and the 2 - (4-pyridyl)ethoxycarbonyl (4-Pyoc) 183 (72) N a_p rotecti ng 
groups, as well as more recently, the p -nitrocinnamyloxycarbonyl (Noc) 211 (73) 
protecting group. 
The 2-Pyoc and the 4-Pyoc groups are themselves extremely stable toward 
acid and base, but, following a simple modification, may be cleaved from the 
amino function under very mild conditions. This involves the quaternization of the 
pyridine nitrogen with methyl iodide, which renders the a-methylene group very 
acidic, and subsequent treatment with a mild base, such as morpholine, in DCM. 
The Noc protecting group can be removed under conditions that are practically 
neutral, 	that 	is, 	by 	palladium(0)-catalysed 	allylic 	transfer, 	in 	which 
+ 
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N,N'-dimethylbarbituric acid (DMBS) is employed as a suitable allylic acceptor 212 . 
One further advantage of this group is its stability to the rhodium(1)-catalysed 
isomerisation and hydrolysis conditions that are used to cleave the allylic ester 
carboxyl protecting group 202 . 
Carboxyl protecting groups 
The benzyl and rerrbutyl ester carboxyl protecting groups have both been 
employed in glycopeptide synthesis 183. The problems associated with these 
groups, for example, the variable stability of Fmoc derivatives during the 
hydrogenolysis of benzyl esters, and the problematic tert.butyl carbocation side 
reactions during deprotection of tert.butyl esters, are well documente& 83, and 
hence alternative protecting groups have been sought. 
One alternative, first described by Ugi at a/ 194 , and applied to glycopeptide 
synthesis by Kunz and Buchholz 195 , is the 2-bromoethyl ester group (74). The 
authors 195  have shown that both the 2-chloro- and 2-bromoethyl esters of amino 
acids and peptides, after conversion to the iodoeth yl ester, can be removed 
selectively with zinc in DMF. These neutral conditions permit the deprotection of a 
carboxyl function in the presence of the Z-protecting group, whilst leaving the 
glycosylserine linkage intact. 
At about the same time, Kemp and Reczek 193 introduced the (9,10-anthraquin-
on-2-yl)methyl (Maq) ester (75) as a possible carboxyl protecting group. Van Boom 
at al 192 successfully employed this ester, which can be cleaved under reductive 
conditions milder than catalytic hydrogenation (e.g. by reaction with sodium 
dithionite in aqueous-organic solution), in 0-glycopeptide synthesis. 
More recently, Kunz and Waldmann have made use of allylic esters (76) in the 
preparation of both N-glycopeptides 213 and 0-glycopeptides 202. In the case of 
O-glycopeptides, quantitative deprotéction of the allylic ester is effected by 
treatment with a solution of tetra kis(triphenylphosphane)palladium(0) in THF, with 
morpholine employed as the acceptor nucleophile. For further syntheses involving 
183 this group - see review.
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Recent advances in glycopeptide synthesis 
A few examples of the chemical glycosylation of suitably protected peptides 
and proteins have now been reported 214215 . Kessler et al 215  for example, have 
adapted the N-iodosuccinimide (NIS) method, introduced by Thiem et al 216  for the 
synthesis of 2-deoxyoligosaccharides, for the stereoselective glycosylation of 
peptide fragments. The authors have shown that peptides up to the pentapeptide 
size, react directly to yield products of almost complete a -diastereoselectivity. 
However, the most noteworthy advance in the preparation of glycopeptides has 
been the introduction of solid phase synthesis, where preliminary reports have 
begun to appear. 
Kunz and Dombo 217  have employed polymeric supports with allylic spacer 
groups to synthesise, for example, glycotripeptides. The base-labile Fmoc 
Na_protecting group 41  has been used (as the deprotection conditions for 
acid-labile groups would result in the loss of the glycosidic linkage - see above), 
and the final cleavage of the glycopeptide from the resin was effected by the 
standard conditions employed by Kunz and Waldmann 202 for the cleavage of the 
allylic ester carboxyl protecting group, namely a solution of tetrakis-
(triphenylphosphane)palladium(0) and morpholine in THF. 
Paulsen et a! 218  have synthesised, using solid phase methodology, two 
hexapeptides, corresponding to the partial structures of ovine submaxillary mucin 
and porcine glycophorin, by employing a strategy that includes the Wang resin (8) 
and Fmoc Na_protection. Interestingly, the final cleavage of the glycopeptide from 
the resin, performed in aqueous TFA (95%), did not result in cleavage of the 
ct-glycosidic threonine-N-acetylgalactosamine linkage. 
Solid phase glycopeptide synthesis in very much in its infancy, but in 





2.1. The 2.2- bis (4'-Nitrophenyl)ethoxycarbonyl (Bnpeoc) Na_protecting group 
2.1.1. Introduction 
The 9- fluoreriylmethoxycarbonyl (Fmoc) group (15) has enjoyed considerable 
employment as the principle base-labile Na_protecting group for solution and solid 
phase peptide synthesis since its introduction by Carpino and Han 41  in 1972. The 
advantage of this transient protecting group is that it allows the use of acid-labile 
semi-permanent protecting groups based on the tertbutyl moiety to be employed 
in the protection of most side-chain functionality. Together with a suitable 
peptide-resin linkage (see Introduction), it introduced a truly orthogonal approach 
to solid phase peptide synthesis, and eliminated several of the problems 
associated with the initial Merrifield resin-Boc protection strategy. 
The removal of the Fmoc group, effected by secondary amines - typically 20% 
(v/v) piperidine in DMF (Scheme 2.1); has been shown to proceed via a 
B-elimination process. 
• 	The byproducts of this cleavage reaction, dibenzofulvene (77) and the tertiary 
amine (78) formed from the addition of piperidine to the double bond of (77) 
(Scheme 2.2) are soluble in DMF and are readily removed. 
The principle drawback to the Fmoc methodology is its cost - Fmoc amino acid 
derivatives are 2-5 times more expensive than their Boc counterparts. It was with 
this in mind that Ramage and Florence 78, and Valentine 79, sought to design and 
develop a cheaper alternative to the Fmoc moiety. The stringent criteria which 
must be achieved for the successful introduction of such a protecting group are as 
follows: 
the protecting group must be easily prepared and introduced 
the protecting group must not introduce an extra chiral centre 
the protected amino acid derivatives must have good shelf 
lives 
the deprotection reaction must be selective, high yielding and 
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must proceed under mild conditions 
separation of the deprotected derivative from the byproducts 
etc. must be readily performed 
all reagents, byproducts etc. must be non-toxic. 
The researchers 78.79 believed that the 2,2- b/s (4'-nitrophenyl)ethoxycarbonyl 
(Bnpeoc) group (16) meets these criteria. 
2.1.2. Preparation of 2,2- bis (4'-nitrophenyl)ethanol 
The method employed at present in this research group for the synthesis of 
2,2-b/s (4'-nitrophenyl)ethanol (Bnpe-OH) (19) has been outlined above (see 
Introduction). While the yields for each of the four steps involved are generally 
acceptable (58-100%), the overall yield for such a synthesis, based on styrene 
oxide and phenylmagnesium bromide, is 40%. Hence it was hoped a reduction in 
the number of steps of the process would decrease the duration of the synthesis, 
and result in an increase in yield (and therefore a reduction in cost). 
Jarczewski and Leffek 219  have shown that it is possible to nitrate the 
4-position of both phenyl rings in diphenylmethane (79) by simply adding the solid 
(79) to a vigorously stirred solution of conc. nitric acid and conc. sulohuric acid at 
reduced temperature. Although the desired product, di-(4-nitrophenyl)methane (80), 
could be separated from any byproducts (i.e. mono-nitrated, 2,4'-dinitro derivatives 
etc.) by recrystallisation from benzene, no yield for the preparation was quoted by 
the authors. 
By employing (80) and adopting the approach outlined by Hamrick and 
Hauser220  for the preparation of 2,2-diphenylethanol either directly by the 
formylation of potassium diphenylmethide or by the reduction of 2,2-diphenylacetic 
acid (which is produced by the quenching of the potassium diphenylmethide with 
carbon dioxide), a 2-step synthesis of (19) could be envisaged (Scheme 2.3). 
Attempts to repeat the process of Jarczewski and Leffek were hindered by their 
poorly defined work up procedure and the aggregation of large quantities of solid 
diphenylmethane on addition to the acid mixture. In order to improve this, the 
diphenylmethane (79) was dissolved in nitromethane and added very slowly to the 
very vigorously stirred reaction mixture at -15 to -10 0C, and stirred for 45 minutes 
at this temperature. An analytical hplc trace of the resulting solid did indeed reveal 
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the existence of more than one product, however, as suggested by Jarczewski and 
Leffek, recrystallisation from benzene (twice) afforded pure di-(4-nitrophenyl)-
methane (80) in 37% yield. 
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H CH2 OH 
(19) 
Scheme 2.3 
In an attempt to increase the yield of (80), a number of alternative reaction 
temperatures/reaction times were studied (Figure 2.1). 
The conclusion that was drawn from these studies was that by increasing the 
duration of the reaction (to 180 minutes), a significant increase in the reaction 
yield is obtained (Scheme 2.4). As for lowering the reaction temperature, it is 
unclear from the above experiments whether this in itself results in any increase in 
yield. 
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reaction temperature reaction duration 
1 	 -15 to -10 °C 30 minutes 
2 	 -15 to -10 °C 45 minutes 
3 	 -15 to -10 °C 90 minutes 
4 	 -25 to -20 0C 30 minutes 
5 	 -25 to -20 °C 90 minutes 
6 	 -25 to -20 °C 180 minutes 
7 	 -25 to -20 °C 180 minutes 
Figure 2.1 
conc. HNO3 
conc. H2SO4 	02N 0"_.0 CH3NO2 	 101'~a 
reduced temp. 
(79) 	 (80) 
Scheme 2.4 
Attempts were then made to react di - (4 -nitrophenyl)methane (80) with a 
suitable base to form the carbanion intermediate (81) and to formylate it. 
Formation of the carbanion using butyl lithium proceeded smoothly (as evidenced 
by the instant generation of the characteristic blue colouration). However 
formylation, using dry formaldehyde afforded only starting material and no (19). 
Repeating this reaction, generating the carbanion both with butyl lithium at -78 0C, 










Carpino 221  more recently introduced a more convenient and higher yielding 
synthesis for the preparation of 9-fluorenylmethanol (84) (Scheme 2.5). In this, 
fluorene (82) was reacted with sodium hydride and ethyl formate to afford the 
aldehyde intermediate (83), which was subsequently reduced to the corresponding 
alcohol (84) by treatment with sodium borohydride. It was hoped that sodium 
borohydride could be used in the presence of nitro groups without resulting in 
their conversion to the corresponding amines. 









The above scheme was therefore repeated using di-(4- nitro phenyl)methane 
(80). However, while the formation of the carbanion intermediate proceeded as 
above, none of the desired aldehyde product could be isolated. Repeating the 
reaction, using sodium ethoxide instead of sodium hydride as the base, had no 
beneficial effect. 
The data in Figure 2.2 suggests that the carbanion intermediate (81) of 
di-(4-nitrophenyl)methane (80)219 should form rapidly and easily - and by the 
generation of the characteristic blue colour in each of the above experiments, this 
appears to be the case. Figure 2.2 summarises the importance of the effect of 
electron withdrawing groups on B -carbon acidity - the electron withdrawing 
power of the 8 - substituent results in the stabilisation of the ionised carbon 
through delocalisation into the electronegative centre. However, this considerable 
delocalisation most certainly results in a substantial reduction in the nucleophilicity 
of the B -carbon, and hence is probably the reason why to date it has been 












2_1.3. Bnpeoc NU-protection  of amino acids 
The first derivative of 2,2 - b/s (4'-nitrophenyl)ethanol (19) to be considered for 
the protection of the N a-functionality of amino acids was the corresponding 
chloroformate (20). Florence 78 had shown that this derivative could be prepared in 
good yield by the reaction of (19) with a solution of phosgene in toluene and 
N-methylmorpho linein 0CM. However, while (20) has been successfully employed 
in the protection of the amine functionality of penicillins and cephalosporins 222 , 
and the 5' sugar hydroxyl of DNA deoxyribose units 223, in amino acids it led to the 
formation of significant quantities of the undesired Bnpeoc clipeptide. Researchers 
have been aware of this problem with the corresponding Fmoc-Cl 224, with which 
up to 20% oligopeptide contaminant may be formed during the protection reaction. 
This can be rationalised by the reaction of the carboxyl function of the amino acid 
with the chioroformate, resulting in the formation of a mixed anhydride 
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(21) 
A number of mixed carbonate derivatives 225 were then considered, with the 
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active ester (21) formed from the reaction of (20) with N -hydroxysuccinimide 109 
being chosen due to its ease of preparation, ease of use and the resulting high 
acylating yields. 
Florence 78 has shown (21) to be useful in the preparation of many Bnpeoc 
Na_protected amino acids in good yield. His method of choice for the protection 
reaction was an adaptation of the method introduced by Lapatsanis 81 , which 
involves dissolving the amino acid in 2 eq. of a cooled, aqueous solution of 10% 
Na 2 CO 3, followed by the slow addition of the active ester in DMF. 
5% NaHCO3 (oq) 	02 N 
H2N—CH—CO2 H 	
10% NO2CO3 (oq) 
CH—R 
OH 	 Bnpeoc—ONSu 	 H 	CH2000NH—CH—CO2 H 
(21) 	 CH—R 
DUE 	 I 
OH 
R - H 
R - CH3 
Scheme 2.6 
Applying this method, a number of Bnpeoc amino acids have been prepared 
(e.g. Bnpeoc-Ala-OH (85), Bnpeoc-Phe-OH (86) and Bnpeoc-Gly-OH (87)) in good 
yield (65-75%). However, when the reaction was repeated with serine and 
threonine, lower reaction yields were obtained (50765%). Florence has shown that 
in order to ensure an excess of base (without significantly altering the pH), an 
additional 1 eq. of an aqueous solution of 5% NaHCO 3 could be added and it was 
shown that in the case of tyrosine, this resulted in a slight increase in yield. By 
applying this to serine and threonine the reaction yields were increased by 10-15% 
(Scheme 2.6). 
An alternative method of protection with ONSu active esters was introduced by 
Rich 82 in 1987, for use with his Teoc Na_protecting group. This requires the 
suspension of the amino acid in water, before the addition of 1.5 eq. of 
triethylamine in dioxan and the solid ONSu active ester. His work also displayed 
the possibility of purifying the protected amino acid derivative by the formation, 
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and the liberation, of the cyclohexylamine (CHA) salt. This optional purification step 
would not be possible with Fmoc amino acids, as the protecting group would be 
cleaved by treatment with CHA. 
Bnpeoc-Ser-OH (88), Bnpeoc-Thr-OH (89) and Bnpeoc-Phe-OH (86) have been 
prepared in good yield (70-80%) by the Rich method, both with and without the 
CHA salt purification step (Scheme 2.7). 
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2.1.4. Deprotection of Bnpeoc N e-protected amino acid derivatives 
On the introduction of the Bnpeoc group, Florence 78  had demonstrated the 
possibility of employing bases such as 1,5-diazabicyclo[4.3.0]non-5-ene (DBN) and 
1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) in stoichiometric quantities for its 
removal. These are strong bases, but importantly weak nucleophiles, and hence the 
possible occurance of unwanted side reactions is reduced. 
Florence has also shown that the deprotection reaction proceeded at a much 
increased rate when DMF was used as the solvent instead of DCM. Also, OBU 
reduced the deprotection time when used in preference to DBN, and increasing the 
number of equivalents of DBU from 1 to 2 effectively resulted in a 50% reduction 
in the elimination time. However, the system now used routinely for the 
deprotection involves the addition of an equimolar quantity of glacial acetic acid to 
the DBU solution. This suppresses the free amine that is generated, together with 
the side reactions that it may cause, but reduces only slightly the effective 
concentration of the DBU and the rate of the B -elimination reaction. 
In order to determine the possible conditions for the removal of the Bnpeoc 
moiety, a study of Bnpeoc/Fmoc deprotections with both DBU/AcOH in DMF and 
64 









0_. ( NO2 
 
+ DBUH+ + 02C—NH—CH2—CO2CH2 
CH2 
(91) 
081.1 + CO2 + H2N-CH2-0O2CH2 —0 
Scheme 2.8 
Bnpeoc-Gly-OBzl (90) was deprotected with a solution of OBU (1 eq.) and AcOH 
(1 eq.) in DMF (Scheme 2.8). At 5 minute intervals, aliquots were removed from the 
reaction mixture, quenched by the addition of excess AcOH and monitored by 
analytical hplc. This revealed that the deprotection reaction was complete within 
30 minutes. When this elimination was repeated with the corresponding 
Fmoc-Gly-OBzl, the deprotection was again shown to be complete within 30 
minutes i.e. the conditions outlined by Florence for the removal of Bnpeoc are not 
specific to Bnpeoc. 
The standard SPPS conditions for the removal of Fmoc i.e. 20% piperidine in 
DMF, were shown to effect the Fmoc elimination reaction within 10 minutes. 
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However the deprotection solution is known to contain not only the liberated 
dibenzofulvene (77), but also the tertiary amine (78) formed from the reaction 
between the base and the olefin (77). 
Florence has reported the apparent lack of reactivity of the 1,1-b/s 
(4' - nitrophenyl)ethen'e moiety (91), in so much that it was thought to be 
particularily stable towards addition. Certainly in the case of DBU/AcOH mediated 
deprotections, analytical hplc has been used to show that no adduct is formed 
between the base and the produced olefin. However if 20% piperidine in DMF is 
employed, the deprotection solution immediately turns dark blue, and analytical 
hplc reveals no peak corresponding to the standard olefin (91). This suggested 
therefore that (91) does indeed form an adduct (92) similar to that which is 
produced with dibenzofulvene (Scheme 2.9). 
In order to confirm the existence of this adduct, an authentic sample of 1,1-b/s 
(4'-nitrophenyl)ethene (91) was prepared, and reacted with an excess of piperidine 
in DMF. 
After attempts to dehydrate the alcohol (19) with acid (p-toluenesulphonic acid) 
had failed, 2,2-b/s (4' -nitrophenyl)ethanol (19) was acetylated with an excess of 
acetic anhydride and pyridine to afford 2,2-b/s (4'-nitrophenyl)ethyl acetate 
(Bnpe-Ac) (93) as an off-white solid in 78% yield. The elimination of 1 mole of 
acetic acid from (93) was accomplished by the addition of 2 eq. of DBN to give the 
required 1,1-b/s (4'-nitrophenyl)ethene (91) as a yellow solid (Scheme 2.10). A 
sample of this olefin was dissolved in DMF, and to this was added piperidine (to 
give a 25% piperidine in DMF solution). The solution immediately turned dark blue, 
however, over 20 minutes this colour faded to a pale yellow. The removal of the 
solvents gave an orange oil which was identified as the proposed tertiary amine 
(92) i.e. 1,1-b/s (4' -nitrophenyl)ethene (91) reacts in a similar fashion to 
dibenzofulvene (77) with piperidine. 
A point of particular interest is that the X max for (91) in DMF occurs at 304 nm, 
whereas for the tertiary amine adduct (92) it occurs at 275 nm (see below). 
Ramage and Florence. and Valentine, have not been the only researchers 
interested in the Bnpeoc protecting group. In 1985, Konig et a1 226 published work 
they had performed using this group. While the synthesis of the protecting group 
and its ONSu active ester derivative proceeded smoothly, the researchers were 
only able to prepare the crystalline phenylalanine derivative, and experienced 
significant problems with the subsequent removal of the protecting group. Using 
10 equivalents of diethylamine in DMF for 45 minutes to deprotect Bnpeoc-Phe-OH 
(86) resulted in the isolation of only 67% of the phenylalanine. N.m.r. data revealed 
the following combination of products: 1,1-b/s (4'-nitrophenyl)ethene (91) (65%), 
N - [2,2 - b/s (4'-nitrophenyl)ethyl]-diethylamine (15%) and N - [ 2,2- b/s (4'-nitrophenyl) 
ethyl]-phenvlalanine (20%) /.e. somewhat surprisingly the researchers found the 
olefin (91) adds more readily to phenylalanine than to a 10 fold excess of 
diethylamine. When the deprotection was repeated using n-propylamine, only 6% 
of the olefin was detected together with 94% of the N-[2,2-b/s 
(4'-nitrophenyl)ethylj-n-propylamine. 
Workers in this research group have yet to detect any significant addition of 
the olefin (91) to amine-free amino acid derivatives using the DBU/AcOH 
deprotection conditions, and in the case of 20% piperidine in DMF, only large 
quantities of the tertiary amine adduct (92) have been shown to be present. 
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2.2. Preparation of a glycotnpeptide by solution phase methodology 
2.2.1. Introduction 
Antifreeze glycopeptides/proteins (AFGP) are polymers of a tripeptide monomer 
unit (with some exceptions), with covalently attached carbohydrate moieties. The 
tripeptide unit consists of two residues of alanine and one of threonine, and the 
carbohydrate, of a disaccharide unit. 
It was the objective of this section of work to synthesise a fully protected 
analogous glycotripeptideunit, 
tetra-O -be nzvl-a/B-D-glucopyra nos yl) benzyl ester (Z -Ala -AIa-Ser-[c&/-D-Gluc-
(BzI) 4]-OBzl) (94), in order to investigate known glycosylation reactions and to 
determine the suitability of the Bnpeoc group for the Naprotection of amino acid 
residues of glycopeptides. To date, Fmoc has been used as the principle 
Na_protecting group in glycopeptide synthesis - with the milder base, 
N-methylmorpholine, used for its deprotection in preference to piperidine, due to 
base sensitivity of the glycosidic linkage. It was therefore hoped that Bnpeoc, 
which can be removed by stoichiometric quantities of DBU/AcOH, would provide 
even milder deprotection conditions. 
2.2.2. Preparation of Bnpeoc-Ser-OBzI 
It was anticipated that the synthesis of Na[2,2b/s (4'-nitrophenyl)-
ethoxycarbonyl]-serine benzyl ester (Bnpeoc-Ser--OBzl) (95) would proceed as the 
analogous preparation of benzyl ester 
(Fmoc-Ser-OBzl) (96). However, whilst the synthesis of (96) was shown to proceed 
in good yield by an adaptation of the method of Wang et 8/ 227 (and Chang et a! 
228), that is, via the formation of the caesium salt of Fmoc-Ser-OH, followed by 
reaction of this salt with a slight excess of benzyl bromide in DMF for 48 hours, 
attempts to repeat this synthesis with Bnpeoc-Ser-OH (88) resulted in the almost 
quantitative isolation of the olefin (91) after 24 hours. 
A study was therefore performed in which Bnpe-OAc (93) was simply stirred in 
DMF, and the analogous solvents, N,N-dimethylacetamide (DMA) and 
N-methylpyrrolidinone (NMP), for 48 hours. The results for the production of the 
olefin (91), as determined by analytical hplc (monitoring at 254 nm), are 
summarised in Figure 2.3. 
solvent 	% olefin formed 
after 24 hours 
Bnpe-OAc 	 DMF 	 29 
Bnpe-OAc 	 DMA 	 7 
Bnpe-OAc 	 NMP 	 100 
% olefin formed 




concentration of Bnpe-OAc = 1.25 x 10 mol/mi 
Figure 2.3 
These data clearly suggested that DMA, in this form, contains the smallest 
quantity of basic impurities. 
The synthesis of Bnpeoc-Ser-OBzi (95) was therefore carried out in DMA via 
the caesium salt of the acid as above (Scheme 2.11). In order to increase the rate 
of the reaction, and hence have the amino acid derivative in the solvent for the 
least amount of time, a larger excess of benzyl bromide (4-5 eq.) was used. Tic 
confirmed the completion of the reaction within 90 minutes, and Bnpeoc-Ser-OBzl 
(95) was isolated in 89% yield. 
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When the above studies were repeated on a sample of Bnpeoc-Thr-OH (89), no 
olefin (91) was detected after 48 hours in any of the three solvent systems. This 
can presumably be attributed to the free acid group neutralising any amines 
present in the solvents. 
solvent % olefin formed % olefin formed 
after 24 hours after 48 hours 
Bnpeoc-Ser-OBzl DMF 14 26 
Bnpeoc-Ser-OBzl DMA 0 10 
Bnpeoc-Ser-OBzl NMP 44 61 
Fmoc-Ser-OBzl DMF 0 7 
Fmoc-Ser--QBzI DMA 0 5 
Fmoc-Ser-OBzl NMP 5 9 
concentration = 2.96 x 10 mol/mi 
Figure 2.4 
A more pertinent study was performed with both Bnpeoc-Ser-OBzl (95) and 
Fmoc-Ser-OBzl (96) in DMF, DMA and NMP. A consideration of the results for the 
two amino acid derivatives (Figure 2.4) clearly reveals support for the above 
conclusion that the DMA, at least as supplied by Aldrich, contains the fewest basic 
impurities. 
While these data suggest that this problem is more acute with Bnpeoc amino 
acid derivatives than Fmoc (this is supported by the PK a  values listed in Figure 
2.2), no actual quantitative comparison can be drawn. This is due to variations in £ 
between the N e-protected amino acid derivatives and their respective olefins, 
which have not been considered in compiling the above data, and which would 
have to be taken into account. 
2.2.3. Preparation of Bnpeoc -Ser(UJB-D-(Bzl)4GlucJ-OBzl 
As was discussed previously (see above), the most practical approach to date 
for the synthesis of glycopeptides has involved the preparation of adequately 
protected N- and 0-glycosyl amino acid derivatives, followed by extension from 
either or both of the C- and N-terminals. Therefore in an attempt to incorporate 
the Bnpeoc N a-protecting group into gylcopeptide synthesis, Bnpeoc-Ser-OBzl 
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(95), was glycosylated with a suitably protected carbohydrate moiety. 
The 	selectively 	protected 	carbohydrate 	that 	was 	chosen 	was 
2,3,4,6 - tetra -0- benzyl-cL-D-glucopyranose [(Bzl) 4 c&Gluc-OH] (98). This was prepared 
from methyl ct-D-glucopyranose (97) by the method of Koto et al 229 (Scheme 
2.12), and involved the protection of the non-anomeric hydroxyls as benzyl ethers 
by the reaction of (97) with sodium hydride and benzyl chloride at elevated 
temperature. The selective hydrolysis of the methyl ether, and therefore the 
exposure of the anomeric hydroxyl, was performed by a mixture of 6M HCI and 
acetic acid, and afforded (98) in 33% yield (based on (97)). 
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(98) 
Scheme 2.12 
The glycosylation of Bnpeoc-Ser-OBzl (95) with (Bzl) 4aGluc-OH (98) was 
initially attempted by both the classical Koenigs-Knorr glycosylation conditions 190 
(i.e. employing mercuric bromide as the catalyst) and the modified Helferich 
conditions 191 , which involves using mercuric cyanide as the catalyst and a mixture 
of toluene and acetonitrile as solvent. However, the reaction mixtures of both 
these preparations were shown (by tIc and hplc) to contain a great many products, 
and this made purification impractical. 
More recently researchers 1 97.198 have turned to the trifluoromethanesulphonic 
71 
(triflic) anhydride method for use in glycosylation reactions. While this has afforded 
glyco-amino acid derivatives in good yields, it has been noted 197,198 that both the 
and B anomeric glycosidic products are obtained, and therefore at some point 
they must be separated. 
The reaction of Bnpeoc-Ser-OBzl (95) (2 eq.) and (Bzl) 4 cLGluc-OH (98) (1 eq.), 
mediated by triflic anhydride, and performed in a solvent mixture of acetonitrile 
and DCM, afforded N - [2,2- b/s (4' - nitrophenyl)ethoxycarbonyl] - ser,ne-(0-2,3,46-
tetra -0-benzyl-c&/8-D-glucopyranosyl) benzyl ester (Bnpeoc-Ser-[cz/ B -D - (Bzl) 4 -
Gluc]-OBzl) (99) in 34% yield in the ratio of 1:1 for and B products, but only 
after a great deal of work.on the purification method (Scheme 2.13). 
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A tic of the final reaction mixture revealed the existence of many byproducts of 
the glycosylation reaction, and hence still presented an overwhelming purification 
problem. Attempts to isolate the desired material (99) by gel filtration, in a variety 
of different solvents and gel media, failed completely. Eventually the final method 
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of purification that was applied involved a small flash chromatography column, 
followed by preparative hplc. The preparative hplc obviously presents problems of 
its own - for example, employing the semi-preparative reverse phase columns that 
are routinely used for peptide purification permits only a small quantity of material 
(5-10 mg) to be loaded on to the column per injection. Separation is not helped by 
the aromatic nature of both the product (99) and the starting materials/byproducts, 
that is, they each have a intense chromophore (cf. peptides) and this in turn 
reduces the quantity of material that the detector can handle per run. Hence this 
method of purification is both time consuming and expensive, and while it was 
possible with this preparation to purify sufficient material in order to proceed with 
the synthesis, steps have to be taken in the future in order to reduce the problems 
and time required to purify such intermediates. One possible solution could be the 
use of much larger bore preparative hplc columns, and this research group has 
recently acquired such a column, that can reputedly handle up to 100 mg of 
peptide per injection. 
What the hplc purification step failed to do in this synthesis, however, was to 
separate the two anomeric products. It was therefore decided to proceed with the 
synthesis of the glycotripeptide in the hope that the /B separation could be 
performed at a later stage. 
2.2.4. Preparation of H-Serla/8-D-(BzI)4GlucJ-OBzI 
The next stage of the synthesis was the selective removal of the Bnpeoc 
N e-protecting group. Florence has shown that while the deprotection of the 
Bnpeoc group proceeds rapidly in a solution of DBU/AcOH in DMF, in DCM it takes 
6-10 times as long. This can presumably be attributed to the greater solvation of 
the charged intermediates of the reaction in the solvent of higher dielectric 
constant. 
This observation was repeated with small-scale deprotections 	of 
Bnpeoc -Ser[cz/8-D-(Bzl) 4GIuc]-OBzl (99) with DBU 0.2 eq.)/AcOH (1.2 eq.) in both 
DCM and DMF. For while the deprotection was shown (by tic and hplc) to be 
complete in less than 20 minutes in DMF, in 0CM it took more than 3 hours. Mass 
spectroscopy confirmed both the absence of the starting material (99), and the 
absence of any products that may have been present as a result of the loss of the 
glycosidic linkage, in the DMF reaction mixture. 
The deprotection of (99) was therefore repeated on a larger scale with DBU (1.2 
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eq.)/AcOH (1.2 eq.) in DMF, and afforded serine(O -2,3,4,6-tetra-O-benzyl-
(x/B - D- glucopyranosyl) benzyl ester (H - Ser[c&/ - D-(Bzl) 4Gluc]-OBzl) (100) in almost 
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2.2.5. Preparation of Z-Ala-Ala-OH 
At this point, the synthesis of Z -Ala -Ala-Ser[a/B-D-(Bzl) 4Gluc]-cjBzl (94) could 
have been performed by two alternative routes from (100). One would have firstly 
involved the coupling of Bnpeoc-Ala-OH (85) to (100), followed by the removal the 
Bnpeoc group, and finally by coupling N - (benzyloxycarbonyl)alanine (Z-Ala-OH) 
(101) to the N-deprotected glycodipeptide. The other, by preparing 
Na_(benzyloxycarbonyl)alanylalanine (Z-Ala-Ala-OH) (103), and coupling it to (100) 
to give (94). The second method was chosen as difficulties were anticipated in 
purifying the glycopeptide intermediates that would result from following the first. 
Z-Ala-OH (101) was prepared in good yield by established literature methods, 
and Na_(benzyloxycarbonyl)alanine N-succinimidyl ester (Z-Ala-ONSu) (102), the 
ONSu active ester of (101), was synthesised by the method of Anderson et a! 109 
As discussed below, the purification of these active esters can be greatly 
simplified by quickly washing the material (dissolved in ethyl acetate) with water. 
The subsequent coupling of Z-Ala-ONSu (102) and alanine was accomplished 
by the aforementioned method of Rich 81 , and provided Z-Ala-Ala-OH (103) in 65% 
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2.2.6. Preparation of Z-Ala-Ala-Ser[w'8-D-(Bzl)4Gluc]-OBzl 
The 	preparation 	of 	Z-Ala-Ala-Ser[ci/8-D-(Bzl) 4Gluc]-OBzl 	(94) 	from 
Z-Ala-Ala-OH (103) and H -- Ser[cz/8 - D- (Bzl) 4Gluc].-OBzl (100) was accomplished 
using the standard DCCl/HOBt activation and coupling procedure, and using 
triethylamine to adjust the pH of the reaction mixture to 9.0. 
The Bnpeoc - Ser[a/8 - D-(Bz1) 4GIuc]-OBzl (99) was deprotected as above with a 
solution of DBU (1.2 eq.)/AcOH (1.2 eq.) in DMF, followed by the partition of the 
reaction mixture between ethyl acetate and water. After washing the ethyl acetate 
layer with further water, the solvent was removed to afford a yellow oil. It was 
decided that due to the small scale of the reaction (i.e. 100 mg of (99)), no further 
purification of (100) would be possible. Therefore in an attempt to maximise the 
isolated yield of the final glycotripeptiide product (94) with respect to (100), two 
equivalents of the dipeptide (103) and the coupling reagents were subsequently 
employed (Scheme 2.16). 
The purification of (94) was also very problematic and was finally performed by 
preparative hplc to afford (94) as a white solid in only 15% yield. While some of 
the reason for this poor yield can be attributed to the problems with the 
purification, it was felt that when considering a repeat of the synthesis, it would 
have to be done on such a scale as to permit the purification of (100). However, 
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there was also some evidence to suggest that the glycotripeptide product was not 
completely stable to the weakly acidic nature of the standard preparative hplc 
solvents (i.e. water/acetonitrile (+0.05% TFA)), and therefore it must be suggested 
that further hplc work in this area be carried out in neutral solvent systems only. 
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The conclusion that can be drawn from this work is that the Bnpeoc group is 
indeed applicable to solution phase glycopeptide synthesis, as the conditions for 
its removal are suitably mild and selective so as to leave intact the glycosidic 
linkage. However, the nature of the coupling of amino acid and peptide derivatives. 
to glyco-amino acid units and their subsequent purification requirements must be 
further investigated if such syntheses are to be understood and are to become a 
matter of routine. 
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2.3. Preparation of Bnpeoc -Ala-Phe-Gly-OH 
In an attempt to further determine the suitability and applicability of the 
Bnpeoc N e -protecting group to both solution and solid phase peptide synthesis, a 
test peptide, N-[2,2- b/s (4 '-nitrophenyl)ethoxycarbonyl] -alanylphenylalanylglycine 
(Bnpeoc-Ala-Phe-Gly--OH) (106) was prepared by three alternative routes: 
2.3.1. Saponification of Bnpeoc-Ala-Phe-GIy-OMe 
Florence 78 has shown that N - [2,2-b/s (4' - nitrophenyl)ethoxycarbonylj-
alanylphenylalanylglycine methyl ester (Bnpeoc -Ala-Phe-Gly-OMe) (105) can be 
prepared by the coupling of Bnpeoc-Ala-OH (85) and the trifluoroacetate salt of 
H-Phe-Gly-OMe (104) (Scheme 2.17). The coupling agent that was chosen was that 
introduced by Ramage et a! 136,137 in 1976, diphenylphosphinyl chloride (45). 
Repeating the preparation afforded the desired protected tripeptide (105) in 60% 
yield. 
Bnpeoc-Ala-OH 	+ 	CF3 CO2 	H2
+ 
 - Phe-Cly--OMe 
(85) 	 (104) 





Florence has also discussed the possibility of removing methyl esters with a 
dilute sodium hydroxide solution, without the loss of the N e -protecting group. 
However, Holden 36  had experienced great difficulties in removing the analogous 
phenyl esters by saponification from Bnpeoc-Gly-OH derivatives. He found that 
significant quantities of the Bnpeoc group were cleaved under a number of 
alternative reaction conditions - confirmed by the presence of ninhydrin active 
spots on tIc's of reaction mixtures and by the isolation and characterisation of 
byproducts. After much experimentation, Holden eventually found conditions (i.e. 
O.1M NaOH (1 eq.) and a solution of H 20 2 (2 eq.) in water, in 20% aqueous acetone 
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for 15 minutes at room temperature) that produced the protected amino acid 
derivative in 65% yield. 
Florence has shown that the methyl ester of Bnpeoc-Ala-Phe-Gly-OMe (105) 
can be cleaved, using 0.025M NaOH (1 eq.), without resulting in the significant loss 
of the Bnpeoc group, in 60% yield (with the remainder isolated as starting material 
(35%) and olefin (91) (5%)). Attempts to repeat that reaction, under a variety of 
reaction conditions, all resulted in the formation of significant quantities of 
ninhydrin active material, and the reaction mixtures were confirmed as containing 
the olefin (91) and free-amine amino acid derivatives by analytical hplc. 
The optimum, but not wholly satisfactory, conditions found for the reaction 
were those introduced by Holden 36 , namely 0.1M NaOH (1 eq.) and a solution of 
H 
2 0  2  (2 eq.) (as an 'a'-effect nucleophile) in water, in 20% aqueous acetone at 
room temperature.This resulted in the isolation of the desired product (106) as a 
white solid (Scheme 2.18), but in only a 55% yield. 
0•1M NaOH 
Bnpeoc -Ala -Phe-Cly-OMe 	 Bnpeoc-Ala-Phe-Cly-OH 
(105) 	 H202 	 (106) 
acetone/H2 0 
- 	 Scheme 2.18 
The conclusion that must be drawn from these studies is that experimental 
conditions may be tailored in order to increase the viability of a route involving 
the removal of methyl esters by saponification in the presence of Bnpeoc, 
however, the insufficiently qualified claim 78,79  that Bnpeoc is stable to NaOH is one 
which merits further investigation. 
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2.3.2. Utilising ONSu active ester methodology 
A second solution phase synthesis of Bnpeoc-Ala-Phe-Gly-OH (106) was 
performed, in which the final step involved the incorporation of the 
Bnpeoc-Ala-OH residue as its ONSu active ester (Scheme 2.19). 
Glycine benzyl ester p -toluenesulphonate (TOsOH 2 -Gly-QBzl) (107) was 
prepared from glycine, p -toluenesulphonic acid and benzyl alcohol in benzene by 
the method of Zervas et al 230 The resulting salt (107) (prepared in 92% yield) was 
then coupled to N - (benzyloxycarbonvl)phenylalan,ne (Z-Phe-OH) (108) (prepared 
by the established literature procedure) by the DCCl/HOBt activation and coupling 
procedure to give N -(benzyloxycarbonyl) -phenylalanyIglycine benzyl ester 
:'(Z-Phe-Gly-OBzl) (109) (88%). 
The removal of both the Z- and benzyl ester protecting groups was performed 
(simultaneously) by hydrogenation in the presence of 10% palladium-charcoal 
catalyst and p -toluenesulphonic acid (1 eq.) (to prevent the unwanted side reaction 
of cyclisation 231 ), at room temperature and pressure, and afforded 
phenylalanylglycine p - toluenesulphonate (TosOH 2 -Phe-Gly-OH) (110) as a green 
oil. All attempts at crystallisation failed, and hence the product (110) was employed 
without further manipulation in the next stage of the synthesis. 
The preparation of the N-succinimidyl ester (Bnpeoc-Ala-ONSu) (111) of 
Bnpeoc-Ala-OH (85) by the method of Anderson et al 109 proceeded satisfactorily. 
Often a problem associated with such a preparation is the removal of the 
excess/unreacted N-hydroxysuccinimide from the final reaction mixture. However, 
as earlier work has demonstrated, this can be accomplished by redissOlving the 
reaction mixture in ethyl acetate and quickly washing (once) with water (even 
though these active esters are water sensitive). In the case of the synthesis of 
(111) this was deemed unnecessary and the product was obtained, in 88% yield. 
The subsequent coupling of (110) and (111) was performed under the 
conditions outlined by Rich 82, and applied to Bnpeoc N a-protection (see above), to 
afford Bnpeoc-Ala-Phe-GIy-OH (106) as a white solid (66% - based on 
Z-Phe-Gly-OBzl (109)). 
This synthesis of (106) has demonstrated the ready preparation of Bnpeoc 
amino acid ONSu active esters, the possibility of successfully incorporating them 
into peptide synthesis, and has confirmed the required stability of Bnpeoc to 
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2.3.3. Utilising solid phase/acid chloride methodology 
As was discussed in the introduction, acid chloride coupling methodology for 
peptide synthesis has been enjoying a recent revival of interest 8992. The use of 
acid-stable urethane-type N e -protecting groups (e.g. Fmoc) has permitted peptide 
synthesis to be achieved with acid chlorides with very little toss of optical purity 
(< 0.1%). 
In an attempt to determine the feasibility of the preparation and reaction of 
acid chlorides of Bnpeoc amino acids, the tripeptide, Bnpeoc-Ala-Phe-Gly-OH (106) 
was prepared by manual solid phase synthesis on the p-alkoxybenzyl alcohol 
(Wang) resin (8), and employing a manual shaker (Scheme 2.20). 
A point to note is that there have been lengthy discussions as to the best 
method of agitation to be employed in the loading of the first amino acid residue 
to the resin 3678. Mechanical stirring can essentially be dismissed due to the 
possibility of damage occurring to the resin beads, and while this is not a problem 
with rotary agitation (in a manual shaker) and ultrasonication, there are 
disadvantages with both of these methods. With rotary inversion there is a conflict 
concerning the volume of solvent in the vessel during the coupling reaction - a 
large volume is required to permit optimum immersion of the resin in the reaction 
mixture during the inversion, however, the higher the concentration of reagents, 
the higher the generally obtained coupling yields. There is also the problem of a 
small quantity of the reaction mixture 'leaking' through the sinter, and thus 
effectively removing it from the reaction vessel. In the case of ultrasonication, the 
minimum volume of solvent may be used to ensure a high concentration of 
reagents. The problem with this method, however, is the resulting mechanical loss 
of product during its removal, washing, drying and repeated couplings etc. 
It was therefore decided that while all manual solid phase peptide couplings 
would be performed by rotary inversion (hence minimum loss of the peptide 
during the synthesis), the coupling of the first amino acid derivative would, in 
general, be performed by sonication (a higher coupling yield is more desirable than 
ensuring no loss of resin, if a subsequent wastage of material is to be avoided). 
However, due to the nature of the reagents involved, and the expectation of high 
coupling yields (via acid chlorides), the loading of the first amino acid derivative in 
this synthesis was performed by rotary inversion. 
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reflux in excess thionyl chloride - its formation being confirmed by infrared 
spectroscopy. The coupling of (112) with the p-alkoxybenzyl alcohol resin (8) was 
performed in DCM, using an excess of pyridine as base, to afford 
Bnpeoc - c3ly--(O-CH 2C H-OR) (113). Microanalysis of (113) revealed a yield of 62% 
after one coupling, and hence a second coupling, undertaken exactly as the first, 
was required to achieve a satisfactory 87% (by microanalysis) coupling yield. 
Bnpeoc - Gly- (O-CH 2C 5 H 4 -OR) (113) was deprotected with a solution of DBU (2 
eq.)/AcOH (2 eq.) in DMF for 1 hour at room temperature. To this was coupled 
Bnpeoc-Phe-CI, prepared as above, in DCM and using N-methylmorpholine as 
base. Attempts to mediate this coupling in pyridine resulted in little of the desired 
product. Two couplings of Bnpeoc-Phe-Cl, each of a duration of 2 hours, were 
required before a sample of the functionalised resin gave a negative Kaiser test 232 
result. As a precaution (perhaps unnecessary considering the result of the Kaiser 
test), any unreacted amine sites were capped with an excess of acetic anhydride 
and pyridine to ensure no subsequent build-up of a deletion peptide. 
Deprotection of the phenylalanine residue was again effected by a solution of 
DBU/AcOH in DMF, before the final coupling of Bnpeoc-Ala-Cl was performed. A 
single (2 hour) coupling was shown to be sufficient to elicit a negative result from 
the Kaiser test. 
The removal of the tripeptide from the resin was performed using TFA in DCM 
and gave a yellow solid, which on purification by gel filtration afforded 
Bnpeoc-Ala-Phe-Gly-OH (106) as a white solid (overall yield = 38%). 
The above synthesis clearly demonstrated the effectiveness of acid chloride 
coupling methodology for use in peptide synthesis. The preparation of acid 
chlorides of Bnpeoc amino acids was shown to be a simple, high yielding 
procedure and also, it is noteworthy that during the course of the synthesis, these 
acid chloride derivatives were shown to be stable overnight if stored in an 
anhydrous atmosphere (at -150C). 
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2.4. Preparation of Bnpeoc-Ser( tBu)-OH and Bnpeoc-Thr( t Bu)-OH 
While the syntheses of Bnpeoc-Ser-OH (88) and Bnpeoc-Thr-OH (89) have 
been reported above, these derivatives are of little use in solution and solid phase 
peptide synthesis due to the presence of the free hydroxyl functionality on the 
side chains of the amino acid residues. Clearly these hydroxyls have to protected, 
and as discussed above, the use of a base-labile N ot- protecting group (such as 
Bnpeoc) for peptide synthesis permits acid-labile tert.butyl ethers to be employed 
for the protection of the side-chain functionality. This in turn allows for the 
simultaneous removal of the protecting group with the acid mediated cleavage of 
the peptide from the resin. 
The syntheses of N -[2,2- b/s (4' - nitrophenyl)ethoxycarbonyl]-serine (0- tert.-
butyl) (Bnpeoc-Ser( tBu)-OH) (119) and Na_[2,2_ b/s (4'-nitrophenyl)ethoxycarbonyl]-
threonine(0- tert.butyl) (Bnpeoc-Thr( t Bu)-OH) (124) were therefore undertaken. 
2.4.1. Bnpeoc-Ser( tBu)-OH 
The synthesis of Bnpeoc-Ser( tBu)-OH (119) essentially consists of the 
preparation of (0-tertbutyl)serine (H-Ser( t Bu)-OH) (118) by the now established 
methods of amino acid derivatisation, followed by the incorporation of the Bnpeoc 
Na_protecting group (Scheme 2.21). 
Serine methyl ester hydrochloride (CiH 2 -Ser-0Me) (114) was prepared by the 
method of Guttmann and Boissonnas 233, which consists of the addition of thionyl 
chloride and serine to methanol at reduced temperature. The resulting salt (114) 
(prepared in 90% yield) was subsequently reacted with benzyloxycarbonyl chloride 
(Z-Cl) in chloroform, while employing a mixture of triethylamine and pyridine as 
base. This afforded Na_(benzyloxycarbonyl)serine methyl ester (Z-Ser-OMe) (115) 
as a white solid in 87% yield. 
Na(Benzyloxycarbonyl)serine(Q_ tert.butyl) methyl ester (Z-Ser( t Bu)-OMe) (116) 
was prepared by firstly dissolving Z-Ser-OMe (115) in DCM and coolina in a 
CO2/acetone bath, and then adding condensed isobutylene together with conc. 
sulphuric acid (as a catalyst) and copper (I) chloride (to prevent the polymerisation 
of the isobutylene). The reaction mixture was securely stoppered and placed in a 
screened area for 7 days, before being worked up to afford Z-Ser( tBu)-OMe (116) 
(47%). 
The subsequent removal of the amine and carboxyl protecting groups was 
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performed in two stages. 
The methyl ester was removed by the method of Shields and Renner 234, which 
involves the reaction of (116) with 1-OM NaOH (1.1 eq.) in aqueous acetone at room 
temperature, to give tert.butyl) (Z -Ser( t Bu)-OH) 
(117). The cleavage of the Z- group required hydrogenation in the presence of 10% 
palladium-charcoal catalyst and in DMF at room temperature and pressure. This 
gave (O - terthutyl)serine (H-Ser('Bu)-OH) (118) in 82% yield. 
The incorporation of the Bnpeoc Na_protecting group was performed as above, 
employing Bnpeoc-ONSu (21) and the method of Rich 82 (with the optional CHA 
purification), to afford Bnpeoc-Ser( tBu)-OH (1 19) (93%). 
2.4.2. Bnpeoc-Thr( tBu)-OH 
The preparation of Bnpeoc-Thr( tBu)-OH (124) followed a similar route to the 
analogous serine derivative (see above), that is, (O - tert.butyl)threonine (123) was 
synthesised by established methods, followed by the incorporation of the Bnpeoc 
Na_protecting group (Scheme 2.22). 
However in an attempt to reduce the number of steps in the synthesis, and 
hence increase the overall yield of (124), a benzyl ester was used for the carboxyl 
protection rather than the methyl - ester. This permitted the simultaneous removal 
of both the amine and the carboxyl protecting groups by hydrogenation. 
Na_(Benzyloxycarbonvl)threonine (Z-Thr-OH) (120) was prepared by an 
established literature method in good yield. The reaction of (120) with triethylamine 
and an excess of benzyl bromide gave Na_(benzyloxycarbonyl)threonine benzyl 
ester (Z-Thr-OBzl) (121) as a white solid (55%). 
The incorporation of the tert.butyl ether protecting group was performed as 
above i.e. by the addition of condensed isobutylene, conc. sulphuric acid and 
copper (I) chloride to a cooled solution of Z-Thr-OBzl (121) in DCM. This afforded 
Na_ (ben  zyloxycarbonyl)threonine(o_ tertbutyl) benzyl ester (Z-Thr( tBu)-OBzl) (122) 
as a white solid in 76% yield. 
The removal of both the amine and carboxyl groups was accomplished by 
hydrogenation at room temperature and pressure in the presence of 10% 
palladium-charcoal catalyst and in DMF, as outlined by Wunsch and Jentsch 235 . 
This gave (O - tert.butyl)threonine (H-Thr( tBu)-OH) (123) in a somewhat 
OCH 2 COCI 




Z—Thr—OBzI 	 Z—Thr(tBu)—OBzI 
H 	u CI 









H 	CH2 000NH—CH—0O2 H 








disappointing yield of 39%. 
The reaction of (123) with Bnpeoc-ONSu (21) by the method of Rich 82 gave 
Bnpeoc-Thr( t Bu)-OH) (124), 	however, unlike the analogous 	serine derivative (119), 
Bnpeoc -Thr( t Bu)-OH required purification by flash chromatography as well as by 
the formation, and the liberation, of the CHA salt. 
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2.5. The design and development of a new coupling reagent for peptide synthesis 
2.5.1. Introduction 
Diphenylphosphtnyl chloride (Ph 2 PQCI) (45), the coupling reagent introduced and 
developed by Ramage et at 136,137 has enjoyed extensive useage in solution and 
manual solid phase peptide synthesis. However, due to the hygroscopic nature of 
the acid chloride (45), it is not suitable for application to automated SPPS. The 
hydrolysis of (45) to the corresponding acid (PI1 2 PO2 H) (125), which is relatively 
insoluble (even in DMF), would result in the possibility of costly blockages in the 
solvent transfer lines and the valve block of an automated synthesiser. 
A reagent that would result in the formation of the same phosphinic-carboxylic 
mixed anhydride (46) as is generated with (45), but yet would be more stable to 
hydrolysis (i.e. less air sensitive), was therefore sought. 
The initial studies in this area were centred on the attempts to prepare the 
HOBt ester derivative (126) of Ph 2POCI. These were largely a failure however, due 






Attention 	was 	therefore 	directed 
	
to 	diphenylphosphinic 	anhydride 
(Ph 2 PO2 POPh 2) ( 127). This was a known literature compound, and its preparation 
was shown to be possible by a number of alternative methods. 
The synthesis of Ph 2 PO 2POPh 2 (127), its stability and reactivity, and the 
possibility of employing it to mediate peptide couplings were then investigated. 
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2.5.2. Preparation of Ph 2PO2POPh2 
A number of preparations of phosphinic anhydrides are present in the literature. 
In general, they may be prepared by the heating of the appropriate phosphinyl 
chloride with the sodium phosphinate in an inert solvent 236 . An alternative method, 
however, involves the treatment of the phosphinyl chloride with triethylamine and 
a restricted quantity of water 237 . 
Perhaps the most versatile route to both aliphatic 238 and aromatic 239 
phosphinic anhydrides is the reaction of phosphinyl chlorides with ethyl 
phosphinates at elevated temperature (150-200 °C) without a solvent. Alternatively 
Moedritzer240  has demonstrated the slightly unusual method of preparing 
symmetrical anhydrides from phosphinyl chlorides and paraformaldehyde. 
The first attempts at the synthesis of Pt1 2PO2 POPh 2 (127) involved the 
treatment of Ph 2 POCI (45) with water (0.5 eq.) in a mixture of 0CM and DMF 
(Scheme 2.23). While there was evidence ( 31 P n.m.r.) to suggest that some of the 
desired product had been formed, the reaction was by no means near completion, 















Attention was therefore directed to the method of Crofts et al 239  in which the 
anhydride can be prepared by the heating of (45) and ethyl diphenylphosphinate 
(Ph 2P(Q)QEt) (128) without a solvent and in an inert atmosphere. Ph 2P(0)OEt (128) 
was prepared by the method of Kosalapoff and Watson 238, which involves the 
addition of sodium ethoxide to a cooled solution of (45) in benzene. After 24 hours 
the sodium chloride formed was filtered off and the solvent removed to give (128) 
as a clear oil. The purification of (128) was achieved by distillation. and afforded 
the ester as a white solid in 75% yield. 
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Ph 2 P(0)OEt (128) and Ph 2 POCI (45) were then heated without a solvent to 
200°C for 2 hours under an argon atmosphere (Scheme 2.24). It was at this point 
that problems with this synthesis were encountered. Crofts et al 239 had 
demonstrated that on cooling, the reaction mixture solidified and that the desired 
anhydride (127) can be obtained pure simply by the recrystallisation of this solid 
from toluene. Efforts to repeat this work up procedure resulted in the 
contamination of the product (127) with a significant quantity (up to 50% - by 31 P 
n.m.r.) of diphenylphosphinic acid (125). Adopting a more rigorous approach to the 
drying of the toluene yielded no beneficial effect. 
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In our modification the reaction was allowed to cool to 60 °C, a sufficient 
volume of toluene was added to dissolve the product, and the vessel was placed 
in an ice/salt bath. Vigorous scratching encouraged the formation of a white 
precipitate which, after storing in a refrigerator for 30 minutes, was filtered off and 
dried. This gave (127) in 59% yield as a white solid and its purity was confimed by 
31 n.m.r. 
While the above two-step synthesis of (127) gave a tolerable overall yield of 
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44% (based on initial Ph 2 POCI), it was felt that improvements could be made. The 
distillation of the intermediate ester (128) was both time consuming and 
predictably wasteful of material, and yet 31  P n.m.r. had shown the crude (128) to 
be only one product. It was therefore decided to Omit the distillation procedure 
and, on removing the benzene from Ph 2P(0)OEt (128), to simply add the acid 
chloride (45) and heat as before. This simple modification increased the obtained 
yield of (127) from 44% to 60% with no loss of purity. 
The route introduced by Moedritzer 240 for the synthesis of phosphinic (and 
phosphonic) anhydrides was also investigated. In this, phosphinyl chlorides are 
heated to 150° C in the presence of paraformaldehyde (1 eq.) (Scheme 2.25). 
However, attempts to repeat the author's preparation of (127) from (45) proved to 
be somewhat problematic. In the majority of the occasions that this reaction was 
performed (using paraformaldehyde (1 eq.)), the final product (127) was shown to 
be contaminated with the acid (125). After much experimentation, it was decided 
that, due to the unreliable nature of this reaction, the resulting low yield (at best, 
45%) and the failure to separate the anhydride from the anhydride/acid mixtures, 
this method would not be pursued 
Q i:%-O 	 150°C 
+ (cl-42 o) 
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It should also be noted that efforts to perform this synthesis using 0.5 and 2 
eq. of paraformaldehyde afforded no reliable increase in yield or guarantee of 
purity. 
Hence the method of choice for the synthesis of Ph 2 PO2 POPh 2 (127) was that 
which involved the preparation, and the use (without distillation), of the 
intermediate Ph 2P(0)OEt (128). 
2.5.3. Initial solution phase peptide couplings with Ph 2PO 2POPh 2 
CR2 Ph 
	
CH2000NH-CH-0O2 H 	+ 	Ph 2 PO2 POPh2 
• 	




CH2 Ph a 	11 1 CH2OCONH-CH--o-PPh 2 	+ 	Ph2po2 - NUMH+ 
(129) 
TosO - H2'GIy08zl 	 NUM 
(107) 
Ch2 Ph 
CH20CDNH-CH-CONH-CH2 -0O2 CH2 
(131) 
Scheme 2.26 
Before any experimentation on the stability and relative reactivity etc. of 
Ph 2PO2 POPh 2 (127) was performed, an attempt had to be made to discover if (127) 
did indeed mediate the formation of amide bonds. This was accomplished by the 
successful preparation of two simple dipeptides, Na_(b enzy l oxycarbony l)ph eny l_ 
alanylglycine benzyl ester (Z-Phe-Gly-OBzl) (109) and 
N-(benzyloxycarbonyl)phenyl-aIanylaIantne benzyl ester (Z-Phe-Ala-OBzl) (132), 
using (127) as the coupling reagent. 
Z-Phe-OH (108) (1 eq.) was activated by the addition of (127) (1 eq.) and 
N -methylmorpholine (1 eq.) at -5 °C in 0CM. After 10 minutes at -5 °C 
TosOH2 '-Gly-OBzI.(1O7) (1 eq.) and N -methylmorpholine (2 eq.) were added, and 
the resulting mixture stirred at room temperature for 2.5 hours. (Scheme 2.26). 
Work up afforded the crude dipeptide, which was purified by recrystallisation to 
give Z-Phe-GIy--OBzI (109) as a white solid in 60% yield. 
In solid phase peptide synthesis, the incoming activated amino acid derivative 
(e.g (129)) is applied in excess (typically 2-4 times excess) in order to push the 
coupling reaction to completion. In an attempt therefore to mimic SPPS and to 
increase the yield of (109) the above reaction scheme was repeated using 
Z-Phe-OH (108) (2 eq.), N-methylmorpholine (2 eq.) and Ph 2 PO 2 PrOPh 2  (127) (2 eq.) 
for the activation step, followed by the addition of TosOH
2 -Gly-OBzl (107.) (1 eq..) 
and N- methylmorpholine (2 eq.). This increased the yield of (109), as predicted to 
76%. 
After the preparation of TosOH 2 -Ala-OBzl (131), in 91% yield, by the general 
method of Zervas at a! 230, as outlined above for the synthesis of the 
corresponding glycine derivative (107), the above procedure was subsequently 
applied to the coupling of Z-Phe-OH (108) (2 eq.) to (131) (1 eq.), employing 
Ph 2 PO2 POPh 2  (127). This afforded Z-Phe-Ala-OBzl (132) as a white solid in 70% 
yield. 
The preparation of Z-Phe-Gly-OBzI (109) and Z-Phe-Ala-OBzI (132) in good 
yield clearly demonstrated the possibility of employing Ph 2 PO 2 POPh 2 (127) for the 
mediation of peptide bond formation, and hence, further stability and reactivity 
studies were performed in order to gain a better understanding of the nature of 
the reagent. 
2.5.4. 31 P n.m.r. monitored stability studies of Ph 2PO2POPh 2 
The heat of hydrolysis of the P-O-P linkage of phosphinic anhydrides is known 
to be more than that for the corresponding pyrophosphate reaction 241 . There is 
evidence confirming the rapid hydrolysis of phosphinic anhydrides with water 242 
and their ready cleavage by alcoholysis 243244 and aminolysis 240 . 
As regards the use of Ph 2 P02 POPh 2  (127) as a peptide coupling reagent, the 
questions that must be considered are, how air sensitive is (127) (at both reduced 
and room temperature), and what is the relative rate of reaction of (127) with 
carboxylic acids (to form phosphinic-carboxylic mixed anhydrides) as against 
alcoholysis and, more importantly, aminolysis? 
Air sensitivity of Ph 2PO2POPh 2 
After the preparation of •Ph 2PO 2 POPh 2 (127), the compound was stored at 
-15°C, and it has been subsequently shown to be completely stable for more than 
four months at that temperature (by 31 P n.m.r.). This permits the synthesis of large 
quantities of the anhydride for storage prior to being required. 
At room temperature, however, the anhydride is not so stable. While its 
stability may be guaranteed for 24 hours in a sealed vessel, longer periods of time 
result in the hydrolysis of the anhydride to. yield significant quantities of the 
analogous acid, Ph 2 PO2H (125) - up to 60% after 30 days. The storing of some of 
the solid (127) in a sealed Applied Biosystems SPPS capsule (see below), flushed 
with nitrogen, confirmed this observation. The anhydride was shown to be 
completely stable at -15 °C for 30 days, and at room temperature for 48 hours, 
however, after 30 days at approximately 40% of the Ph 2 PO 2H (125) was found to 
be present. 
The conclusions that may be drawn from these studies are: 
on preparation of the anhydride (127), it must be stored in a 
freezer (-15 ° C) prior to use 
the anhydride has sufficient stability to be handled (for 
weighing purposes etc.) at room temperature and in air 
at room temperature, the stability of the anhydride can only be 
guaranteed for 24 hours in a sealed vessel (48 hours if sealed 
under nitrogen), after that a slow but steady build up of 
Ph 2P02H (125) takes place. 
Stability of Ph 2PO2POPII2 to N-methylmorpholine 
Before the stability of Ph 2 PO 2 POPh 2 (127) to N-methylmorpholine was 
examined, samples of the anhydride were dissolved in DMF, DMA and NMP. The 
removal of aliquots of these solutions at 15 minute intervals for 60 minutes, and 
monitoring by 31 P n.m.r., confirmed no significant loss of the starting anhydride 
over the duration of the study. 
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Subsequently (127) was dissolved in a mixture of CD 2 Cl 2/DMA at room 
temperature, and N-methylmorpholine (3 eq.) was added. 31 P n.m.r. was again used 
to confirm that no loss of the starting anhydride (due to the base) was observed 
over the 60 minute period. 
Stability of Ph 2PO2POPh 2  to free-amine amino acid derivatives 
As discussed above, the ready aminolysis of phosphinic anhydrides is known to 
take place. It was interesting therefore to compare the relative rates of reaction of 
(127) with TosOH 2 -Gly-OBzl (107) (1 eq.) in the presence of N -methylmorpholine, 
with that of the formation of phosphinic-carboxylic mixed anhydrides (see below). 
n.m.r. revealed the existence (after 15 minutes) of the diphenylphosphinate 
anion (Ph 2 PO 2 ) ( 130) signal, and its steady but slow increase in size. 
Stability of Ph 2PO2POPh2 to alcohols 
Again, the known reaction of alcoholysis of phosphinic anhydrides has been 
discussed. 
Dissolving the anhydride (127) in a solution of CD 2 Cl 2/methanol, and a solution 
of CD 2Cl 2/benzyl alcohol,, resulted in no significant loss of the anhydride signal 
over a period of 30 minutes (by 31 P n.m.r.) in either case. On the addition of 
N- methyl morpholine (2 eq.) to the methanol solution, the anhydride signal 
diminished completely within 30 minutes to afford two signals, one corresponding 
to the phosphinyl ester and the other to the phosphinate anion (130). The benzyl 
alcohol solution on the other hand, revealed a much reduced loss of the anhydride 
signal, and the introduction of a small phosphinate anion signal. 
These studies clearly demonstrate the possibility of performing both the 
aminolysis and the alcoholysis of Ph 2 PO2 POPh 2 (127), but at a relatively slow rate 
compared to that of phosphinic-anhydride mixed anhydride formation (See below). 
2-5.5. 31 P n.m.r. monitored peptide couplings with Ph 2PO2POPt12 
In an attempt to further understand the Ph 2 PO2 POPh 2 (127) mediated coupling 
reaction of Z-Phe-OH (108) and TosOH 2 -Gly-OBzI (107), the reaction was 
repeated on a scale such that it could be followed by 31 P n.m.r. 
The activation reaction (Scheme 2.26) was shown to be complete within 15 
minutes, that is , 	n.m.r. revealed the presence of Only two signals - one 
corresponding to the mixed anhydride (129), the other to the phosphinate anion 
(130) - after such time (see Figure 2.5). 
The subsequent coupling to TosOH 2 -GIy-OBzJ (107), in the presence of 
N- methylmorpholine, was shown to be complete within 20 minutes - only a large 
phosphinate anion signal remained after this time. 
A similar coupling of Fmoc-Arg(Pmc)-OH (133) and (107) was performed using 
Ph 2 PO2 POPh 2 and followed by 31 P n.m.r. A somewhat different activation 
conclusion was reached, in which a significant quantity of the starting anhydride 
(127) remained as well as the formation of the mixed anhydride (46) and the 
liberation of the phosphinate anion (130). However; on the addition to the reaction 
of the TosOH 2 +-Gly-OBzl (107) and further N-methylmorpholine, the reaction was 
driven to completion and the coupling performed within 20 minutes. 
A number of alternative N e-protected amino acid derivatives with protected 
side-chain functionality (e.g. Fmoc-Cys(Acm)-OH and Fmoc-His(Trt)-OH) were 
activated using (127) and coupled to (107), and monitored by 3 P n.m.r. In all cases 
the activation step was shown to be complete, whether actually to the complete 
reaction of (127), or to an 'equilibrium' position concerning the starting anhydride 
(127), the mixed anhydride (46) and the phosphinate anion (130) as above, within 
15 minutes, and the coupling complete within 30 minutes. 
The studies above concerning the alcoholysis of (127) were also considered 
further. In a simple attempt to study the relative rates of mixed anhydride 
formation as against alcoholysis, Bnpeoc-Ser-OH (88) was activated with (127) and 
coupled to (107), and monitored by 31 P n.m.r. A position was reached almost 
immediately with the activation reaction, whereby the starting anhydride (127), the 
mixed anhydride and the phosphinate anion were all present. The relative sizes of 
the peak heights of these signals changed little over a 20 minute period. No signal 
for the phosphinyl ester that may have been formed by the reaction of the 
anhydride (127) with the free hydroxyl function of the side-chain of the serine 
residue was observed. 
The subsequent coupling was shown to be complete within 20 minutes of the 
addition of the TosOH 2 -Gly-OBzl (107) and N-methylmorpholine. 
Fmoc-Asn-OH (134), that is, N e-protected asparagine with free side-chain 
amide functionality, is routinely coupled as the HOBt ester derivative (prepared 
(A) Z-Phe-OH / Ph 2 PO 2 POPh 2 / NMM 
5 minutes after mixing 
(B) Z-Phe-OH / Ph 2 PO 2 pOph / NMM 
15 minutes after mixing 
Figure 2.5 Activation of Z-Phe-OH and coupling to TosOH2'-GIy-OBzI. 
(C) Z-Phe-ODpp / TosOH 2 -Gly-OBzI / NMM 
15 minutes after mixing 
(D) Z-Phe-ODpp / TosOH
2 + -3Iy-OBzI / NMM 




using a carbodiimide) in solid phase synthesis. This is due to the fact that mixed 
anhydrides of, for example, Fmoc -Asn-OH, undergo an internal cyclisation which 
results in the dehydration of the side-chain functionality (Scheme 2.27). 
NH2 	 + NH2 
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Fmoc-NH-CH-C-0-pph 2 	 Fmoc-NH-CH-C-0-pph 2 
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It was predicted therefore that attempts to activate Fmoc-Asn-OH (134) with 
Ph 2P02 POPh 2 would result in the aforementioned dehydration. Indeed when this 
activation was performed on a 31 P n.m.r. scale, it revealed the complete decay of 
the starting anhydride (127) signal to afford only the phosphinate anion signal 
signal within 20 minutes. An infrared spectrum of the reaction mixture confirmed 
the presence of the characteristic nitrile peak (2260 cm 1 ). 
At this point it was decided to investigate the suitability of the Mbh side-chain 
protecting group for asparagine and glutamine. Fmoc-Gln(Mbh)-OH (135) was 
activated as above with (127). 31 P n.m.r. revealed the presence of only two signals 
after 15 minutes, one corresponding to the activated mixed anhydride, the other to 
the phosphinate anion (130). The ratio of the peak heights of these two signals 
changed little over a 60 minute period. The coupling was shown to be complete 
within 15 minutes of the addition of TosOH 2 -Gly-OBzl (107) and further 
N-methylmorpholine. 
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The stability of the formed phosphinic-carboxylic mixed anhydride (129) was 
also investigated. Z-Phe-OH (108) was activated with (127) and 
N-m ethyl morpholine by the method outlined above. After 10 minutes, a position 
had been reached whereby three signals were present by 31 P n.m.r., the mixed 
anhydride (129), the starting anhydride (127) and the phosphinate anion (130). As 
the ratio of the peak heights of these signals remained unchanged over 4 hours at 
room temperature, it was assumed that the mixed anhydride (129) had the required 
stability and was not prone to unwanted side reactions (e.g disproportionation). 
2.5.6. Further solution phase peptide couplings with Ph 2P02POPh 2 . 
The 31 P n.m.r. coupling experiment with Bnpeoc-Ser-OH (88) and 
TosOH 2 -Gly-OBzi (107) suggested that it may be possible to activate, and couple. 
a N e-protected amino acid derivative with free hydroxyl side-chain functionality 
(Scheme 2.28). The above experiment was therefore repeated on a preparative 
scale. A tic of the final reaction mixture revealed a number of reaction products, 
however, separation was possible by flash chromatography and Na_[2,2_b/ s 
(4'- nitro phenyl)ethoxycarbonyl]-serylglycine benzyi ester (Bnpeoc-Ser-Gly-OBzI) 
(136) was obtained as a yellow oil in 61% yield. Apart from the limited preparative 
applications of this reaction, it confirms the observation of selective 
phosphinic-carboxylic mixed anhydride formation over phosphinyl ester generation. 
The coupling of Fmoc-GIn(Mbh)-OH (135) to (107) was also repeated on a 
preparative scale to afford N - (9 -fluorenylmethoxycarbonyl)glutamyl [N-bis 
(4'- methoxyphenyl)methyi]-glycine benzyl ester (Fmoc-Gln(Mbh)-Gly-OBzl) (137) as 
a white solid in 77% yield. This confirmed the suitability of the Mbh group for use 
in side chain amide protection while employing a phosphinic-carboxylic mixed 
anhydride activation and coupling methodology. 
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2-5.7. Racemization studies 
Investigations concerning the possible occurance of racemization of the 
activated amino acid derivatives that are generated with Ph 2 POCI (45) have been 
carried out 139,144,  and have identified no such problems providing urethane-type 
N a -protecting groups are used. As the phosphinic-carboxylic mixed anhydride (46) 
that is produced with Ph 2 PO2 POPh 2 (127) is the same as is generated with (45), no 
problems with the loss of optical purity are anticipated. 
However, by way of a check, (127) was employed in the activation and coupling 
of Fmoc-L-Phe-OH and Fmoc-D-Phe-OH to TosOH 2 -Ala-OBzl (131) to afford 
Na_(9_fluorenylmethoxvcarbonyl)_L_ phenylalanyl-L-alanine benzyl ester 
(Fmoc-L-Phe-L-Ala-OBzl) (138) and Na_(9_fl u oreny lm ethoxycarbony l)_D_ph eny l_ 
alanyl-L-alanine benzyl ester (Fmoc-D-Phe-L-Ala-OBzl) (139) respectively (in 58 
and 62% yields). Any racemization would lead to the partial inversion of the 
phenylalanine centre and therefore lead to the contamination of both of the 
diastereomers with the other. 
Analytical reverse phase hplc traces of the two products revealed a slight 
difference in retention times, but not one sufficient to give base-line resolution of 
the two peaks when a hplc trace was run of a mixture of the two products. 
11. 
Therefore, while the studies revealed that certainly no major degree of 
racemization (i.e. 20%) had taken place during the activation and coupling, the 
limits were not such that lower quantities could be identified. 
Ph 2 PO 2 POPh 2 (127) has also been employed in the loading of the first amino' 
acid derivative (i.e. the C-terminal amino acid residue of a peptide chain) on to the 
p-alkoxybenzyl alcohol resin (8) (see below). That is, it has been used in the 
mediation of ester, as well as amide, bond formation. 
The possibility of a loss of optical purity of an N a-protected amino acid 
derivative when activated with (127) and coupled to an alcohol, to form an ester 
bond, was also siniilarily investigated. Fmoc-L-Ala-OH and Fmoc-D-Ala-OH were 
coupled to (-)-menthol to afford Na_(9_fl uoren y l methoxycarb ony l)_L_ a l an i ne 
(-)-menthyl ester (Fmoc-L-Ala-O[(-)Men]) (140) and 
Na_(9_fluorenylmethoxvcarbonvl)_D_alanine (-)-menthyl ester 
(Fmoc-D-Ala--O[(-)Men]) (141) respectively (in 43 and 48% yields). Again, while a 
separation of the 2 diastereomers was possible by reverse phase hplc, it was not 
such that base-line resolution could be obtained. Hence no small quantities of 
racemization, if they had occured, could be identified. 
These studies on the possibility of racemization with Ph 2PO 2 POPh 2 (127) are by 
no means complete, and are continuing at present within this research group. 
2-5.8. Peptide couplings with Ph 2PO2POPh2 and Zn1 2 
Jacquier 	has 	recently 	discussed 	(but not 	yet published) 	work 	on 	peptide 
couplings with Ph 2 POCI (45) when used in conjunction with Zn1 2 . His research has 
suggested that the addition of a quantity of Znl 2 (approximately 	0.1 	eq.) to 	his 
couplings of dipeptides 	to amino 	acid 	derivatives has 	resulted 	in 	a 	significant 
reduction 	in 	the 	observed racemization (due 	to aziactone 	formation) 	of 	the 
dipeptide moiety. 
It was therefore decided to investigate the effect of adding Zn1 2 to 
Ph 2 PO2 POPh 2 (127), and to the couplings mediated with this reagent. 
Stability of Ph2PO2POPh2 to ZnI2 
The addition of Zn1 2 (0.1 eq.) and N- methyl morpholine (1 eq.) to a solution of 
(127) in CD 2Cl 2/DMF resulted in no change in the 31 P n.m.r. signal for the 
anhydride (127) over a 75 minute period. However, if Znl 2 (1 eq.) was added, 3P 
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n.m.r. revealed the instantaneous and complete generation of an alternative 
phosphorus species. The addition of N -methylmorpholine caused a further shift in 
the location of the phosphorus signal. Clearly some form of complex is being 
generated , with the Zn1 2, however the identity of this 'complex' has yet to be 
ascertained. 
31 n.m.r. monitored peptide couplings with Ph 2PO2POPh2 and Znl2 
A repeat of the reaction of Z-Phe-OH (108) with Ph 2 PO 2 POPh 2 (127) and 
N-methylmorpholine, gave complete activation within 15 minutes as above. The 
addition of Znl 2 (0.1 eq.) to this activation solution resulted in a change in the 31 P 
n.m.r. spectrum - what had been a sharp peak for the phosphinate anion (130), had 
shifted in position and become a broad hump. No relative change in the integrals 
of these signals occured over a 10 minute period, and therefore 
TosOH 2 '-Gly-08zl (107) and further N-methylmorpholine were added. The 
coupling was shown to be complete within 10 minutes. 
Performing the above reaction again, but with the Zn1 2 (0.1 eq.), present at the 
beginning of the activation, rather than adding it at the end, gave, immediately on 
mixing, three signals: one corresponding to the activated mixed anhydride (129), 
one to the starting anhydride (127) and one to the phosphinate anion (130) (a 
broad signal). The ratio of the peak heights of these signals remained unchanged 
over a 10 minute period. The subsequent coupling of (129) and (107) was shown to 
be complete within 10 minutes of the addition of (107) and further 
N-methylmorpholine. 
As mentioned above Jacquier has been using Zn1 2 to suppress the racemisation 
taking place in dipeptide centres during 'activation and coupling. It was therefore 
decided to investigate this observation by coupling Fmoc-Met-Gly-OH to 
TosOH 2 -GIy-OBzl (107) using Ph 2 PO2 POPh 2 (127). As above, the reaction was 
performed twice - firstly with the Zn1 2 added after, the activation, and secondly, 
with it present at the Start of the activation. 
Fmoc-Met-Gly-OH was therefore activated with (127) in the presence of 
N-methylmorpholine as outlined above. Immediately on mixing 31 P n.m.r. revealed 
three signals: the activated anhydride, the starting anhydride (127) and the 
phosphinate anion (130). Over the following 20 minute period, the signals for the 
mixed anhydride and the starting anhydride decreased, while that of the 
phosphinate anion increased in relative size. This can be attributed to the 
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formation of an aziactone intermediate, and hence is responsible for the 
racemization which is observed in couplings of this type. However, on the addition 
of Zn1 2  (0.1 eq.), an unexpected observation was made. The previously discussed 
broad hump for the phosphinate anion was revealed, but a large, sharp signal was 
also immediately present. It was not possible, however, to ascertain the identity of 
this signal i.e whether or not it was the starting anhydride or the mixed anhydride. 
Over a 10 minute period the ratio of the relative peak heights of these signals 
remained unchanged. TosOH 2 -Gly-OBzl (107) and further N-methylmorpholine 
were added, and 31 P n.m.r. revealed the completion of the coupling within 20 
minutes. Mass spectroscopy confirmed the presence of a peak at 576 (i.e. 
corresponding to Fmoc-Met-Gly-Gly-OBzl) in the spectrum of the reaction mixture. 
The reaction was repeated with the Znl 2 present at the beginning of the 
activation. 5 minutes after the activation components were mixed, 31 P n.m.r. 
revealed three signals: the mixed anhydride, the starting anhydride (127) and the 
phosphinate anion (130) (broad signal). The relative ratio of the peak heights of 
these signals did not change over the following 15 minute period. The subsequent 
coupling with (107) in the presence of further N-methylmorpholine was shown to 
be complete within 20 minutes (mass spectroscopy again confirming the presence 
of a peak at 576). 
In an attempt to study further the effect of the presence of Znl 2, the coupling 
of Z-Phe-OH (108) and TosOH 2 -Ala-OBzl (131) was repeated as above on a 
preparative scale, but with Znl 2 (0.1 eq.) present. Work up afforded the crude 
dipeptide, which was purified by flash chromatography to give Z-Phe-Ala-OBzl 
(132) in 81% yield. This compares favourably with the aforementioned yield of 70% 
for the coupling without the addition of the Znl 2 . 
The conclusions that can be drawn from the above Ph 2 PQ2 POPh 2/2n1 2 
experiments are, that in the example: of the coupling of Z-Phe-OH (108) and 
TosOH2 4 -Gly-OBzl (107), the addition of the Znl 2 appears to increase the rate of 
both the activation and coupling reactions, as well as the yield. In the coupling of 
Fmoc-Met-Gly-OH to (107), the Znl 2 (if present at the start of the activation) 
appears to tie up the activated dipeptide in such a fashion that azlactone 
formation does not take place, and this in turn prevents racemization. Beyond this, 
the role of Zn1 2 in these reactions remains somewhat of a mystery, and one which 
merits further investigation and understanding. 
2.5.9. Regeneration of Ph 2POCI 
One advantage of the use of the coupling reagents Ph 2 POCI (45) and 
Ph 2 PO 2 POPh 2  (127) is that they may be regenerated from re-isolated Ph 2 PO2 H 
(125). This has been of particular importance in this work bearing in mind the 
considerable number of attempted preparations of (127) which have resulted in 
inseparable mixtures of (127) and (125). 
The Ph 2 PO2 PQPh 2/ph 2 pO 2 H mixtures from these failed preparations were 
converted completely into Ph 2 PO2 H by simply partitioning them between ethyl 
acetate and 1M NaOH. The separated aqueous layer was acidified to pH 2.0 by the 
addition of 1M HCI, and the resulting white precipitate worked up to afford 
Ph 2 P02H (125). The conversion of (125) to Ph 2POCI (45) was performed by the 
method of Kreutzkamp and Schlindler 236, which involves simply heating the acid in 
thionyl chloride, followed by distillation, to give (45) as a yellow oil in 86% yield. 
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2.6. Solid Phase Peptide Synthesis 
The objectives of this section of work were to prepare a number of peptides 
using current solid phase methodology, while introducing the Bnpeoc 
No- protecting group (16) and the diphenyiphosphinic anhydride (127) activation 
and coupling reagent, bn an Applied Biosystems 430A automated solid phase 
peptide synthesiser. 
2.6.1. Loading the first residue onto the p-alkoxybenzyl alcohol resin 
As discussed above, the coupling of the first amino acid residue (i.e. the 
C-terminal residue of a peptide chain) to the p-alkoxybenzyl alcohol resin (8) was 
performed outside the automated synthesiser. This permitted the coupling to be 
accomplished by ultrasonication, and hence provide the optimum coupling yield. 
The standard method employed in this research group for this coupling involves 
the formation of the activated symmetrical anhydride of the N o-protected amino 
acid derivative using a carbodlimide (Did). However, this method often requires the 
use of a second coupling in order to obtain an acceptable yield. Hence a 
considerable excess of Na_protected amino acid must be used and is therefore 
wasted. Figure 2.6 provides some examples of the yields that have been obtained 
using this DICI mediated symmetrical anhydride coupling method. 
amino acid derivative 	 quantity 	 coupling yield 
	
Fmoc-Gly-OH 	 1 x 4 eq. 	 54% 
Bnpeoc-Gly-OH 	 1 x 4 eq. 	 52% 
Bnpeoc-Ala-OH 	 2 x 4 eq. 	 78% 
Figure 2.6 
Figure 2.6 shows that a considerable quantity of Na_protected amino acid must be 
used in order to give an acceptable coupling of the first residue. While this can be 
tolerated with the cheaper amino acid derivatives (e.g. Fmoc-Gly-OH), it becomes 
unacceptable with the costly ones (e.g. Fmoc-Arg(Pmc)-OH). 
Attempts were therefore made to mediate this ester bond formation using the 
Ph 2PO2 PQPh 2  (127) coupling reagent (Scheme 2.29). A number of Not-protected 
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amino acids were activated by the addition of (127) and N -methylmorpholine at 
room temperature in DMA (or DMF). After stirring for 15 minutes, the activated 
mixture was transferred to a vessel containing the p-alkoxybenzyl alcoholresin (8) 
previously swollen in DMA (or DMF), and further N-methylmorpholine, together 
with a catalytic quantity of DMAP, were added. Agitation by the preferred method 
of ultrasonication was performed for 3 hours at room temperature before the resin 
was filtered, washed and dried. 
Fmoc-NH-CH 2 -CO2 H 	+. 	Ph2 PO2 POPh2 
NUM 
- 	+ 
Fmoc—NH—CH 2 —CO2POPh2 	+ 	Ph2 PO2 NUUH 
NW4/DMAP 	HO 	 OCH2 
(8) 
Fmoc—NH—CH2 —0O2 	 OCH2 _Q_ILYUER 
Scheme 2.29 
Figure 2.7 summarises the yields that were obtained when the coupling of the 
first amino acid residue was performed using Ph 2 PO 2 POPh 2 (127). 
102 
amino acid derivative 	 quantity 	 coupling yield 
Fmoc-Gly-OH 	 1 x 4 eq. 	 80% 
Fmoc-Ala-OH 	 1 x 4 eq. 	 78% 
Fmoc-Ala--OH 	 2 x 2 eq. 	 79% 
Figure 2.7 
The data in Figure 2.7 clearly • suggested that when a similar quantity of 
Na-protected amino acid derivative was employed in the Ph 2 PO2 POPh 2 mediated 
couplings as to the DICI mediated ones, the obtained yields were significantly 
higher. This therefore permits a smaller number of equivalents of the incoming 
first amino acid to be used in order to obtain similar coupling yields with the 
Ph 2 PO2 POPh 2 reagent as to the that which are provided with DICI. 
2.6.2. Solid Phase Peptide Synthesis 
A number of peptides were prepared introducing Ph 2 POI 2 POPh 2 (127) and 
Bnpeoc (16) to solid phase methodology. 
The first peptide synthesised by employing the (127) coupling reagent was 
tyro sylisoleucylphenylalanylalanylglycine (H-Tyr-Ile-Phe-Ala-Gly-OH) (144). The 
synthesis was performed on a 0.5 rnmol scale and was accomplished using Fmoc 
amino acid derivatives, the functionalised resin Fmoc-Gly-(O-CH 2 C 6 H 4-OR) (142) 
and tert.butyl ether protection for the tyrosine side chain hydroxyl. 
Apreprogrammable 'double couple' cycle was prepared and employed which 
involved, firstly, the activation of the incoming Fmoc amino acid (2 eq.) with 
Ph 2PO2POPh 2  (127) (2 eq.) in the presence of N-methylmorpholine (2 eq.) at room 
temperature in (what is known as) the activation vessel on the synthesiser. The 
resulting phosphinic-carboxylic mixed anhydride was then transferred to the 
reaction vessel and coupled to the free-amine resin bound product, with the 
addition of further N-methylmorpholine (1 eq.) and 2,6-lutidine (4 eq. - see before). 
After 40 minutes coupling time the reaction mixture was removed and the resin 
and washed with further solvent. The activation and coupling cycle was then 
repeated (and hence the term 'double couple') in order to force the coupling to 
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completion, before the functionalised resin was washed well and capped (i.e any 
unreacteci amine sites were blocked by acetylation in a solution of acetic 
anhydride and pyridine). Deprotection was performed by the now-standard 
conditions for the cleavage of Fmoc, that is, 20% piperidine in DMF (or DMA) 
(Scheme 2.30). 
	
Fmoc-NH-CH-COH 2 	 OCH3 	 LYUER 
deprotection 
H2 N-H-CO2 CH2 	 OCH2 	 LYUER 
R2 
Fmoc-NH-CH-0O2 POPh2 	NUU (2 eq.) 
(2 eq.) 
2 




Throughout the above synthesis the Pti 2PO2POPh 2 (127) was stored in a 
solution of DMA and simply transferred to the activation vessel when required. 
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The cleavage of the peptide from the resin, performed with a solution of TFA in 
DCM, together with the simultaneous removal of the tert.butyl ether protecting 
group from the side-chain hydroxyl function of the tyrosine residue, afforded the 
crude pentapeptide as a yellow solid. Analytical reverse phase hplc revealed this 
solid to contain a number of reaction products, however, purification by 
preparative reverse phase hplc proceeded smoothly and the desired pentapeptide 
(144) was isolated as a white solid in an overall yield of 41%. 
At this point checks were made as to the long term stability of the anhydride 
(127) in the DMF and DMA solutions, bearing in mind its susceptibility to hydrolysis 
31 at room temperature as the solid. 	P n.m.r. revealed that a significant quantity of 
the anhydride was hydrolysed to the corresponding acid (125) if stored in solution 
for a number of days. This observation therefore rules out the possibility of 
preparing large volumes of the anhydride in a solution of •DMF (or DMA) for 
prolonged use on the automated synthesiser. Clearly a method had to be found 
whereby the anhydride was only taken into solution immediately prior to being 
required. The method employed for the synthesis of the remaining Ph 2 PO2 POPh 2 
prepared peptides in this section, was to have the anhydride stored on the 
synthesiser in capsules similar to those ones which are used to contain the 
Not- protected amino acid derivatives. In the case of the amino acid derivatives, 
solvent is added to the capsule immediately prior to the derivative being required, 
it is taken into solution and then transferred to the activation vessel. By simply 
alternating the amino acid capsules with the anhydride ones, the anhydride could 
be taken into solution and transferred to the activation vessel when required. 
The 	 pentapeptide, 	 Ieucylisoleucylphenylalanylalanylglycine 
(H-Leu-Ile-Phe-Ala-GIy-OH (145), corresponding to residues 43-47 of ubiquitin, 
was subsequently prepared using the aforementioned 
Fmoc/Ph 2PO 2 POPh 2/p-alkoxybenzyl alcohol resin 'double couple' (2 x 2eq.) cycle 
but with the anhydride stored on the synthesiser as a solid, rather than in solution. 
Analytical reverse phase hplc of the crude peptide on cleavage from the resin and 
work up revealed only one product. Nevertheless the peptide was passed down a 
gel filtration column and lyophilised to afford - (145) as a white solid in excellent 
yield (78%). 
By way of comparison the same peptide, H-Leu-lle-Phe-Ala-Gly-OH (145), was 
prepared using Fmoc amino acids and Fmoc-Gly-(O-CH 2C 6 H 4-OR) (142), but 
employing the DICl/HOBt activation and coupling methodology which is routinely 
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used on this research group's 430A synthesiser (for cycle - see Experimental). This 
synthesis also afforded the crude pentapeptide as one peak by analytical reverse 
phase hplc, and subsequently resulted in the isolation of (145) as a white solid in 
73% yield after gel filtration. 
What is interesting to note is that the same peptide was prepared in almost 
the same yield (if anything, a yield consideration would favour the Ph 2 PO 2 POPh 2 
prepared peptide) with the Fmoc/Ph 2 PO2 POPh 2 (127) methodology as with the 
Fmoc/DICl/HOBt methodology. However, in the case of the Ph 2 PO 2 POPh 2 prepared 
peptide, only a total of four equivalents of the Fmoc amino acid derivative was 
required per residue, compared with the six required when DlCl/HOBt methodology 
is employed. Another beneficial aspect of using Ph 2 PO2 POPt1 2 methodology is that 
the residue time (i.e. the length of time it takes to incorporate one residue into the 
peptide chain) is reduced from 4-5 hours (with DlCl/HOBt) to 2-3 hours. This is 
more significant than might be first imagined as often the limiting factor in solid 
phase synthesis is the lack of available machine time, rather than the subsequent 
purification and analysis. 
The pentapeptide H-Leu-Ile-Phe-Ala-Gly-OH (145) was synthesised on two 
subsequent occasions - again using both Ph 2 PO 2 POPh 2 and DICl/HOBt 
methodology, but employing Bnpeoc N a-protected amino acid derivatives and 
Bnpeoc-Gly(O-CH 2C 6 H 4-OR) (113) for both preparations. 
In the case of the Bnpeoc/DlCl/HOBt prepared peptide, analytical reverse phase 
hplc of the crude peptide after cleavage from the resin and work up, revealed two 
products: a major peak (corresponding to the desired pentapeptide), and a minor 
peak. Amino acid analysis of the crude product (Gly 1 1.08, Ala 1 0.77, lle 1 l.03, 
Leu 1 l.03, Phe 1 l.06) suggested the impurity to be the tetrapeptide 
H-Leu - Ile-Phe-4-'(-OH. On purification of the material by preparative reverse phase 
hplc, the major product was indeed identified as the desired pentapeptide (145) (in 
61% yield), and the minor as the suggested tetrapeptide. Clearly the initial 
deprotection of the glycine residue had not gone to completion. However, on the 
subsequent alanine residue deprotection, it appears that the remainder of the 
glycine was also deprotected. While steric constraints could be regarded as one 
possible explanation for the incomplete removal of the Bnpeoc protecting group 
from the glycine residue (Bnpeoc is significantly larger than Fmoc), it is more 
difficult to explain why the remaining Bnpeoc-Gly(O-CH 2 C 6 H 4 -OR) (113) should be 
deprotected during the second set of deprotections, where if. anything, the 
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problems of steric bulk around the surface of the resin must surely be greater. 
When the peptide (145) was prepared by Bnpeoc/Ph 2 PO 2 POPh 2  methodology, a 
shoulder was also found to be present on the major product peak (which 
corresponded to the desired pentapeptide) in the analytical reverse phase hplc 
trace of the crude product on cleavage from the resin and work up. Purification 
was again accomplished by preparative reverse phase hplc, and afforded the 
pentapeptide (145) on the removal of the hplc solvents by lyophilisation as a white 
solid in 58% yield. 
What these studies appear to have shown is that the deprotection 
conditions/timings etc. for the Fmoc protecting group can not be automatically 
applied to the Bnpeoc deprotection. Considerable further experimentation must be 
performed if the Bnpeoc is to be successfully incorporated into existing solid 
phase methodology. 
In an attempt to gain further solid phase experience with Ph 2 PO2 POPh 2 (127), a 
further two peptides were prepared using the aforementioned Fmoc/Ph 2 PO2PQPh 2 
'double couple' (2 x 2 eq.) cycle. 
Firstly, prolylglycylprolyl-D-phenylalanylalanine (H-Pro-Gly-Pro-D-Phe-Ala-OH) 
(146) was prepared using the above cycle for the incorporation of all the residues 
with the exception of glycine - this was incorporated in a single (1 x 4 eq.) 
coupling rather than the standard (2 x 2 eq.) double cycle. Also in an attempt to 
reduce the volume of solvent present in the reaction vessel during the coupling (a 
result of reducing the volume was that the effective concentration of reagents was 
increased, and it was hoped that this in turn would lead to an increase in coupling 
efficiency), a solution of N- methylmorphofine (2 eq.) in DMF (or DMA) was used to 
dissolve the anhydride (127) in the capsule - rather than dissolving the anhydride 
in DMF (or DMA) and then adding the base solution. 
Analytical reverse phase hplc of the crude product on cleavage from the 
support revealed essentially one product. However, all attempts at this stage to 
obtain the peptide as a solid failed and therefore preparative reverse phase hplc 
was employed to purify the obtained oil. This gave the desired pentapeptide as a 
white solid in excellent yield (79%). Clearly the modifications to the employed 
cycle had no detrimental effect on the quality and quantity of the prepared peptide. 
The 	synthesis 	of 	a 	larger 	fragment 	of 	•ubiquitin, 
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leucylvalylleucylarginylleucylarginylglycylglycine (H -Leu-VaI-Leu-Arg-Leu-
Arg-Gly-Gly-OH) (ubiquitin 69-76) (147), was also performed. Again the standard 
Fmoc/Ph 2 PO 2 POPh 2 'double couple' cycle was used for all residues with the 
exception of glycine. Studies 245  on the swelling characteristics of functionalised 
resins in 0CM, OMF, DMA, and mixtures of DCM/DMF and 0CM/DMA have revealed 
that while the resins swell more in DCM than in DMF or DMA, in mixtures of 
DCM/DMF and DCM/DMA the swelling was actually less than that found with DMF 
and DMA on their own. It was therefore decided to synthesise (147) in DMA only 
rather than in the mixtures of DCM/DMF and 0CM/DMA that had been used 
previously. 
During initial attempts at the preparation of (147) both the coupling of the first 
arginine residue (with side-chain Pmc protection) and the valine residue did not go 
to completion. This can presumably be attributed to the steric problems involved 
with having such bulky side chains. Therefore when the synthesis was repeated, 
the second coupling of each of these two residues was left overnight rather than 
for the standard 40 minutes. This enabled the peptide (147) to be successfully 
synthesised, removed from the resin (with a solution of TFA in DCM, which also 
removed the side-chain Pmc protecting groups) and purified by preparative reverse 
phase hplc. The removal of the hplc solvents by lyophilisation afforded the 
octapeptide (147) as a white solid in 44% yield. The relatively low yield reflects the 
difficulty of the sequence from a preparative point of view due the bulky nature of 
the residues involved. 
At this point investigations into the actual cycles employed in conjunction with 
Ph 2PO2POPh 2 (127) were performed. All the aforementioned peptide synthesis  with 
(127) had made use of the standard (2 x 2 eq.) 'double couple' cycle. It was 
therefore decided to prepare a peptide by this standard cycle (as a reference), but 
also by two other cycles: a 'triple couple' cycle - involving one coupling of 2 
equivalents of the N ot-protected amino acid derivative and (127), and two 
couplings of one equivalent of each (i.e. 1 x 2 eq. + 2 x 1 eq.), and a 'quadruple 
couple' cycle - involving four couplings of one equivalent of each (4 x 1 eq.). The 
peptide chosen for this study was threonylleucylserylisoleucyiglycine 
(H-Thr-Leu-Ser-lie-Gly-OH) (148), due to the bulkiness of each of the side chains 
(with the exception of glycine) i.e. it was hoped that any deficiencies in the 
activation and coupling procedure would be amplified by the steric constraints 
placed on the peptide by the nature of the residues involved. 
108 
The three syntheses of (148) were performed 37 ' 246, and in each case the crude 
peptide was removed from the resin, examined by analytical reverse phase hplc 
and purified by preparative reverse phase hplc. Somewhat disappointingly the 
results revealed no appreciable difference in both the quality of the crude peptide 
and the quantity obtained by preparative hplc from each of the syntheses. The 
standard cycle (2 x 2 eq.) has therefore been retained, due to the simplicity of the 
cycles involved, and the fact that the residue time for the standard cycle is 
considerably less than that for the other two (this is due to increased washing 
time etc.). 
The final peptide prepared in this section of work returned to the use of the 
Bnpeoc N a_protecting group. It was a repeat of the synthesis of 
H-Thr-Leu-Ser-Ile-Gly-OH (148), but employing Bnpeoc Naprotection, tertbutyl 
ether side-chain hydroxyl protection (see above for the preparation of 
Bnpeoc-Ser( tBu)-OH (119) and Bnpeoc-Thr( t Bu)-OH (124)), the functionalised resin, 
Bnpeoc-Gly(O-CH 2C 6 H 4 -OR) (113), and DICl/HOBt activation and coupling. 
The synthesis appeared to proceed smoothly (followed by UV deprotection 
trace - see Experimental), and on cleavage of the peptide from the resin, a yellow 
solid was obtained. Analytical reverse phase hplc of this solid revealed essentially 
one product, however, on purification by preparative reverse phase hplc, the 
pentapeptide was isolated in a disappointing yield of only 33%. At this point in 
time, simply no explanation of why such a low yield of the peptide was obtained 
can be suggested, but obviously further experimentation must be performed if 
conditions/timings etc. are to be found that are compatible with the Bnpeoc group. 
In summary, the solid phase peptide work discussed in this section has proved 
the worth of the Ph 2 PO2 POPh 2 (127) coupling reagent for the mediation of both 
amide and ester bond formation. It has been shown to afford peptides of a similar 
quality and quantity as might be expected if the DICl/HOBt activation and coupling 
procedure had been adopted, while using considerably less amounts of 
Na_protected amino acids. This work, while clearly indicating the potential of the 
Bnpeoc protecting group, suggests that further experimentation will have to be 





All amino acids and protected amino acid derivatives were purchased from the 
SAS group of companies and from Novabiochem respectively, and unless 
otherwise stated were of the L-configuration. All Z- amino acids were prepared by 
literature methods. All Bnpeoc- amino acids were prepared by one of the two 
methods discussed below for the synthesis of Bnpeoc-Ser-OH (88), with the 
obtained characterisation data in agreement with that provided by Florence 78 . 
Melting points were recorded in open capillary tubes on an electrically heated 
Buchi 510 melting point apparatus and are uncorrected. Optical rotations were 
measured on an AA1000 polarimeter using a 10 cm cell in the solvents quoted in 
the text. Thin layer chromatography (tIc) was carried out on commercially available 
plastic sheets precoated with silica gel 60 Gf-254 (Merck) in the following systems: 
(Al) 33/67 ethyl acetate/chloroform 
40/60 methanol/chloroform 
25/75 ethyl acetate/chloroform 
20/80 methanol/chloroform 
50/50 ethyl acetate/chloroform 
60/20/20 n-butanol/acetic acid/water 
ethyl acetate 
25/75 methanol/chloroform 
15/85 ethyl acetate/chloroform 
(AlO) 50/50 methanol/chloroform 
Visualisation of the compounds was achieved by a suitable combination of the 
following methods: UV absorption at 254 nm, potassium permanganate, 
bromophenol blue, 4,4'-bis (dimethylamino)phenyl carbinol (Mary's reagent) and 
ninhydrin sprays. High-performance liquid chromatography (hplc) was performed 
using either a Waters system i.e. 2 x 600A pumps, a U6K injector, a 680 automatic 
gradient controller, a model 441 ultraviolet detector, and a 308 computing 
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integrator; or an Applied Biosystems system i.e. 2 x 1406A solvent delivery 
systems, a 1480A injector/mixer, and a 1783A detector/controller. Analytical 
separations were performed on the following columns and gradients of 
water/acetonitrile (+0.05% TFA): 
Spherisorb C 18, 50/50 to 0/100 (28 minutes), 254 nm 
Spherisorb C 8, 80/20 to 0/100 (28 minutes), 214 nm 
Spherisorb C 8, 50/50 to 0/100 (25 minutes), 229 nm 
Spherisorb C 1 , 80/20 to 0/100 (25 minutes), 229 nm 
Aquapore C 18, 70/30 to 0/100 (28 minutes), 214 and 254 nm 
Aquapore C 18, 90/10 (5 minutes), 90/10 to 0/100 (20 minutes), 229 nm 
(87) Spherisorb C 18, 50/50 to 30/70 (40 minutes), 229 nm 
(B8) Spherisorb C 8, 50/50 to 0/100 (50 minutes), 229 nm 
(89) Aquapore C 18, 90/10 to 40/60 (25 minutes), 229 nm 
(BlO) Aquapore C 8, 90/10 to 0/100 (28 minutes), 229 nm 
(Bi 1) Aquapore C 18, 100/0 (10 minutes), 100/0 to 60/40 (20 minutes), 229 nm 
(812) Aquapore C 18, 95/5(10 minutes), 95/5 to 20/80 (20 minutes), 229 nm 
(B13) Aquapore C 18, 80/20 (5 minutes), 80/20 to 0/100 (30 minutes), 214 nm 
The flow rate was 1 ml/min., and elution of the samples was monitored by 
ultraviolet absorption at 214, 229 or 254 nm as indicated (see above). Amino acid 
analysis were carried Out on a LKB 4150 amino acid analyser following sealed tube 
hydrolysis with constant boiling hydrochloric acid at 110 °C for 18 hours. Infra-red 
spectra were recorded on a Perkin Elmer 781 double beam spectrophotometer in 
the solvent indicated or by the KBr disc technique, with polystyrene (1603 cm') 
employed as the standard. Ultraviolet spectra were recorded in SPPS-grade DMF 
(unless otherwise stated) on a Pye-Unicam SP8-400 spectrophotometer. High and 
low resolution fast atom bombardment (FAB) spectra were measured on a Kratos 
MS 50TC machine. Proton n.m.r. were recorded on a Jeol FX-60 (60 MHz), a Bruker 
WP80 (80 MHz), a WP200 (200 MHz) or a WH360 (360 MHz) machine in the solvent 
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indicated, using tetramethylsilane (TMS) as the external standard (6 = 0.000). 
Carbon-13 n.m.r. spectra were recorded on a Bruker WP200 machine operating at 
50.3 MHz. Samples were dissolved in the solvent indicated and chemical shifts 
were measured relative to TMS assigned to zero. Phosphorus-31 n.m.r. were 
recorded on a Jeol FX-90 (36.3 MHz) or a Bruker WP200 (81.1 MHz) machine, and 
the chemical shifts measured relative to an external 85% aqueous phosphoric acid 
standard assigned as zero. Elemental analysis were carried Out on a Carlo Erba 
elemental analyser (model 1106). All solvents were distilled before use and the 
following were dried using the reagents given in parentheses when required: 
benzene (sodium wire), chloroform (phosphorus pentoxide), dichloromethane 
(calcium hydride), diethyl ether (sodium wire), ethanol (magnesium - iodine) and 
toluene (sodium wire). N,N-Dimethylformamide and N,N - dimethylacetamide were 
commercially supplied by Applied Biosystems, Rathbone and Aldrich, were stored 
over 4A molecular sieves and were used without distillation. 
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Qj=(4=rjitrQp ~ @9yj)met_hane 180) 
The compound was prepared by the adaptation of the general method of 
Jarczewski and Leffek 219 . 
Diphenyimethane (79) (10.0 g, 59.5 mmol) was dissolved in nitromethane (33 ml) 
and added slowly to a vigorously stirred solution of conc. HNO 3 (52 ml) and conc. 
H 2 SO4 (63 ml) maintained at -15 to -25 °C. Stirring was continued for 3 hours 
keeping the temperature below -20 °C, after which the solution was poured into an 
excess of ice-water. The resulting precipitate was filtered oft and washed with 
water (300 ml), cold methanol (15 ml), and diethyl ether (50 ml). Recrystalilsation 
from benzene (twice) afforded the title compound (8.10 g, 53%) as yellow needles: 
tic R f (Al) 0.70; m.p. 182-183 °C (lit. 219 1830C); max.  (bromoform mull) 1520, 1350 
(NO 2), 860 (g-disubstit. benzene) cm -  S H (200 MHz, d 7-DMF) 8.16 (4H, d, J 8.8AS 
Hz, Bnpe aromatic CH's), 7.32 (4H, d, J AS  8.8 Hz, Bnpe aromatic CH's), 4.17 (21-I, s, 
CH  2);  m/z(FAB), 259 (MW), 243, 195; hplc R t  (131) 13.8 minutes. 
N-[22- b/s (4'-Nitrophenyl)ethoxycarbonylj-serine (88) 
Bnpeoc-Ser-OH 
Method A 
The compound was prepared by the general method of Lapatsanis 81 , and 
applied to Bnpeoc N e-protection by Florence 78 . 	 - 
Serine (2.415 g, 23.0 mmol) was dissolved in an aqueous solution of 10% 
Na 2CO 3 (52.0 ml, 46.0 mmol) and 5% NaHCO 3 (38.6 ml, 23.0 mmoi), and cooled to 
0°C. Bnpeoc-ONSu (21) (7.990 g, 18.6 mmol) in DMF (55 ml) was added slowly, and 
the resulting white suspension was stirred at 0 °C for 20 minutes and at room 
temperature for 2 hours. Water (600 ml) was added and the aqueous mixture 
extracted with diethyl ether (2 x 150 ml) and ethyl acetate (3 x 150 ml). The 
aqueous phase was cooled, acidified with conc. HC1 to pH1.5 and extracted with 
ethyl acetate (4 x 200 ml). The combined organic phases were washed with water 
and brine, and dried over Na 2SO 4. The solvent was removed in vacua to afford a 
green oil which crystallised from diethyl ether/chloroform. The material was 
recrystallised from acetone/light petroleum (b.p. 40-60 °C) to give the title 
compound (5.570 g, 71%) as a white solid: tic R f (A2) 0.27; m.p. 171-173 °C (lit. 78 
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169-1730C); [cUD27 +2.9 0 (c = 1, DMF) (lit. 
78 +31 0 (C = 1, DMF)); umax (bromoform 
mull) 1730. 1670 (C=O), 1520, 1350 (NO 2)'  1155 crn1; 5H (200 MHz, CD 3COCD 3) 8.21 
(4H, d, J 	 8.8 Hz, Bnpeoc aromatic CH's), 7.69 (4H, d, J 	 8.8 Hz, Bnpeoc aromaticAB 
CH's), 6.43 (1H, bd, NH), 4.77 (3H, m, Bnpeoc CH,CH 2), 4.28 (1H, m, Ser ctCH), 3.88 
(2H, m, Ser BCH 2);6 C (50 MHz, CID 3 COCD 3) 170.3 (acid C=O), 154.9 (urethane C=O), 
147.1, 146.3 (Bnpeoc quaternary aromatic C's), 128.8, 122.8 (Bnpeoc aromatic CH's), 
64.9 (Bnpeoc CH 2), 61.0 (Ser BCH 2), 55.3 (Ser cUCH), 48.8 (Bnpeoc CH); m/z (FAB), 
420 (MW), 325, 307; hrms, found 420.10427, C 18 H 18 N 309 requires 420.10429 (< 1 
ppm). 
Method B 
The compound was prepared by the generalmethod of Rich 82 
To a stirred suspension of serine (4.893 g, 46.6 mmol) in water (46 ml) was 
added a solution of triethylamine (9.72 ml, 69.9 mmol) in dioxan (46 ml). To the 
resultant solution was added Bnpeoc-ONSu (21) (20.001 g, 46.6 mmol) and the 
mixture stirred at room temperature for 24 hours. Water (300 ml) was added and 
the aqueous mixture extracted with ethyl acetate (3 x 300 ml). The aqueous phase 
was acidified to pH2 with a saturated aqueous solution of KHSO 4 and extracted 
with ethyl acetate (3 x 300 ml). The combined organic phases were dried over 
Na 2 SO 4 and the solvent removed in vacuo to yield a white foam. The material was 
triturated with diethyl ether/chloroform and was recrystallised from acetone/light 
petroleum (b.p. 40-60 °C) to afford the title compound (15.238 g, 78%) as a white 
solid. Characterisation was in agreement with the above, plus the following 
additional data: Found: C, 51.2; H, 4.03; N, 9.87 Calc. for C 18 H 17 N 30 9 C, 51.6; H, 4.05; 
N, 10.0%. 
Deprotection of Bnøeoc-Gly-OBzl (90) with DBU/AcOH 
Bnpeoc-Gly-OBzl (90) (0.064 g, 0.13 mmcl) was dissolved in DMF (5 ml) at 
room temperature and given 5 minutes to equilibrate. To this was added DBU (20.0 
jil, 0.13 mmol) and AcOH (7.7 .iI, 0.13 mmol), and the resulting mixture was stirred 
for 30 minutes. At 5 minute intervals, aliquots (0.5 ml) of the reaction solution 
were removed and quenched by adding to 1M AcOH (1.0 ml) and hplc grade 
acetonitrile (2.0 ml). After running the standard Bnpeoc-Gly-OBzl (90) and 1,1-b/s 
(4'-nitrophenyl)ethene (91), a sample of each aliquot was monitored by analytical 
hplc. The deprotection was shown to be complete in less than 30 minutes. 
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Degrotectionof Fmoc:lv:..QI..with.  DBU/AcOH 
Fmoc-Gly-OBzl (0.052 g, 0.13 mmol) was dissolved in DMF (5 ml) at room 
temperature and given 5 minutes to equilibrate. To this was added DBU (20.0 j.il, 
013 mmol) and AcOH (7.7 ill. 0.13 mmol), and the resulting mixture was stirred for 
30 minutes. At 5 minute intervals, aliquots (0.5 ml) were removed and prepared as 
above for monitoring by analytical hplc. The deprotection reaction was shown to 
be complete within 30 minutes. 
2,2- b/s 	 ( 93)  
Bnpe-OAc 
2,2-b/s (4'-Nitrophenyl)ethanol (19) (3.000 g, 10.4 mmol) was dissolved in pyridine 
(20 ml) and acetic anhydride (1.169 g, 11.5 mmol), and stirred at room temperature 
for 24 hours. The reaction mixture was concentrated in vacuo, co-evaporating 
(three times) with toluene, to yield a yellow solid. The product was recrystallised 
from chloroform/diethyl ether (twice) to afford the title compound (2.680 g, 78%) 
as an off-white solid: tIc R f (A3) 0.65; m.p. 113-114 °C (lit. 78 107-1080C); Found: C, 
58.2; H, 4.36; N, 8.40 CaIc. for C 16 H 14 N 206 C, 58.2; H, 4.24; N, 8.48%; 'ama,. (CH 2 Cl 2 ) 
1740 (C=O), 1520, 1350 (NO 2)'  1220, 1040, 860 cm 1 ;ISH (80 MHz, COd 3) 8.16 (4H, d, 
AS 
8.9 Hz, Bnpeoc aromatic CH's), 7.38 (4H, d, J 8.9 Hz, Bnpeoc aromatic CH's),AS 
4.63 (3H, m, Bnpeoc CH,CH 2), 1.96 (3H, s, CH); 6c  (50 MHz, CDC 13)170.4 (C=O), 
147.2, 146.8 (quaternary aromatic C's), 124.0, 123.5 (aromatic CH's), 65.2 (Bnpeoc 
CH 2), 49.4 (Bnpeoc CH), 20.5 (CH 3 ). 
1,1-b/s (4'-Nitrophenyl)ethene (91) 
The compound was prepared by the method of Florence 78 
2,2-b/s (4'-Nitrophenyl)ethyl acetate (93) (1.824 g, 5.53 mmol) was dissolved in 
chloroform (18 ml) and to this was added DBN (1.37 ml, 11.1 mmol). On addition of 
the base, the initially pale yellow solution turned dark blue and a white precipitate 
formed. After 15 minutes the reaction mixture was diluted with further chloroform 
(12 ml) and washed with 2M HCl (2 x 30 ml), water (1 x 30 ml), 1M NaOH (2 x 30 
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ml) and brine (2 x 30 ml). After drying over Na 2 SO 4 , the solvent was removed in 
vacuo to yield a yellow solid. The product was recristallised from chloroform/light 
petroleum (b.p. 40-60 °C) to afford the title compound (1.031 g, 69%) as a yellow 
solid: tic R f (A3) 0.75; m.p. 174-175 °C (lit. 78  175-176 0C); Found: C, 61.8; H, 3.73; N, 
10.3 CaIc. for C 14 H 10 N 204 C, 62.2; H, 3.70; N, 10.4%; Umax  (CH 2Cl 2) 1605, 1520, 1350 
(NO 2), 870 cm 1 ; X max 304 nm; tS (200 MHz, COd 3) 8.22 (4H, d, JAB9.0 Hz, Bnpe 
aromatic CH's), 7.46 (4H, d, J 
AB  9.0 Hz, Bnpe aromatic CH's), 5.77.(2H, 5, CH 2 ); 
(50 MHz, COd 3) 147.6, 146.5, 146.4 (3 x quaternary C's), 128.8, 123.7 (aromatic 
CH's), 120.0 (CH 2 ); m/z(FAB), 271 (MH), 255, 240, 176; hplc R t (Bi) 16.8 minutes. 
N-[2,2-bis (4' - Nitrophenyl)ethyfl7piperkJine (92) 
1,1-b/s (4'-Nitrophenyl)ethene (91) (0.105 g, 0.39 mmol) was dissolved in DMF 
(3.0 ml) at room temperature. On addition of piperidine (1.0 ml), the initially pale 
yellow solution turned dark blue. After 20 minutes the solution had returned to a 
pale yellow colour. The removal of the solvent in vacua co-evaporating with DCM 
(twice), afforded an orange oily residue; X max  275 nm; SH  (200 MHz, CDCI 3) 8.12 
(4H, d, J AB  8.9 Hz, Bnpe aromatic CH's), 7.37 (41-1, d, J 8.9 Hz, Bnpe aromatic CH's),AB 
4.41 (1H, t, J 7.7 Hz, Bnpe CH), 2.89 (21-1, d, J 7.7 Hz, Bnpe CH 2), 2.40 (41-1, m, 2 x 
CH 2)'  1.41 (61-1, m, 3 x CH 2 );  6c (50 MHz, CDCI 3) 149.8, 146.5 (quaternary aromatic 
C's), 129.0, 123.5 (aromatic CH's), 63.3 (Bnpe CH 
2)'  54.5 (CH 2), 48.3 (Bnpe CH), 25.7, 
24.0 (CH 2)' 
ester (95) 
Bnpeoc-Ser-OBzl 
Na_[2,2_b/S (4'-Nitrophenyl)ethoxycarbonyl]-serine (88) (3.018 g, 7.20 mmol) was 
dissolved in dioxan/water (1:1) (80 ml) and cooled to 0 °C. The solution was 
neutralised by the addition of an aqueous solution of 20% Cs 2CO 3 and lyophilised 
overnight. The resulting salt was dissolved in DMA (40 ml), and to this was added 
benzyl bromide (6.156 g, 36.0 mmol). The reaction mixture was stirred at room 
temperature for 90 minutes, before being filtered (to remove CsBr) and 
concentrated in vacua The residue was redissolved in ethyl acetate (100 ml), 
washed with water (2 x 100 ml), a saturated aqueous solution of NaHCO 3 (2 x 100 
ml) and brine (2 x 100 ml), and dried over Na 2 SO4 . The removal of the solvent in 
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vacuo afforded a yellow oil which was purified by dry flash chromatography on 
silica (employing a gradient of light petroleum (b.p. 40-60 0C)/ethyl acetate) to give 
the title compound (3.278 g, 89%) as a yellow foam: tic R (A3) 0.20; -11.6 ° 
(C = 1, DMF); umax. (CH 2Cl 2) 3420 (NH), 1725 (C=O), 1605, 1595 (C-C aromatics), 
1520, 1350 (NO 
2)' 1190 CM -1 ; SH (200 MHz, CDCI 3) 8.13 (4H, d, J AB  8.7 Hz, Bnpeoc 
aromatic CH's), 7.34 (9H, m, Bnpeoc aromatic CH's, benzyl CH's), 5.74 (1H, d, J 8.2 
Hz, NH), 5.15 (2H, s, benzyl CH 2), 4.62 (3H, m, Bnpeoc CH,CH 2), 4.38 (1H, m, Ser 
CH), 3.75 (2H, m, Ser BCH 2), 2.58 (1H, bs, OH); c (50 MHz, CDCI 3) 170.0 (ester 
C=O), 155.5 (urethane C=O), 147.1, 146.2 (Bnpeoc quaternary aromatic C's), 134.9 
(benzyl quaternary C), 129.0 (Bnpeoc aromatic CH), 128.5, 127.9 (benzyi CH's), 123.9 
(Bnpeoc aromatic CH), 67.3 (benzyl CH 2), 66.0 (Bnpeoc CH 2 ), 62.3 (Ser BCH 2), 56.0 
(Ser ctCH), 49.5 (Bnpeoc CH); ,n/z (FAB), 510 (MH), 345, 181, 109; hrms, found 
510.15125, C 25 H 24 N 30 9 requires 510.15124 (< 1 ppm); hpic R 
t 
(Bi) 11.8 minutes. 
N - (9-Fluorenmethocarbonyl)rine_benzil ester (96)  
Fmoc-Ser-OBzl 
The compound was prepared from N-(9-fluorenylmethoxycarbonyl)serine by the 
general method described for compound (95) as discussed above. The compound 
was described previously 227  less the following additional data: s5 (200 MHz, CDCI 3 ) 
7.78-7.25 (13H, m, Fmoc aromatic CH's, benzyl aromatic CH's), 5.89 (1H, d, J 7.8 Hz, 
NH), 5.21 (2H, s, benzyl CH 2), 4.44 (3H, m, Fmoc CH,CH 2), 4.20 (1H, t, J 6.9 Hz, S e r 
CH), 3.96 (2H, m, Ser BCH 2), 2.57 (1H, bs, OH); ô (50 MHz, COd 3) 170.3 (ester 
C=O), 156.1 (urethane C0), 143.7, 143.5, 141.2 (Fmoc quaternary aromatic C's), 
135.0 (benzyl quaternary aromatic C), 129.4-119.8 (Fmoc aromatic CH's, benzyl 
CH's), 67.4, 67.1 (Fmoc CH 2, benzyl CH 2), 63.0 (Ser BCH 2), 56.1 (Ser CH), 47.0 
(Fmoc CH); m/z(FAB), 418 (MH), 403, 268, 239, 215, 203. 
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(Bzl) 4 c*Gluc-OH 
The compound was prepared by the method of Koto eta! 229 
The material was purified by recrystallisation from ethyl acetate/hexane (yield = 
33%): tic R f (A4) 0.79; m.p. 149-150 °C (lit. 229  149-149.5 0C); [c] 0 27 +46.1 0 (C = 1, 
dioxan) (lit. 229  +480 (C = 1, dioxan)); 'umax. (CH 2 Cl 2) 1500, 1365, 1070 cm 1 ; Found C, 
75.5; H, 6.85 CaIc. for C 34 H 360 6 C, 75.6 H, 6.67%; 5H  (200 MHz, COd 3) 7.33 (20H, m, 
aromatic CH's), 5.26 (d, J 3.6 Hz, equatorial CH [C 1 ]), 5.01-4.47 (91-1, m, axial CH [C 1 ], 
4 x benzyl CH 2), 4.07-3.55 (61-1, m, 4 x glucose CH, glucose CH 
2); 'S (50 MHz, 
COd 3) 138.5-137.6 (quaternary aromatic C's), 128.2, 127.8, 127.5 (aromatic CH's), 
97.4 (equatorial CH [C 1 ]), 91.1 (axial CH [C 1 ]), 84.5, 83.1, 81.7, 80.0, 77.8 (CH's), 75.5, 
74.9, 73.4, 73.1 (benzyl CH 2 's), 70.2 (CH), 69.0, 68.7 (glucose CH 2); hplc R 1 (132) 23.0 
minutes. 
benyl- cz/B-D-glucopyranosyl1benzyiester) 
Bnpeoc-Ser[cz/B-D-(Bzi) 4 Gluc]-OBzl 
Trifluoromethanesulphonic anhydride (0.175 ml, 1.05 mmol) was added to a solution 
of Bnpeoc-Ser-OBzl (95) (1.070 g, 2.10 mmol) in acetonitrile/DCM (1:1) (10 ml) at 
-15°C. 2,3,4,6-Tetra-0-benzyl-c&-D-glucopyranose (98) (0.653 g, 1.20 mmol) in 0CM 
(12 ml) was added, maintaining the temperature at -15 °C. The reaction mixture 
was then allowed to warm to room temperature and stirred for a further 90 
minutes. Water (30 ml) was added and the aqueous solution extracted with DCM (3 
x 30 ml). The combined organic phases were washed with a saturated aqueous 
solution of NaHCO 3 (2 x 50 ml), water (1 x 50 ml) and dried over Na 2 SO4 . The 
removal of the solvent in vacuo gave a yellow oil, an aliquot of which was purified 
by, firstly, flash chromatography on silica (employing a gradient of light petroleum 
(b.p. 40-600C)/diethyl ether), and, secondly, preparative hplc, using an Aquapore C 8 
reverse phase prep. column with acetonitrile/water (+0.05% TFA) as the eluent and 
monitoring at 254 nm. Removal of the solvents by lyophilisation afforded the title 
compound (0.145 g, calculated yield = 34%) as a yellow solid: tic R (A3) 0.78, 0.80; 
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(360 MHz, COd 3) 8.12 (4H, m, Bnpeoc aromatic CH's), 7.21 (29H, m, Bnpeoc 
aromatic CH's, benzyl CH's), 5.94 + 5.67 (1H, d + d, J 8.6, 8.0 Hz, NH), 5.15 (2H, m, 
benzyi ester CH 2), 4.91-4.27 (13H, m, anomeric CH, 4 x benzyl ether CH 2' Ser aCH, 
Bnpeoc CH,CH 2), 4.12-3.29 (8H, m, Ser BCH 2, 4 x glucose CH, glucose CH 2);  m/z 
(FAB), 1032 (MH), 1002, 558, 523, 325; hrms, found 1032.39184, C 59 H 58 N 30 14 
requires 1032.39185 (< 0.1 ppm); hplc R 
t 
(85) 21.8, 22.6 minutes. 
Seri ne-(O-2,3,4,6 -tetra -O- benzyl -a/ - D-giucopyranosyl benzy .! ester (100) 
H-Serf ci! B -D - (Bzl) 4Gluc]-OBzi 
Bnpeoc-Ser[ct/-D-(Bzl) 4Gluc]-OBzl (99) (0.194 g, 0.19 mmol) was dissolved in DMF 
(8 ml), and to this was added DBU (1.57 ml of a solution of 0.219 g in DMF (10 ml), 
0.22 mmol) and glacial acetic acid (0.72 ml of a solution of 0.187 g in DMF (10 ml), 
0.22 mmol). The reaction was stirred for 45 minutes, monitoring by tic. Ethyl 
acetate (150 ml) and water (150 ml) were added, and the separated organic layer 
washed with water (1 x 100 ml), an aqueous solution of 5% citric acid (1 x 100 ml), 
water (1 x 100 ml) and brine (1 x 100 ml), and dried over Na 2 SO 4. The removal of 
the solvent in vacuo afforded a yellow oil which was purified by flash 
chromatography on silica (employing a gradient of light petroleum (b.p. 
40-600C)/ethyl acetate/methanol). The removal of the solvent in vacuo gave the 
title compound (0.126 g, 93%) as a yellow oil: tic R f (A7) 0.54; 6H  (360 MHz, CDCI 3 ) 
7.28 (25H, m, benzyl CH's), 5.15 (2H, m, benzyl ester CH 2), 4.94-4.27 (10H, m, Ser 
aCH, anomeric CH, 4 x benzyl ether CH 2), 4.14-3.34 (8H, m, Ser BCH 2 , glucose CH 2' 
4 x glucose CH); m/z (FAB), 718 (MH), 628; hrms, found 718.33801, C44 H 48N0 8 
requires 718.33797 (< 1 ppm). 
Nci_(Benzyloxycarbonyl)alanineN_qccInimidyl ester (102) 
Z-Ala - ON S u 
The compound was prepared by the general method of Anderson at a! 109 
1,3-Dicyclohexylcarbodiimide (1.860 9,  9.01 mmol) was added slowly to a 
solution of Z-Ala-OH (101) and N-hydroxysuccinimide (1.036 g, 9.01 mmol) in 
dioxan (22 ml), keeping the temperature at 14-16 0C during the, addition. The 
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reaction mixture was transferred to a refrigerator and stored for 24 hours. The 
formed dicyclohexylurea was filtered oft and washed with dioxan. The combined 
filtrates were concentrated in vacuo to yield a white oil which soon crystallised. 
The solid was redissolved in ethyl acetate (100 ml), washed quickly with water (1 x 
100 ml), and dried over Na 2 SO4 . The removal of the solvent in vacuo afforded a 
white solid which was recrystallised from ethyl acetate/light petroleum (b.p. 
40-60°C) to give the title compound (2.546 g, 88%) as a white solid: tic R (A5) 
0.37; m.p. 122-123°C (lit. 109  123-123.50C); [c] 0 27 -39.9° (c = 2, dioxan) (lit. 109  -37.2° 
(c = 2. dioxan)); Found C. 56.2; H, 5.24; N, 8.91 CaIc. for C 15 H 16 N 206 C, 56.2; H, 5.03; 
N. 8.75%; 'max.  (CH 2 Cl 2) 3435 (NH), 1820, 1790, 1750 (C0), 1510, 1205, 1065 cm -1 ; 
iS (200 MHz, COd 3) 7.35 (5H, s. aromatic CH's), 5.31 (1H, d, J 8.2 Hz, NH), 5.12 (2H, 
s, Z- CH 2), 4.78 (1H, m, Ala czCH), 2.83 (4H, s, 2 x succinimidyl CH 
2)' 1.59 (3H, d, J 
7.2 Hz, CH3); c (50 MHz, CID d 3) 168.6 (ester, 2 x succinimidyl C=O), 155.2 
(urethane C=O), 135.8 (aromatic quaternary C), 128.4, 128.0 (aromatic CH's), 67.1 (Z-
CH 2), 47.9 (Ala CH), 25.4 (succinimidyl CH 2 's), 18.3 (CH 3 ); m/z (FAB), 321 (MH), 
277, 181. 
N -1BenzyloxycarbonyIiayjianine .(1Q) 
Z-Ala-Ala-OH 
To a stirred suspension of alanine (0.833 g, 9.36 mmol) in water (9 ml) was added 
a solution of triethylamine (1:95 ml, 14.0 mmol) in dioxan (9 ml). To this was added 
Z-Ala-ONSu (102) (2.997 g, 9.36 mmol) and the mixture stirred at room 
temperature overnight. Water (20 ml) was added, the solution acidified to pH1.5 
using 2M KHSO4 (aq)  and extracted with ethyl acetate (3 x 50 ml). The combined 
organic phases were washed with water (2 x 40 ml) and dried over Na 2 SO4 . The 
removal of the solvent in vacuo gave a white solid, which was purified by flash 
chromatography on silica (eluting with ethyl acetate). The resulting material was 
recrystallised from ethyl acetate/light petroleum (b.p. 40-60 °C) to give the title 
compound (1.791 g, 65%) as a white solid: tIc R f (A6) 0.29; m.p. 149-150 °C; [c] 27 
-36.4 0 (C = 1, MeOH); Found C, 57.5; H, 6.38; N, 9.61 CaIc. for C 14 H 18 N 205 C, 57.1; H, 
6.16; N, 9.52%; Vmax  (CH 2Cl 2) 3420 (NH). 1725, 1680 (C=O), 1510 cm; 5H  (200 MHz, 
CD3COCD 3) 7.57 (11-1, bd, J 7.5 Hz, arnide NH), 7.36 (5H, m, aromatic CH's), 6.54 (1H, 
bd, J 7.3 Hz, urethane NH), 5.08 (2H. s, Z- CH 2), 4.47, 4.29 (2H, m, 2 x Ala CH), 1.35 
(6H, m, 2 x CH3); 6  (50 MHz, CID 3COCD 3) 172.3, 171.4 (amide, acid C=O), 155.0 
(urethane C=O), 136.5 (quaternary aromatic C), 127.5, 126.9 (aromatic CH's), 65.2 (Z- 
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CH 2), 49.6, 46.9 (2 x Ala CH), 17.0. 16.2 (2 x CH 3);  m/z (FAB), 295 (MH); hrms, 
found 295.12940, C 14 H 19 N 20 5 requires 295.12939 (< 1 ppm). 
N - (BeQyzloxycarbonMl)anylalanylserine - (Q- 2,3 1 46 -- tetra-Q-- 
ester (94J 
Z-Ala -Ala -Ser[c/ B -D-(Bzl) 4 Gluc]-OBzi 
Bnpeoc -Ser[c&/B - D-(Bzi) 4GIuc]-OBzl (99) (0.100 g, 0.097 mmol) was dissolved in 
DMF (4.0 ml), and to this was added DBU (2.78 ml of a solution of 0.062 g in DMF 
(10 ml), 0.11 mrnol) and glacial acetic acid (0.60 ml of a solution of 0.096 g in DMF 
(10 ml), 0.11 mmol). The reaction mixture was stirred for 40 minutes, monitoring by 
tic. Ethyl acetate (50 ml) and water (50 ml) were added, and the separated organic 
layer was washed with water (2 x 50 ml) and dried over Na 2SO 4 . The removal of 
the solvent in vacuo afforded a yellow oil which was used without further 
manipulation. 
Z-Ala-Ala-OH (103) (0.057 g, 0.19 mmol) was dissolved in DMF (2.0 ml) and to 
this was added HOBt (0.026 g, 0.19 mmol) in DMF (0.5 ml). After stirring for 2 
minutes 1,3-dicyclohexylcarbodiimide (0.040 g, 0.19 mmol) was added and the 
reaction mixture stirred for a further 2 minutes. The deprotected glyco-amino acid 
from above (100) was dissolved in OMF (1.0 ml), added to the reaction mixture and 
the pH of the resulting solution adjusted to 9.0 by the addition of triethylamine. 
The reaction mixture was stirred for 18 hours at room temperature, before filtering 
(to remove the formed urea) and isolating the desired product by preparative hplc, 
employing an Aquapore C 18 reverse phase prep. column, with water/acetonitrile 
(+0.05% TFA) as eluent and monitoring at 229 nm. The removal of the hplc 
solvents by lyophilisation afforded the title compound (0.015 g, 15%) as a white 
solid: tic R 1 (A7) 0.71; dH (360 MHz, D 20/CD 3 COCD 3) 7.27 (30H, m, Z-, benzyl ether, 
benzyl ester aromatic CH's), 5.16-4.40 (14H, m. 4 x benzyl ether CH 2'  benzyl ester 
CH 2, anomeric CH, Ser ciCH, 2 x Ala ciCH), 4.10-3.68 (61-1, m, 4 x glucose CH, 
glucose CI-1 2), 3.55 (2H, m, Ser BCH 2), 1.25 (6H, m, 2 x Ala CH 3);  m/z(FAB), 994 (M'), 
610, 562, 472, 454, 367; hrms, found 994.44904, C 58 H 63 N 30 12 requires 994.44896 (< 
1 ppm); hplc R 
t 
(B13) 28.2, 28.4 minutes. 
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Na_[2,2_ b/s (4' -Nitroptinyl)ethoxycarbonyl]-alany!henyiajayIgJycine methyl 
ester (105) 
Bnpeoc-Ala-Phe-Gly-OMe 
This compound was prepared by the method of Florence 78 
The material was purified by recrystallisation from ethyl acetate/light petroleum 
(b.p. 40-60°C) (yield = 60%) :  tIc R (A4) 0.70; m.p. 159-161 °C (lit. 78  159-1620C); 
-16.1 ° (c = 1, DMF) (lit. 78  -3.9° (c = 1, DMF)); Found C, 57.7; H, 4.92; N, 11.2 
Caic. for C 30 H 31 N 50 10 C, 58.0; H, 5.03; N, 11.3%; 'V max  (CH 2Cl 2) 3420 (NH), 1750, 
1730, 1680 (C=O), 1525, 1350 (NO 2) cm 1 ; OH  (200 MHz, CD 3COCD 3) 8.22 (4H, d, J 
AB 
8.8 Hz, Bnpeoc aromatic CH's), 7.69 (4H, d, J AB  8.8 Hz, Bnpeoc aromatic CH's), 7.25 
(5H, m, Phe aromatic CH's), 6.68 (1H, bd, urethane NH), 4.74 (4H, m, Phe aCH, 
Bnpeoc CH,CH 2), 4.10 ('IH, m, Ala CH), 3.95 (2H, m, Gly CH 2), 3.65 (3H, s, OCH 3 ), 
3.10 (2H, m, Phe BCH 2), 1.22 (3H, d, J 7.7 Hz, Ala CH 3); 6 c  (50 MHz, CD 3COCD 3 ) 
171.2, 170.4. 169.1 (2 x amide C=O, ester C=O), 154.8 (urethane C=O), 147.3, 146.5 
(Bnpeoc quaternary aromatic C's), 136.7 (Phe quaternary aromatic C), 129.3-122.9 
(aromatic CH's), 65.0 (Bnpeoc CH 2), 53.1, 50.5, 50.2, 48.9 (Bnpeoc CH, OCH 3, 2 x 
CH), 39.5, 37.0 (Phe 8CH 2, Gly CH 2)'  16.6 (Ala CH 3); n7/z(FAB), 622 (M), 254, 237, 
167; amino acid analysis, Gly 1 l.03, A1a 1 0.99, Phe 1 0.98; hplc R 
t 
(83) 17.0 minutes. 
N-[2,2- his 
Bnpeoc-Ala-Phe-Gly-OH 
Bnpeoc-Ala-Phe-Gly-OMe (105) (0.117 g, 0.19 mmol) was dissolved in 
acetone/water (8:2) (8 ml), and to this was added 0.10M NaOH 
(ag)  (1.92 ml, 0.19 
mmol) and H 2 0 2  (3% solution in water; 216 Ml. 0.19 mmol). The reaction mixture 
was stirred for 40 minutes at room temperature. The pH of the solution was 
adjusted to 1.5 by the addition of conc. HCI, extracted with ethyl acetate (3 x 40 
ml), and dried over Na 2SO 4. Concentration of the reaction mixture in vacua 
afforded a yellow oil, which was purified by preparative hplc, employing an 
Aquapore C. reverse phase prep. column with water/acetonitrile (+0.05% TFA) as 
the eluent and monitoring at 254 nm. The removal of the solvents by lyophilisation 
gave the title compound (0.063 g, 55%) as a white solid: tic R f (A4) 0.19. R  (A6) 




8.7 Hz, Bnpeoc aromatic CH's), 7.87 (1H. bd , NH), 7.68 (4H, d, J 	 8.7 Hz, BnpeocAS 
aromatic CH's), 7.33 (1H, d, NH), 7.21 (5H, s, Phe aromatic CH's), 4.64 (4H, m, Phe 
c*CH, Bnpeoc CH,CH 2). 3.95 (1H, m, Ala ctCH), 3.77 (2H, d, Gly CH 2), 2.97 (2H, m, P h e 
1.07 (31-1, d, J 7.0 Hz, Ala CH 3 ); m/z (FAB), 608 (MW), 585. 329, 176; hrm. 
found 608.19921, C 29 H 30 N 50 10  requires 608.19925 (< 1 ppm); amino acid analysis, 
Gly 1 1.02, A1a 1 0.98, Phe 1 1.00; hplc R  (B4) 22.8 minutes. 
Q: Juene !pl9nate tI071 
TosOH 2 -Gly-OBzl 
The compound was prepared by the method of Zervas et 3/230 
Glycine (9.466 9.  0.126 mol), p-toluenesulphonic acid monohydrate (24.543 g, 
0.129 moll and benzyl alcohol (50.0 ml, 0.483 moll were added to benzene (50 ml) 
and heated under reftux collecting the water produced in a Dean and Stark 
receiving apparatus, for 5 hours. The mixture was left to cool to room temperature 
overnight. Benzene (125 ml) and diethyl ether (200 ml) were added, and the flask 
stored at 5 °C for 2 hours. The crystalline material was filtered, washed with diethyl 
ether and recrystallised from methanol/diethyl ether to give the title compound 
(39.053 g, 92%) as a white, crystalline solid: m.p. 132-133 °C (lit. 230 132-1330C); 
Found C, 56.6; H, 5.62; N, 4.23 CaIc. for C 16 H 19 N0 5S C, 57.0; H, 5.68; N, 4.15%; Vma* 
(bromoform mull) 1750 (C=O), 1550, 1425, 905, 810 cm1; 5H (200 MHz, d 6 -DMSO) 
8.30 (3H, bs, NH 3 ), 7.54 (2H, d, JAB  8.1 Hz, tosyl aromatic CH's), 7.41 (5H, m, benzyl 
aromatic CH's), 7.14 (2H, d, J AS  8.1 Hz, tosyl aromatic CH's), 5.23 (21-1, s, benzyl CH 2)' 
3.91 (2H, s, Gly CH 2), 2.30 (3H, s, CH 3); m/z(FAB), 166 (H 3N-CH 2CO 2CH 2 Ph), 150. 
Na(Benzyloxycarbonyt)phenjlaniglycine benzyl ester (1 -09)  
Z-Phe-Gly-OBzl 
Z-Phe-OH (108) (10.004 g, 33.4 mmol) and N-hydroxybenzotriazole (4.986 g, 36.9 
mmol) were dissolved in DMF (50 ml) and cooled to 0 °C. To this solution was 
slowly added 1,3-dicyclohexylcarbodiimide (6.909 g, 33.4 mmol) in DMF (25 ml), 
maintaining the temperature at 0 °C. After stirring for 5 minutes, 
TosOH 2 -Gly-OBzl (107) (11.273 g, 33.4 mmol) in DMF (25 ml) was added and the 
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pH adjusted to 9.0 by the addition of triethylamine. The reaction was then stirred 
for 17 hours at 5 °C. The formed dicyclohexylurea was filtered off and the filtrate 
concentrated in vacuo to yield an off-white solid. This was redissolved in ethyl 
acetate (250 ml) and placed in a refrigerator for 2 hours, after which time the 
solution was again filtered. The filtrate was washed with a saturated aqueous 
solution of NaHCO 3 (2 x 100 ml), water (2 x 100 ml), an aqueous solution of 5% 
citric acid (2 x 100 ml) and brine (1 x 100 ml), and dried over Na 2 SO 4 . The removal 
of the solvent in vacuo afforded a white solid, which was recrystallised from ethyl 
acetate/light petroleum (b.p. 40-60 °C) to yield the title compound (13.097 g, 88%) 
as a white solid: tic R (A4) 0.75; m.p. 134-135 °C (lit. 247 135 0C); [a] D27 -1.82 ° (c = 1, 
acetone) (lit. 247 -3.750 (c = 1, acetone)); Found C, 70.0; H, 5 : 96; N, 6.42 CaIc. for 
C 26 H 26N20 5 C, 69.9; H, 5.87; N, 6.27%; vma..  (CH 2 Cl 2) 3425 (NH), 1745, 1685 (C0), 
1600, 1500, 1195 cm1; 6H  (200 MHz, CID 3COCD 3) 7.78 (1H, bs, amide NH), 7.30 (15H, 
m, Z- aromatic CH's, benzyl aromatic CH's, Phe aromatic CH's), 6.58 (1H, bd. 
urethane NH), 5.18 (2H, S. benzyl CH 2), 5.00 (2H, m, Z- CH 2), 4.57 (1H, m, P h e aCH), 
4.02 (2H, m, Gly CH 2), 3.13 (2H, m, Phe BCH2); 6c (50 MHz, CID 3COCD 3) 170.9, 168.6 
(amide, ester C=O), 155.1 (urethane C=O), 137.0, 136.5, 135.5 (quaternary aromatic 
C's), 128.6-125.6 (aromatic CH's), 65.5, 65.2 (Z- CH 
2'  benzyi CH 2), 55.6 (Phe c*CH), 
40.3 (Gly CH 2), 37.4 (Phe BCH 2 ); m/z (FAB), 447 (MW), 403, 372, 313, 225; hrms, 




PhenylaIanylglycineptoiuenesulpjonate (1 10 
TosOH2 -Phe-GIy-OH 
Z-Phe-Gly-OBzl (109) (3.005 g, 6.73 mmol) was dissolved in DMF (25 ml) together 
with -toluenesulphonic acid monohydrate (1.282 g, 6.73. mmol) and was 
hydrogenated for 7 days at room temperature and pressure in the presence of 10% 
palladium-charcoal catalyst (0.905 g, 30% by weight of protected dipeptide). 
Filtration through 'celite', followed by concentration of the reaction mixture in 
vacuo gave the title compound as a green oil. All attempts at recrystallisation 
failed, and the product was used without further manipulation: tic R f (A6) 0.25; m/z 
(FAB), 223 (HP 1'-CH(CH2Ph)CONHCH2CO2H). 
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N -12,2- b/s (4' -Nitroghenyftthpycarbonyl]-alanine N-succinimiyL ester 
(ill) 
Bnpeoc-Ala-ONSu 
1,3-Dicyctohexylcarbocliimide (1.537 g, 7.45 mmol) was added slowly to a solution 
of Bnpeoc-Ala-OH (85) (3.006 g, 7.45 mmol) and N-hydroxysuccinimide (0.859 g, 
7.45 mmol) in dioxan (25 ml), maintaining the temperature between 10-15 °C 
throughout the addition. After stirring for 1 hour at 10-15 °C, the mixture was 
transferred to a refrigerator for 24 hours. The formed dicyctohexylurea was filtered 
off and washed with dioxan (70 ml). The combined filtrates were concentrated in 
vacua to give a colourless oil, which was redissolved in ethyl acetate (30 ml) and 
stored at 5 °C for 2 hours. Again the precipitated urea was filtered off, and the 
solvent was removed in vacuo to yield the title compound (3.187 g, 86%) as a 
white foam: m.p. 73-76°C; [aID27 -24.2 ° (c = 1, dioxan); 'max. (CH 2Cl 2 ) 1835, 1805, 
1755 (C=O), 1530, 1355 (NO 
2)' 1215 cm1; 5H (200 MHz, CID 3 COCD 3) 8.21 (4H, d, JAB 
8.7 Hz, Bnpeoc aromatic CH's), 7.69 (4H, d, J AB  8.7 Hz, Bnpeoc aromatic CH's), 7.12 
(1H, d, J 7.9 Hz, NH), 4.77 (3H, m, Bnpeoc CH,CH 2), 4.62 (1H, m, Ala c&CH), 2.90 (4H, 
s, 2 x succinimidyl CH 2)'  1.52 (3H, m, CH 3); & ( 50 MHz, CD 3COCD 3 ) 168.5, 168.0 (2 
x succinimidyl C=O, ester C=O), 155.0 (urethane C=O), 147.2, 146.5 (Bnpeoc 
quaternary aromatic C's), 128.9, 122.9 (Bnpeoc aromatic CH's), 65.1 (Bnpeoc CH 
2)' 
49.0 (Ala (xCH), 47.4 (Bnpeoc CH), 24.7 (succinimidyl CH 
2)'  16.1 (CH 3);  m/z'(FAB), 501 
(MW), 485, 404, 307, 225; hrms, found 501.12573, C 22 H 21 N40 10 requires 501.12575 
(< 1 ppm). 
Na[2,2 bL 	 anphenyaljyjgcine (106) 
Bnpeoc-Ala-Phe-Gly-OH 
TosOH 2 -Phe-Gly-OH (110) (2.375 g, 6.03 mmol) was dissolved in water/dioxan 
(1:1) (20 ml), and to this was added triethylamine (1.72 g, 17.2 mmol) in dioxan (2 
ml). Bnpeoc-Ala-ONSu (111) (4.524 g, 9.05 mmol) in dioxan (20 ml) was added 
slowly, and the reaction mixture stirred overnight at room temperature. Water (500 
ml) was added, the pH adjusted to 1.5 by the addition of conc. HCI, and the 
aqueous solution extracted with ethyl acetate (3 x 300 ml). The combined organic 
phases were dried over Na 2 SO4 and the solvent removed in vacua to yield an oily 
solid. This material was purified by flash chromatography on silica (employing a 
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gradient of ethyl acetate/methanol) to give a white solid. Lyophilisation of this 
solid from dioxan/water (2:1) (60 ml) afforded the title compound (2.399 g, 66%) as 
a white solid: tic R (A4) 0.20. R f (A6) 0.80; m.p. 111-113°C; 6H (200 MHz,d 6 -DMSO) 
8.30 (11-1, t, amide NH), 8.17 (41-1, d, J AB 8.7 Hz, Bnpeoc aromatic CH's), 7.84 (11-1, d, 
NH), 7.65 (41-1, d, JAB 8.7 Hz, Bnpeoc aromatic CH's), 7.31 (11-1, d, NH), 7.19 (51-1, s, Phe 
aromatic CH's), 4.63 (41-1, Phe czCH, Bnpeoc CH,CH 2 ), 3.95 (11-1, m, Ala c&CH), 3.78 (21-1, 
d, Gly CI-1 2), 2.95 (21-1, m, Phe BCH 2), 1.04 (31-1, d, J 7.0 Hz, Ala CH); m/z (FAB), 608 
(MH), 584, 329, 271;hrms, found 608.19921, C 29 H 30 N 50 10 requires 608.19925 (< 1 
ppm); amino acid analysis, Gly 1 l.01. A1a 1 0.98, Phe 1 1.01; hpic R 1 (B4) 22.8 minutes. 
N - [2,2 - bis j4' - Nitrop 	o 	 -My 	chlonde]1 jfl  
Bnpeoc-Gly-Cl 
Thionyl chloride (1.61 ml, 22.0 mmol) was added to Bnpeoc-Gly-OH (87) (0.857 g, 
2.20 mmol) in DCM (100 ml) and heated under refiux for 90 minutes under 
nitrogen. The solvent and excess thionyl chloride were removed in vacua 
re-evaporating three times with DCM to ensure complete removal of the thionyl 
chloride. The resulting foam was used without further manipulation: vma.. (CH 22 ) 
3425 (NH), 1805 (acid chloride C=O), 1740 (urethane C=O), 1525, 1350 (NO 
2)cm 1 . 
Na_[2,2_ his (4 '-Nitrophenyi)ethoxycarbonyi]jycyjp -alirobenzylalcohol 
resin (113) 
Bnpeoc-Gly-(O-CH 2C 6 H 4 -OR) 
Q-Alkoxybenzyl alcohol resin (8) (Bachem, 1.01 mmol/g) (1.982 g, 2.00 mmol) was 
swollen in 0CM (35 ml) and to this was added pyridine (4.85 ml, 60.0 mmol) and 
the preformed Bnpeoc-Gly-Cl (112) (2.20 mmol) in DCM (15 ml). The reaction 
mixture was agitated for 3 hours on a manual shaker at room temperature under 
nitrogen. The resin was filtered, washed with 0CM (3 x 1 minute), DMF (3 x 1 
minute) and DCM (3 x 1 minute), and dried: Found N, 1.90%; 
Bnpeoc-Gly-(O-CH 2C6 H 4-OR) requires N, 3.08%; hence coupling yield = 62%. A 
second coupling reaction, performed exactly as the first, was therefore necessary: 
Found N, 2.68%; hence coupling yield (after second coupling) = 87%; 'max.  (KB' 
disc) 1720, 1665 (C=O). 1515, 1350 (NO 
2 ) CM- 
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Bnpeoc-Ala-Phe-Gly-OH 
The synthesis of (106) was accomplished using the functionalised resin, 
Bnpeoc-Gly-(O-CH 2 C 5H 4-OR) (113), and employing a repetitive solid-phase cycle 
on a manual shaker which involved: 
(1) washing the functionalised resin - DCM (2 x 1 minute), (2) capping of any 
unreacted sites - acetic anhydride (2.08 ml, 22.0 mmol) and pyridine (1.78 ml, '22.0 
mmol) in DCM (35 ml) (1 hour), (3) washing - DCM (2 x 1 minute), DMF (2 x 1 
minute), 0CM (2 x 1 minute), (4) removal of Na_protecting  group - OBU (600 lii. 
4.02 mmol) and acetic acid (230 .jl, 4.02 mmol) in DMF (35 ml) (1 hour), (5) washing 
- DMF (2 x 1 minute), DCM (2 x 1 minute), (6a) coupling of Bnpeoc-Phe-Cl (2.40 
mmcl) in N-methylmorpholine (6.60 ml, 60.0 mmol) and 0CM (35 ml) (2 hours) 
(double couple), (6b) coupling of Bnpeoc-Ala-Cl (2.40 mmol) in 
N-methylmorpholine '(6.60 ml, 60.0 mmol) and 0CM (35 ml) (2 hours) (single 
couple), (7) washing - 0CM (2 x 1 minute), DMF (2 x 1 minute), DCM (2 x 1 minute). 
Samples of the resin were removed after steps (6a) and (6b), and subjected to the 
Kaiser test 232 to determine the extent of coupling. 
The cleavage of the peptide from the support was performed by reaction with 
trifluoroacetic acid (25 ml) in DCM (25 ml). The reaction mixture, was shaken for 1 
hour under nitrogen at roam temperature, before the resin was filtered off and 
washed with DMF (3 x 1 minute) and DCM (3 x 1 minute). The combined filtrates 
were concentrated in vacuo to give a yellow oil, which was triturated from ethyl 
acetate/light petroleum (b.p. 40-60 °C) to give a yellow solid. This material was 
purified by gel filtration on Sephadex LH20, eluting with methanol, to afford the 
title compound (0.458 g, 38%) as a white solid: tic R f (A4) 0.20, R  (A6) .0.80; m.p. 
113-115°C; vma..  (CH 2Cl 2) 1725, 1670 (C=O), 1525, 1350 (NO2) CM-  1; 5H  (200 MHz, 
CD 3COCD 3) 8.20 (4H, d, JAB  8.8 Hz, Bnpeoc aromatic CH's), 7.68 (4H, d, J AB  8.8 Hz, 
Bnpeoc aromatic CH's), 7.23 (5H, m, Phe aromatic CH's), 4.75 (4H, m, Phe aCH, 
Bnpeoc CH,CH 2), 4.06 (1H, m, Ala aCH), 3.99 (2H, d, J 3.0 Hz, Clv CH 2), 3.07 (2H, m, 
Phe BCH 2), 1.21 (3H, d, J 7.2 Hz, Ala CH 3 );  c (50 MHz, CD 3COCD 3) 171.4, 170.4, 
169.7 (2 x amide C=O, acid C=O), 154.8 (urethane C=O), 147.3, 146.6 (Bnpeoc 
quaternary aromatic C's), 136.8 (Phe quaternary aromatic C), 129.0-122.9 (aromatic 
CH's), 65.2 (Bnpeoc CH 2), 53.2, 50.2. 49.1 (Bnpeoc CH, 2 x aCH), 40.0, 37.0 (Phe 
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BCH 2, Gly CH 
2)' 
16.7 (Ala CH 3);  m/z (FAB), 608 (M), 592, 323, 307, 271; hrms, found 
608.19921, C 29 H 30 N 5O 0 requires 608.19925 (< 1 ppm); amino acid analysis, 
Gly 1 0.99, Ala 1 l.02, Phe 1 0.99; hplc R f (B4) 22.8 minutes. 
Sftn_m,tb1lt!r hydrochloride j114) 
CI - H 2 e r- OM e 
The compound was prepared by the method of Guttmann and Boissonnas 233 
Methanol (500 ml) was cooled in a CO 2 /acetone bath, and thionyt chloride (130 
ml) was added dropwise at such a rate as to maintain the temperature below 
-200C. The bath was removed and serine (52.5 g, 0.50 mol) was added in portions 
over 30 minutes. The reaction mixture was allowed to warm to room temperature 
and stirred for 24 hours. The formed precipitate was filtered and recrystallised 
from methanol/diethyl ether to give the title compound (70.10 g, 90%) as a white 
solid: tic R (A8) 0.22; m.p. 164-165 °C (lit. 233  1680 C); [cz] 027 +5.00 (c = 2, methanol) 
(lit. 233 []o 23 +5.50  (c = 1.8, methanol)); Found: C, 30.8; H, 6.84; N, 8.72 CaIc. for 
C4 H 10 NO 3C1 C, 30.9; H, 6.48; N, 9.00%; 'm8..  (bromoform mull) 1750 (C=O), 1510, 
1300, 1140 cm 1 ; dH  (200 MHz, CID 3 OD) 5.00 (3H, bs, NH 3 ), 4.25 (1H, m, S e r cCH), 
4.08 (2H, m, Ser BCH 2 ), 3.95 (3H, s, CH 3); ô (50 MHz, CID 3OD) 167.5 (C=O), 58.8 (Ser 
CH 2), 54.2 (Ser CH), 51.8 (CH 3);  m/z(FAB), 120 (H 3N-CH(CH 2 OH)CO 2 CH 3), 85, 32. 
N-(Benzyloxycarbonyl)serinemethvj ester (1 15)  
Z-Ser-OMe 
CIH 2 -Ser-OMe (114) (61.0 g, 0.392 mol) was dissolved in triethylamine (56.0 ml, 
0.402 mol) and chloroform (800 ml) and cooled to 0 °C. After stirring for 10 
minutes, benzyloxycarbonyl chloride (32.0 ml, 0.224 mol), triethylamine (56.0 ml, 
0.402 mol), benzyloxycarbonyl chloride (32.0 ml, 0.224 mol) and pyridine (72.0 ml, 
0.890 mol) were added at 5 minute intervals respectively. The reaction mixture was 
allowed to warm to room temperature and stirred for 90 minutes. Water (500 ml) 
was added, and the organic and aqueous layers were separated. The organic phase 
was washed with water (1 x 500 ml), 2M HCI (2 x 500 ml), water (1 x 500 ml) and 
dried over Na 2SO4. The removal of the solvent in vacuo gave an oil, which, after 
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washing well with tight petroleum (b.p. 40 -60°C), was purified by dr -V flash 
chromatography on silica (employing a gradient of chloroform/ethyl acetate) to 
yield the title compound (86.8 g, 87%) as a colourless oil (which solidified on 
standing in a refrigerator): tic R  (A9) 0.19; m.p. 33-34 ° C (lit. 247 33-350C); 
'D27 
-11.2 0 (c = 1, methanol) (lit. 247 [(&]02° -13.2° (c = 10, methanol)); 'umax (CH 2 C1 2 ) 
3430 (NH), 1750, 1720 (C=O), 1510, 1210 cm1; 6H (200 MHz, CDCI 3) 7.30 (5H, s, Z-
aromatic CH's), 6.01 (1H, bd, J 8.0 Hz, NH), 5.08 (2H, 5, Z- CH 2), 4.39 (1H, m, Ser 
xCH), 3.88 (2H, m, Ser BCH 2), 3.70 (3H, s, CH 3), 3.25 (1H, bs, OH); m/z (FAB), 254 
(MH), 210. 150. 
methyl ester (116) 
Z-S e r(t  Bu ) - OM e 
Z-Ser-OMe (115) (27.25 g, 108 mmoi) was dissolved in DCM (120 - ml) and cooled in 
a CO 2/acetone bath. To this was added condensed isobutylene (approximately 120 
ml), conc. H 2 SO4  (1.2 ml) and CuCI (0.5 g). The vessel was securely stoppered and 
placed in a screened area for 7 days at room temperature. The reaction mixture 
was again cooled in CO 2/acetone, before triethylamine (7.1 ml) was added. The 
excess isobutylene was removed by very gentle warming and the reaction mixture 
concentrated in vacua to give an oil. This material was redissolved in ethyl acetate 
(150 ml) and washed with a saturated aqueous solution of NaHCO 3 (3 x 150 ml), 
water (1 x 150 ml) and brine (1 x 150 ml), and dried over Na 2 SO 4 . The removal of 
the solvent in vacua gave a brown oil which was triturated under tight petroleum 
(b.p. 60-80 °C) with rapid cooling to yield an off-white solid. This was recrystailised 
(twice) from light petroleum (b.p. 60-80 0C) with rapid cooling to give the title 
compound (31.04 9.  47%) as a white solid: tic R  (A9) 0.64; m.p. 40 0C (lit. 
248 
40-41 °C); [cL]0 +2.5 ° (c = 2, ethanol) (lit. (] 25 +6 0 (C = 1.996, ethanol)); Found: 
C, 62.1; H, 7.68; N, 4.45 Cal c. for C 16 H 23N05 C, 62.1; H, 7.49; N, 4.53%; V max 
(CH 2 Cl 2) 3435 (NH), 1750, 1725 (C=O), 1070 cm-1; 5H  (200 MHz, COd 3) 7.30 (5H, m, 
Z- aromatic CH's), 5.63 (1H, bd, J 8.6 Hz, NH), 5.12 (2H, s, Z- CH 2), 4.45 (1H, m, Ser 
aCH), 3.70 (2H, m, Ser BCH 2), 1.11 (9H, s, 3 x CH3); c  (50 MHz, COd 3) 171.0 (ester 
C0), 156.0 (urethane C=O), 136.2 (Z- quaternary aromatic C), 128.8, 128.4, 128.0, 
127.4 (Z- aromatic CH's), 73.3 (Bu quaternary C), 66.8 (Z- CH 
2), 61.9 (Ser BCH 2 ), 
54.6 (Ser aCH), 52.1 (ester CH 3), 27.1 (tB
u  CH 3);  m/z(FAB), 310 (MH), 254, 210, 146. 
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( @@D zylo 	(117) 
Z- S e r(t  Bu )- OH 
The compound was prepared by the general method of Shields and Renner 234 
Z-Ser( t Bu)-OMe (116) (29.84 g, 96.6 mmol) was dissolved in acetone (200 ml), 
and to this was added 1.OM NaOH (107 ml, 107 mmol) over a period of 30 minutes. 
The reaction mixture was left stirring for a further 3.5 hours. The acetone was 
removed in vacuo and the aqueous phase washed with diethyl ether (1 x 100 ml) 
before being acidified to pH 3.0 with an aqueous solution of 5% citric acid and 
extracted with ethyl acetate (3 x 100 ml). The combined organic phase was washed 
with water (2 x 100 ml), brine (1 x 100 ml) and dried over Na 2 SO4 . The solvent was 
removed in vacuo to yield an oil, which solidified on standing. This material was 
recrystallised from ethyl acetate/light petroleum (b.p. 40-60 °C) to afford the title 
compound (21.78 g, 76%) as a white solid: tic R f (A9) 0.15; m.p. 86-87 °C (lit. 234 
85-870C); (]27  +18.2 0 (C = 1, ethanol) (lit. 234 [] 21 +21.2 0 (c = 2.82, 95% ethanol)); 
Found: C, 60.9; H, 7.42; N, 4.70 CaIc. for C 15 H 21 N05 C, 61.0; H, 7.17; N, 4.74%; Vmax 
(CH 2Cl 2) 3430 (NH), 1760, 1715 (C0), 1500, 1420 cm-1; 5H (360 MHz, CID 3 COCD3 ) 
7.35 (5H, m, Z- aromatic CH's), 6.24 (1H, bd, J 8.2 Hz, NH), 5.10 (2H, s, Z- CH 2), 4.37 
(1H, m, Ser aCH), 3.76 (2H, m, Ser BCH 2), 1.15 (9H, s, 3 x CH); m/z (FA B), 296 
(MW), 240, 196, 162. 
(0- tertButyl)serine (1 i) 
H -Se r(t  Bu)- OH 
Z-Ser( t Bu)-OH (117) (9.95 g, 33.7 mmol) was dissolved in DMF (100 ml) and to this 
was added 10% palladium-charcoal catalyst (1.00 g, bob  by weight of the amino 
acid derivative), slowly under nitrogen. The reaction mixture was hydrogenated for 
22 hours at room temperature and pressure. Filtration through 'celite', washing 
with DMF and water, followed by concentration of the aqueous washings in vacua 
gave the title compound (4.45 g, 82%) as an off-white solid: tic R (A6) 0.32; m.p. 
> 220°C (lit. 248  203-2040C), 
D27 
-15.2 ° (C = 0.91, water) (lit. 248 []25 -13.2° (C = 
0.91, water)); vma,.  (bromoform mull) 1625 (C=0), 1345, 1200, 900 cm 1 ; d (200 
MHz, D20) 3.81 (3H, m, Ser aCH,.BCH 2), 120 (9H, s, 3 x CH 3);  6c (50 MHz, 020) 
172.2 (C=O), 74.9 (Bu quaternary C), 60.2 (Ser BCH 2), 55.2 (Ser aCH), 26.4 (CH 
3); 
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m/z(FAB), 162 (MW), 146; hrms, found 162.11300, C 7 H 16 NO 3 requires 162.11301 (< 
1 ppm). 
N-[2.2- b/s(4'7Nitrop.heftyllethoxyc4rbonyi]-serine(Q-ferrbutyQ (11 .9) 
Bnpeoc-Ser( tBu)-OH 
To a stirred suspension of H-Ser( tBu)-OH (118) (3.270 g, 20.3 mmol) in water (30 
ml) was added a solution of triethylamine (4.21-,ml, 30.5 mmol) in dioxan (20 ml). 
Bnpeoc-ONSu (21) (8.710 g, 20.3 mmol) was added to the resultant solution and 
the reaction mixture was stirred at room temperature for 24 hours. Water (250 ml) 
was added and the pH adjusted to 2.0 by the addition of an aqueous solution of 
KHSO4. The aqueous solution was extracted with ethyl acetate (3 x 150 ml), and 
the combined organic phases were dried over Na 2SO 4 and concentrated in vacuo 
to yield an oily residue. This residue was redissolved in diethyl ether (100 ml) and 
cyclohexylamine (2.56 ml, 22.4 mmol) was added. After stirring for 90 minutes, the 
formed precipitate was filtered, washed with diethyl ether and suspended in a 
mixture of ethyl acetate and 20% citric acid 
(a)  (1:1) (200 ml). The mixture was 
stirred for 45 minutes, before separating the organic layer and drying it over 
Na 2SO 4 . The removal of the solvent in vacua co-evaporating (twice) with diethyl 
ether, afforded the title compound (9.002 g, 93%) as a yellow foam: tic R  (A6) 0.77, 
R f (AlO) 0.70; []27  +13.70 (c = 1, methanol); Vmax  (CH 2 C1 2) 3430 (NH), 1770, 1730 
(C0), 1605, 1595, 1525, 1350 (NO 2)'  860 cm 1 ; Amax  274 nm (c = 19811); 6H (200 
MHz, CD 3COCD 3) 8.25 (4H, d, J AS  8.9 Hz, Bnpeoc aromatic CH's), 7.73 (41-1, d, J AB  8.9 
Hz, Bnpeoc aromatic CH's), 4.80 (3H, m, Bnpeoc CH,CH 2), 4.32 (1H, m, Ser CH), 3.71 
(2H, m, Ser 8CH 2), 1.10 (91-1, s, 3 x CH); ôc  (50 MHz, CID 3COCD 3) 170.1 (acid C=O), 
154.8 (urethane C=O), 147.2, 146.3 (Bnpeoc quaternary aromatic C's), 128.8, 122.8 
(Bnpeoc ardmàtic CH's), 72.0 (tBu  quaternary C), 64.8 (Bnpeoc CH 2), 60.8 (Ser CH 2 ), 
53.6 (Ser CH), 48.8 (Bnpeoc CH), 25.8 (CH 3);  m/z (FAB), 476 (MW), 420, 254, 225; 
hpic R 1 (B2) 17.8 minutes. 
N-(Benzyloxycarbonyi)threonine benzyi ester (121) 
Z-Th r-O Bzi 
Z-Thr-OH (120) (95.59 g, 0.378 moll was dissolved in DMF (155 ml) and the stirred 
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solution cooled in an ice/salt bath. To this was added triethylamine (52.7 ml, 0.378 
mol) and benzyl bromide (49.5 ml, 0.416 mol) over 30 minutes. The reaction 
mixture was allowed to warm to room temperature and stirred for 24 hours. Water 
(1250 ml) was added and the aqueous solution extracted with ethyl acetate (3 x 
200 ml). The combined organic phases were washed with water (1 x 200 ml), brine 
(1 x 200 ml) and dried over Na 2 SO4. The removal of the solvent in vacuo afforded 
an orange oil, which solidified on standing. This material was filtered, washed well 
with light petroleum (b.p. 40-60 °C) and redissolved in ethyl acetate (400 ml), 
before being washed with a saturated aqueous solution of NaHCO 3 (4 x 200 ml) 
and dried over Na 2SO4. The reaction mixture was concentrated in vacuoto yield an 
oily residue which was recrystallised from acetone/light petroleum (b.p. 40-60 ° C) 
to afford the title compound (71.23 g, 55%) as a white solid: tic R f (A3) 0.54; m.p. 
78-80°C (lit. 249  80-80.50C); [a] D 27 -22.1 0 (c = 1, chloroform) (lit. 249  -13.8° (c = 2.5, 
chloroform)); Found: C, 66.2; H, 6.29; N, 4.12 CaIc. for C 19 H 21 N05 C, 66.5; H, 6.16; N, 
4.08%; Vmax  (CH 2 Cl 2) 3440 (NH), 1725 (C0), 1510, 1215 cm1; 5H  (200 MHz, COd 3 ) 
7.33 (10H, s. Z- and benzyl aromatic CH's), 5.79 (1H, d, J 9.2 Hz, NH), 5.18 (2H, s, 
benzyl CH 2), 5.11 (2H, s, Z- CH 2), 4.34 (2H, m, Thr /BCH), 2.45 (1H, bs, OH), 1.21 
(3H, d, J 6.4 Hz, CH 3);  iSc (50 MHz, CDC 13) 170.9 (ester C=O), 156.6 (urethane C=O), 
136.0, 135.1 (quaternary aromatic C's), 128.5, 128.4, 128.0, 127.9 (aromatic CH's), 
67.8 (Thr BCH), 67.2, 67.0 (Z- and benzyl CH 2), 59.2 (Thr czCH), 19.7 (CH 3);  m/z(FAB), 
344 (MW), 340, 210, 164. 
Na(Benyjcarbonyl)threonine(Orerthutyfl benzyj ester (12) 
Z-Thr( tBu)-OBzl 
Z-Thr-OBzl (121) (35.045 g,  0.102 mol) was dissolved in DCM (120 ml) and cooled 
in a CO 2/acetone bath. To this was added condensed isobutylene (approximately 
120 ml), conc. H 2 SO4 (1.2 ml) and CuCI (0.5 g). The vessel was securely stoppered 
and placed in a screened area for 7 days at room temperature. The reaction 
mixture was again cooled in CO 2/acetone, before triethylamine (7.1 ml) was added 
and the excess isobutylene removed by allowing the bath to warm to room 
temperature overnight. The removal of the solvent in vacuo gave a green oil 
which, on redissolution in ethyl acetate (150 ml), was washed with water (1 x 150 
ml), a saturated aqueous solution of NaHCO 3 (3 x 150 ml), water (1 x 150 ml) and 
brine (1 x 150 ml). After drying over Na 2 SO 4, the solvent was removed in vacuo to 
give a green oil which was purified by flash chromatography on silica (eluting with 
132 
chloroform) to afford the title compound (65.563 g, 76%) as a white solid: tic R 1 
(A3) 0.86; m.p. 53-55°C; ma,i (CH 2 Cl 2) 3440 (NH), 1720 (C=O), 1500, 1200, 1070 
cm 1 ; 6m (60 MHz, CDCI 3) 7.40 (10H, m, Z- and benzyl aromatic CH's), 5.20 (4H, S. 
Z- and benzyl aromatic CH 2), 4.35 (2H, rn, Thr c&/BCH), 1.25 (3H, d, Thr CH 
3)'  1.10 
(9H, s, 3 x 'Bu CH 3);  m/z(FAB), 400 (MH), 344, 300, 210. 
(0- tert2utyj)threonine [1 23)  
H-Th r(tB  u)-O H 
The compound was prepared by an adaptation of the method of Wunsch and 
Jentsch 235 . 
Z-Thr( t Bu)-OBzl (122) (4.627 g, 11.6 mmol) was dissolved in DMF (50 ml) and to 
this was added 10% palladium-charcoal catalyst (0.50 g, 10% by weight of the 
amino acid derivative), slowly under nitrogen. The reaction mixture was 
hydrogenated for 22 hours at room temperature and pressure. Filtration through 
'celite', washing with DMF and water, followed by the concentration of the aqueous 
washings in vacuo afforded the title compound (0.791 g, 39%) as a white solid: tic 
R f (A3) 0.39; m.p. >220 °C (lit. 215  259-2600 C); [ct] 027 -40.3 (c = 2, methanol) (lit. 235 
[a] 2° -42.1 (c = 2, methanol)); vma,. (bromoform mull) 1650 (C=O), 1390, 1240, 
1040 cm1; 6 H (360 MHz, D 20) 4.30 (1H, m, Thr 8CH), 3.57 (1H, d, J 3.4 Hz, Thr 
aCH), 1.33 (3H, d, J 6.6 Hz, Thr CH 3), 1.22 (9H, s, 3 x 'Bu CH 
3 );  6c (50 MHz, D 20) 
173.0 (C=O), 75.6 (tBu  quaternary C), 66.1, 60.3 (Thr cz/BCH), 27.5 ('Bu CH 3), 20.8 (Thr 
CH 3); m/z(FAB), 176 (MH), 147, 132. 
Nct_[2,2_ bis (4' - Nitrophenethoxycarbonyl]-threonine(Q- tert.butyl) (14) 
Bn pe oc-Thr( t Bu)- OH 
To a stirred suspension of H_Thr(tBu)_OH  (123) (0.729 g, 4.17 mmol) in water (6 ml) 
was added a solution of triethylamine (0.87 ml, 6.26 mmol) in dioxan (6 ml). 
Bnpeoc-ONSu (21) (1.789 g, 4.17 mmol) was added to the resultant solution and 
the reaction mixture stirred at room temperature for 24 hours. Water (150 ml) was 
added and the pH adjusted to 1.5 by the addition of a saturated aqueous solution 
of KHSO 4. The aqueous solution was extracted with ethyl acetate (3 x 100 ml), and 
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the combined organic phases were dried over Na 2 SO 4  and the solvent was 
removed in vacuo to yield a yellow oil. This material was redissolved in ethyl 
acetate/diethyl ether (1:1) (50 ml) and cyclohexylamine (0.53 ml, 4.59 mmol) was 
added. After stirring for 4 hours, the resulting precipitate was filtered, washed with 
diethyl ether and suspended in a mixture of ethyl acetate and 20'Y0 Citric acid 
(1:1) (100 ml). The reaction mixture was stirred for 90 minutes, before separating 
the organic layer and drying it over Na 2 SO 4 . The removal of the solvent in vacuo 
gave a yellow oil which was purified by dry flash chromatography on silica (eluting 
with chloroform) to yield the title compound (1.583 g, 78%) as a yellow foam: tic 
R f (A4) 0.48; [a]0 +970 (c = 1, MeOH); 	(CH 2 Cl 2 ) 3420 (NH), 1770, 1730 (C=O), 
1525, 1350 (NO 2), 860 cm-1; 5H  (200 MHz, CD 3 COCD 3) 8.22 (41-1. d, J 	 8.8 Hz,AB 
Bnpeoc aromatic CH's), 7.71 (41-1, d, J 8.8 Hz, Bnpeoc aromatic CH's), 4.80 (31-1, m ,AB 
Bnpeoc CH,CH 2), 4.22, 4.12 (21-1, m, Thr a/B), 1.12 (12H, m, Thr CH 3'  3 x 
tBu  CH 
3); &-
(50 MHz, CID 3COCD 3) 170.5 (acid C=O), 155.2 (urethane C=O). 147.3, 147.2, 146.3 
(Bnpeoc quaternary aromatic C's), 128.8, 122.8 (Bnpeoc aromatic CH's), 72.8 (tB u 
quaternary C), 64.8 (Bnpeoc CH 2), 66.3. 58.6 (Thr a/BCH), 48.9 (Bnpeoc CH), 26.9 (tB u 
CH 3)'  19.1 (Thr CH 3); hplc R t (132) 21.0 minutes. 
Ethyl_jpylphosQhjnatefl28) 
Ph 2 P(0)OEt 
The compound was prepared by the method of Kosolapoff and Watson 238 
Diphenyiphosphinyl chloride (45) (54.30 g, 0.231 mol) was dissolved in benzene 
(400 ml), and the resulting solution cooled to 0 °C. A solution of sodium (5.31 g, 
0.231 mol) in ethanol (dried from magnesium and iodine) (100 ml) was added over 
30 minutes, and the reaction mixture allowed to warm to room temperature and 
stirred for 24 hours. Filtration through 'celite', followed by the removal of the 
solvent in vacua afforded a clear oil, which on distillation, gave the title compound 
(42.84 g, 75%) as a white solid: m.p. 37-38 °C; b.p. 135-136 °C at 0.03-0.04 mmHg 
(lit. 238 140-145°C at 0.05 mmHg); Found: C, 68.4; H, 6.33 Calc. for C 14 H 150 2P C, 
68.3; H, 6.10%; v ma .. (CH 2Cl 2) 1445, 1230 (P0), 1135, 1040, 960 cm 1 ; 6,. (200 MHz. 
CDCI 3) 7.76 (4H, m, aromatic CH's), 7.39 (61-1, m, aromatic CH's), 4.03 (2H, m, CH 
2)' 
1.29 (31-1, t, J 7.1 Hz, CH 
3); 6C (50 MHz, COd 3) 132.9 (aromatic quaternary C), 131.9, 
131.5, 131.3 (aromatic CH's), 130.2 (quaternary aromatic C), 128.5, 128.2 (aromatic 
CH's), 60.9 (CH 2)'  16.3 (CH 3);  6 (36 MHz, COd 3) 31.50; m/z (FAR), 246 (M), 218, 
134 
202, 77, 51. 
Dipheflylphosphinicanhydride (i27) 
Ph 2 PO2 POPh 2 
Method A 
The compound was prepared by the method of Crofts et a1 239 
Diphenyiphosphinyl 	chloride 	(45) 	(36.52 	g, 	0.155 	mol) 	and 	ethyl 
diphenylphosphinate (128) (38.80 g, 0.158 mol) were heated at 200 °C for 2 hours 
under argon. The reaction mixture was allowed to cool to 55 °C, toluene (20 ml) 
was added, and the resulting solution cooled in an ice/salt bath. Vigorous 
scratching encouraged the rapid formation of a white precipitate. After storing in a 
refrigerator for 30 minutes, the precipitate was filtered, washed with a little toluene 
and dried to afford the title compound (37.95 g, 59%) as a white solid: m.p. 
140-142°C (lit. 239 143.5-144.50C); Found: C, 68.8; H. 4.81 Calc. for C 24 H 200 3 P2 C, 
68.9; H, 4.80%; 'Vma,(  (CH 2 Cl 2 ) 1440, 1235 (P=O),.-1130, 940 ,1(P-O-P) cm1; 6H (200 
MHz, CDCI 3) 7.85-7.65 (8H, m, aromatic CH's), 7.53-7.25 (12H, m, aromatic CH's); &, 
(50 MHz, CDCI 3) 134.0-127.9 (aromatic CH's, quaternary aromatic C's); d (36 MHz, 
CH 2Cl 2) 27.64; 6p (36 MHz, COd 3) 28.60; m/z (FAB), 418 (M), 341. 277, 218, 202, 
152; hrms, found 4 19.09657, C 24 H 2 0 3 P2 requires 419.09659 (< 1 ppm). 
Method B 
The compound was prepared as method A, without the distillation of the ethyl 
diphenylphosphinate (128) intermediate. 
Diphenyiphosphinyl chloride (45) (13.45 g, 56.9 mmol) was dissolved in benzene 
(100 ml), and the resulting solution cooled to 0 °C. A solution of sodium (1.31 g, 
56.9 mmol) in ethanol (27 ml) was added over 90 minutes, and the reaction mixture 
allowed to warm to room temperature and stirred for 24 hours. Filtration through 
'celite', followed by the removal of the solvent in vacuo afforded ethyl 
diphenylphosphonate (128) (11.89 g, 85%) (confirmed by 31 P n.m.r. - (36 MHz, 
CDCI 3) 31.57). 
To (128) (11.33 g, 46.1 mmol) was added diphenylphosphinyl chloride (45) (10.90 
135 
g, 46.1 mmol), and the resulting mixture was heated to 200 °C for 2 hours under 
argon. The reaction mixture was allowed to cool to 55 °C, toluene (20 ml) was 
added, and the resulting solution cooled in an ice/salt bath. Vigorous scratching 
encouraged the formation of a white precipitate, which was filtered and washed 
with a little cold toluene to afford the title compound (13.31 g, 70%) as a white 
solid: m.p. 138-140°C; 5H (60 MHz, CDCI 3) 7.90-7.10 (m, aromatic CH's); 6 p (36 
MHz, CD 2 Cl 2) 27.37. 
Method C 
The compound was prepared by the Igeneral method of Moedritzer 240 
Dry paraformaldehyde (based on CH 2O - 3.164 9 , 0.105 mol) was added to 
diphenylphosphinyt chloride (45) (24.95 g, 0.105 mol), and the resulting slurry 
heated under argon at 150 °C for 50 minutes (i.e. until the solution had become 
clear). After the reaction mixture had been allowed to cool to room temperature, 
the flask was placed under vacuum for 10 minutes. The resulting oil was dissolved 
in toluene (20 ml) and cooled in an ice/salt bath. Vigorous scratching resulted in 
the formation of a white precipitate. After storing in a refrigerator for 60 minutes, 
the precipitate -was filtered off, washed with a little cold toluene and dried to 
afford the title compound (9.95 g, 45%) as a white solid: m.p. 139-142°C; 
umax 
(CH 2 Cl 2) 1440, 1235 (P=O), 1135, 940 (P-O-P) cm-1; 6H (80 MHz, CDCI 3) 7.92-7.52 
(8H, m, aromatic CH's), 7.49-7.16 (12H, m, aromatic CH's); S (81 MHz, CD 2 Cl 2 ) 
27.89. 
Na_(Benzyloxycarbonyl)ppYlalanylglycine benzyl ester (109) 
Z-Phe-G ly-OBzl 
(A) Z-Phe-OH (108) (0.501 g. 1.67 mmol) was dissolved in DCM (5 ml) and cooled 
to -5 0C. To this was added N-methylmorpholine (0.185 ml, 1.67 mmol) and 
diphenylphosphinic anhydride (127) (0.716 g, 1.67 mmol), and the reaction mixture 
stirred at -5 °C for 10 minutes. TosOH 2 -Gly-OBzl (107) (0.563 g, 1.67 mmol) in 
DMA/DCM (1:5) (6 ml) and N-methylmorpholine (0.370 ml, 3.34 mmol) were added, 
and the reaction mixture allowed to warm to room temperature and stirred for 2.5 
hours. Water (250 ml) and ethyl acetate (250 ml) were added, and the organic and 
aqueous layers were separated. The organic phase was washed with a saturated 
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aqueous solution of NaHCO 3  (2 x 100 ml), water (1 x 100 ml), an aqueous solution 
of 5% citric acid (2 x 100 ml), water (1 x 100 ml) and brine (1 x 100 ml), and dried 
over Na 2 SO 4. The removal of the solvent in vacuo afforded a white solid, which 
was recrystallised from ethyl acetate/light petroleum (b.p. 40-60 °C) to give the title 
compound (0.450 g, 60%) as a white solid: tic R (A4) 0.76; m.p. 133-134 ° C; [ct] 0 27 
-1.94 0 (c = 1, acetone) (lit. 247 -3.75 0 (c = 1, acetone)); V max  (CH 20 2) 3425 (NH), 
1750, 1725, 1685 (C=O), 1500, 1200 cm1; 5H (200 MHz, CD 3 COCD3) 7.30 (15H, m, 
aromatic CH's), 6.70 (1H, bd, NH), 5.18 (2H, s, benzyl CH 2), 5.00 (2H, m, Z- CH 2), 4.55 
(1H, m, Phe ctCH), 4.06 (2H, d, J 5.9 Hz, Gly CH 2), 3.10 (2H, m, Phe BCH 2); m/z(FAB), 
447 (MW), 403, 372, 313, 225; hplc R (B2) 18.5 minutes. 
(B) Z-Phe-OH (108) (1.003 g, 3.34 mmol) was dissolved in DCM (10 ml) and 
cooled to -5 °C. To this was added N-methylmorpholine (0.370 ml, 3.34 mmol) and 
diphenylphosphinic anhydride (127) (1.433 g, 3.34 mmol), and the reaction mixture 
stirred at -5 °C for 10 minutes. TosOH 2 -Gly-OBzl (107) (0.564 g, 1.67 mmol) in 
DMAJDCM (1:5) (6 ml) and N - methylmorpholine (0.370 ml, 3.34 mmol) were added, 
and the reaction mixture allowed to warm to room temperature and stirred for 2.5 
hours. The reaction mixture was worked up as above to afford the title compound 
(0.564 g, 76%) as a white solid. Characterisation was in agreement with above. 
d!1'a 	ny! ._toluenesulphonate (131) 
TosOH 2 -AIa-OBzl 
The compound was prepared by the general method of Zervas et al 230 as outlined 
above for the preparation of TosOH 2 -Gly-QBzl (107). 
The material was purified by recrystallisation from benzene/diethyl ether (yield 
= 91%): m.p. 106-108 °C; [ct] 027 -3.8 0  (c = 1, MeQH); Found: C, 58.2; H, 6.07; N, 4.11 
CaIc. for C 17 H 21 N05S C, 58.1; H, 6.02; N, 3.99%; v max. (bromoform mull) 1750 (C=O), 
1600, 1520 cm 1 ; 6 (200 MHz, d 6- DMSO) 8.40 (3H, bs, NH 3 ), 7.55 (2H, d, J AB  7.9 
Hz, tosyl aromatic CH's), 7.39 (5H, m, benzyl aromatic CH's), 7.14 (2H, d, J 7.9 Hz,
AS 
tosyl aromatic CH's), 5.23 (2H, s, benzyl CH 2), 4.18 (1H, q, Ala czCH), 2.29 (3H, s, 




Z-Phe-OH (108)(1.0009, 3.34 mmol) was dissolved 	DCM (10 ml) and cooled to 
-5 °C. To this w'ás added N-methylmorpholine (0.370 ml, 3.34 mmol) and 
diphenyiphosphinic anhydride (127) (1.432 g, 3.34 mmol), and the reaction mixture 
was stirred for 10 minutes at -5 ° C. TosOH 2 -Ala-OBzl (131) (0.587 g, 1.67 mmol) 
in DMA/DCM (1:5) (6 ml) and N-methylmorpholine (0.560 ml, 4.95 mmol) were 
added, and the reaction mixture was allowed to warm to room temperature and 
stirred for 2.5 hours. The reaction mixture was worked up as above for 
Z-Phe-Giy-OBzi (109), to give a white solid, which, on recrystallisation from 
acetone/light petroleum (b.p. 40-60 0C), afforded the title compound (0.540 g, 70%) 
as a white solid: tic R (A4) 0.67; m.p. 122-124 °C; [ct] 0 27 -20.9 0 (C = 1, acetone); 
Found: C, 70.4; H, 6.24; N, 6.03 CaIc. for C 27 H 28 N 205 C, 70.4; H, 6.13; N, 6.08%; V max 
(CH 2 Cl 2) 3420 (NH), '1740, 1680 (C=O), 1500, 1200, 1135 cm -1 ; 6. (200 MHz, 
CID 3COCD 3) 7.78 (1H, m, amide NH), 7.33 (15H, m, aromatic CH's), 6.54 (1H, bd, 
urethane NH), 5.18, 5.00 (benzyl CH 
2'  Z- CH 2), 4.62 (2H, m, Phe ctCH, Ala czCH), 3.10 
(2H, m, Phe BCH 2), 1.39 (3H, d, J 7.3 Hz, Ala CH 
3);  ôc (50 MHz, CID 3 COCD 3) 171.3, 
170.2 (amide C=O, ester C=O), 155.0 (urethane C=O), 136.9, 136.4, 135.4 (quaternary 
aromatic C's), 130.4-125.5 (aromatic CH's), 65.4, 64.9 (benzyl CH 
2'  Z- CH 2), 55.1 (Phe 
ciCH), 47.1 (Ala ctCH), 37.1 (Phe BCH 2), 16.0 (Ala CH 3); m/z (FAB), 461 (MH), 242, 
219, 91; flrms, found 46 1.20762, C 27 H 29 N 20 5 requires 46 1.20763 (< 1 ppm); hplc R 
(B2) 19.0 minutes. 
31 n.m.r. monitored stability studies o .f _diphenylphosphinic a nhydride (17. 
(1) Stability of diphenyIphosphinjcatihdridei27Jto N-methylmorholine 
Diphenylphosphinic anhydride (127) (0.035 g, 0.084 mmol) was dissolved in 
CID 2Cl 2/DMA (2:3) (0.5 ml) at room temperature, and to this was added 
N-methylmorpholine (0.027 ml, 0.25 mmol). The resulting solution was monitored 
by 31 P n.m.r. (36 MHz), acquiring spectra at given time intervals. No significant loss 
of the starting anhydride signal (27.09 ppm) was observed over 60 minutes. 
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( _Stability 	 anhydride (i27j_to TosOH 2 -Gly-OBzl 
(107) 
Diphenylphosphinic anhydride (127) (0.035 g, 0.084 mmol) was dissolved in 
CID 2Cl 2/DMA (2:3) (0.5 ml) at room temperature, and to this was added 
T0sOH 2 4 -Gly-OBzl (107) (0.028 g, 0.084 mmol) and N-methylmorpholine (0.020 ml,' 
0.168 mmol). The resulting solution was monitored by 31 P n.m.r. (36 MHz), acquiring 
a spectrum immediately on the addition of the amine component and the base, 
and subsequently at 15 minute intervals for 60 minutes. After 15 minutes a small 
phosphinate anion signal (16.02 ppm) was shown to be present, which increased in 
size at a steady but slow rate. 
(3) Stability ofpn.yp_qs_jpjjride (127)- to methanol 
Diphenylphosphinic anhydride (127) (0.035 g, 0.084 mmol) was dissolved in 
CID 2Cl 2/MeOH (2:3) (0.5 ml) at room temperature. The solution was monitored by 
31 
P n.m.r. (36 MHz), acquiring spectra at 10 minute intervals for 30 minutes. No 
change in the starting anhydride signal (31.10 ppm) was observed over the 30 
minutes. 
To the above solution was subsequently added N-methylmorpholine (0.020 ml, 
0.167 mmol) and spectra again recorded at 10 minute intervals for 30 minutes. 
After the 30 minutes, the starting anhydride signal had completely diminished to 
afford 2 other signals, one corresponding to the phosphinyl ester (35.27 ppm), and 
the other to the phosphinate anion (20.87 ppm). 
4) Stability of diphenvlDhosDhinicanydride(]7obenzyI alcohol 
Diphenylphosphinic anhydride (127) (0.035 g, 0.084 mmol) was dissolved in 
CD2Cl 2/benzyl alcohol (2:3) (0.5 ml) at room temperature. The solution was 
monitored by 31 P rim.r. (36 MHz), acquiring spectra at 10 minute intervals for 30 
minutes. No change in the starting anhydride signal (30.89 ppm) was observed 
over the 30 minutes. 
To the above solution was added N-methylmorpholine (0.020 ml, 0.167 mmol) 
and spectra again acquired at 10 minute intervals for 30 minutes. Over the 30 
minutes the starting anhydride signal (30.22 ppm) was reduced slightly and a small 
phosphinate anion signal (21.13 ppm) appeared. 
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1 Ln.m.r. monitored c9plLng __with.diphenylphosphinic . anhydricie127) 
(11CoplingofZ-Phe_OH(108) and TosOH-Gly-QBzl (107) 
Z-Phe-OH (108) (0.050g, 0.167 mmol) was dissolved in CD 2 Cl 2/DMA (2:3) (0.5 
ml) at room temperature, and to this was added N -methylmorpholine (0.019 ml, 
0.167 mmol) and diptienylphosphinic anhydride (127) (0.071 g, 0.167 mmol). The 
solution was monitored by 31 P n.m.r. (36 MHz), acquiring spectra at given time 
intervals for 15 minutes. After the 15 minutes, the activation was shown to be 
complete. 
To the above solution were added TosOH 2 -Gly-OBzl (107) (0.056 g, 0.167 
mmol) and N-methylmorpholine (0.038 ml, 0.334 mmol), and again spectra were 
acquired at given time intervals. The coupling was shown to be complete after 30 
minutes (i.e only the phosphinate anion signal (16.99 ppm) was present after this 
time). 
The above coupling of Z-Phe-OH (108) and TosOH 2 '-Gly-OBzl (107) was 
repeated as above, except that d 7-DMF (0.5 ml) was used as the solvent instead of 
a mixture of CD 2Cl 2/DMA. The monitoring of the reaction solution by 31 P n.m.r. (36 
MHz) revealed that the activation was complete within 5 minutes, and the coupling 
reaction within 10. 
(2) Coupling of Fmoc-Arq(pmc)-Oi-i (1) and Toso jjy-Oazl (107) 
Fmoc-Arg(Pmc)-OH (133) (0.055 g, 0.084 mmol) was dissolved in CD 2 Cl 2/DMA 
(1:4) (0.5 ml) at room temperature, and to this was added N -methylmorpholine 
(0.010ml, 0.084 mmol) and diphenylphosphinic anhydride (127) (0.035 g, 0.084 
mmol). The solution was monitored by 31 P n.m.r. (36 MHz). After 5 minutes a 
position appeared to have been reached whereby the starting anhydride (127) 
(27.25 ppm), the activated mixed anhydride (26.77 ppm) and the phosphinate anion 
(16.37 ppm) were all present. 
To this solution were added TosOH 2 '-Gly-OBzl (107) (0.028 g, 0.084 mmol) and 
N-methylmorpholine (0.019 ml, 0.168 mmol). The reaction solution was again 
monitiored by 31 p n.m.r., acquiring spectra at given time intervals for 20 minutes. 
The coupling was shown to be complete within 20 minutes. 
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( Coupliqg of Bnpeoc-Ser-QH (88) and ToSOH ',.+ -Gly-QBzI [1 07) 
Bnpeoc-Ser-OH (88) (0.035 g, 0.084 mmol) was dissolved in CD 2Cl 2/DMA (1:4) 
(0.5 ml) at room temperature, and to this was added N-methylmorpholine (0.010 
ml 0.084 mmol) and diphenylphosphinic anhydride (127) (0.035 g, 0.084 mmol). The 
solution was monitored by 31 P n.m.r. (36 MHz), acquiring spectra at given time 
intervals for 20 minutes. After 5 minutes a position appeared to have been reached 
whereby the starting anhydride (127) (27.39 ppm), the activated mixed anhydride 
(26.96 ppm) and the phosphinate anion (16.56 ppm) were all present. The ratio of 
the peak heights of these signals remained largely unchanged over the 20 minute 
period. 
TosOH2 -Gly-OBzl (107) (0.028 g, 0.084 mmol) and N - methylmorpholine (0.019 
ml, 0.168 mmol) were added to the above solution, and again spectra were 
collected for 20 minutes. The coupling was shown to be complete within the 20 
minutes. 
(4)Atternpted cpQhn.gof Fmoc-As ,-QH (1 4) 	T5Q H-GIy .-OBzI (107) 
Fmoc-Asn-OH (134) (0.030 g, 0.084 mmol) was dissolved in CD 2 Cl 2/DMA (1:4) 
(0.5 ml) at room temperature, and to this was added N-m ethyl morpholine (0.010 
ml, 0.084 mmol) and diphenylphosphinic anhydride (127) (0.035 g, 0.084 mmol). The 
monitoring of the reaction solution by 31 P n.m.r. (36 MHz) revealed the complete 
decay of the starting anhydride signal (27.06 ppm) within 20 minutes, to afford 
only a phosphinate anion signal (17.30 ppm). The characteristic nitrile peak (2260 
cm 1 ) was shown to present in an IR spectrum of the reaction mixture. 
(5) CoMpjjg of Fmoc-Gin(Mbh)-OH (135) 	TpQIyQL(1Q7) 
Fmoc-Gln(Mbh)--OH (135) (0.050 g, 0.084 mmol) was dissolved inn CID 2 Cl 2 (1:4) 
(0.5 ml) at room temperature, and to this was added N-methylmorpholine (0.010 
ml, 0.084 mmol) and diphenylphosphinic anhydride (127) (0.035 g, 0.084 mmol). The 
reaction solution was monitored by 3 P n.m.r. After 15 minutes, 2 signals were 
shown to be present, one corresponding to the activated mixed anhydride (27.80 
ppm), the other to the phosphinic anion (16.56 ppm). The ratio of the peak heights 
of these 2 signals changed little over a 60 minute period. 
After the 60 minutes, TosOH 2 -Gly-OBzl (107) (0.028 g, 0.084 mmol) and 
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N - methylmorpholine (0.019 ml, 0.168 mmol) were added. 31 P n.m.r. revealed that 
the coupling was complete within 15 minutes. 
31 
 P n.m.r. monitored stability Qf (O@Pzyloxyp@rboRyjjhqnyiaianyi pbosphiniç 
mixed_anhyride (129) 
Z-Phe-OH (108) (0.050 g, 0.167 mmol) was dissolved in CID 2 C1 2/DMA (1:4) (0.5 
ml) at room temperature, and to this was added N-methylmorpholine (0.019 ml, 
0.167 mmol) and diphenylphosphinic anhydride (127) (0.071 g, 0.167 mmol). The 
solution was monitored by 31 P n.m.r. (81 MHz), acquiring spectra at given time 
intervals:for 4 hours. After 10 minutes, a position had been reached with the mixed 
anhydride (129) (27.91 ppm), the starting anhydride (127) (27.81 ppm) and the 
phosphinate anion (16.64 ppm) all present. The ratio of the peak heights of these 
signals remained unchanged over the 4 hours. 
N -[2- O/s (4'-Nit 	benzyl ester (1 36) 
Bnpeoc-Ser-Gly-OBzl 
Bnpeoc-Ser-OH (88) (1.399 g, 3.34 mmol) was dissolved in DMA (5 ml) and cooled 
'to 0° C. To this was added N-methylmorpho line(0.370 ml, 3.34 mmol) and 
diphenylphosphinic anhydride (127) (1.433 g, 3.34 mmol) and the reaction mixture 
was stirred for 10 minutes. TosOH
2 +-Gly-OBzl (107) (0.564 g, 1.67 mmol) in 
DMAJDCM (1:5) (8 ml) and N - methylmorpholine (0.370 ml, 3.34 mmol) were added, 
and the reaction mixture was allowed to warm to room temperature and stirred for 
2.5 hours. Water (200 ml) and ethyl acetate (200 ml) were added, and the organic 
and aqueous layers were separated. The organic phase was washed with water (1 
x 100 ml), an aqueous solution of 5% citric acid (2 x 100 ml), water (1 x 100 ml), a 
saturated aqueous solution of NaHCO 3 (2 x 100 ml) and water (1 x 100 ml), and 
dried over Na 2 SO 4 . The removal of the solvent in vacuo afforded an off-white 
solid, which was purified by flash chromatography on silica (employing a gradient 
of diethyl ether/chloroform) to yield the title compound (0.580 g, 61%) as a yellow 
oil: tic R (A4) 0.70; Vma..  (CH 2Cl 2) 3430 (NH), 1735, 1685 (C0), 1605, 1595, 1525, 
1350 (NO 2)'  1210 cm-1; 5H (200 MHz, CD 3 COCD 3) 8.21 (4H, d, J A13 8.9 Hz, Bnpeoc 
aromatic CH's), 7.68 (4H. d, 
JAB 8.9 Hz, Bnpeoc aromatic CH's), 6.50 (1H, bd, NH), 
5.17 (2H, s, benzyl CH 2), 4.77 (3H, m, Bnpeoc CH,CH 2). 4.23 (1H, m, Ser aCH), 4.05 
(2H, d. J 5.7 Hz, Gly CH 2), 3.78 (2H, m, Ser BCH 2);6 C (50 MHz, CD 3COCD 3) 169.9, 
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168.9 (amide C=O, ester C=O), 155.0 (urethane C=O), 147.3, 146.4 (Bnpeoc 
quaternary aromatic C's), 135.3 (benzyl quaternary aromatic C), 128.9-122.9 
(aromatic CH's), 65.5, 65.0 (Bnpeoc CH 2 , benzyi CI-1 2), 61.5 (Ser BCH 2), 56.0 (Ser 
cLCH), 48.9 (Bnpeoc CH), 40.2 (Gly CH); m/z (FAB), 568 (MW), 438, 392, 355; hplc R 
(B6) 21.3 minutes. 
ptyJ)jniyU:glycin.izyLter(i 37) 
Fmoc-Gln(Mbh)-Giy-OBzl 
Fmoc-Gln(Mbh)-OH (135) (0.300 g, 0.51 mmol) was dissolved in DMF (15 ml) and 
cooled to 0°C. To this was added N-methylmorphoiine (0.057 ml, 0.51 mmoi) and 
diphenviphosphinic anhydride (127) (0.211 g, 0.51 mmoi), and the reaction mixture 
stirred for 10 minutes. TosOH 2 +-Giy-OBzi (107) (0.168 g, 0.51 mmol) in DMF (5 ml) 
and N-methyimorpholine (0.114 ml, 1.01 mmoi) were added, and the reaction 
mixture allowed to warm to room temperature and stirred for 2.5 hours. Ethyl 
acetate (150 ml) was added, and the resulting solution was washed with water (2 x 
100 ml), a saturated aqueous solution of NaHCO 3 (4 x 100 ml), water (1 x 100 ml), 
an aqueous solution of 10% citric acid (2 x 100 ml) and brine (1 x 100 ml). After 
drying the organic phase over Na 2 SO 4, the solvent was removed . in vacuo to yield 
a white solid. This material was recrystailised from ethyl acetate/light petroleum 
(b.p. 40-60 °C) to afford the title compound (0.290 g, 77%) as a white solid: tic R f 
(A7) 0.70; m.p. 194 - 196 °C; [a]0 27 -3.9 0 (c = 1, DMF); Vma*  (bromoform mull) 1730, 
1690, 1640 (C=O), 1540, 1510, 1255 cm1; 6H  (200 MHz, d 6-DMSO) 8.48 (11-1, d, J 8.5 
Hz, amide NH), 8.42 (11-1, bt, amide NH), 7.91-7.21 (14H, m, Fmoc aromatic CH's, 
benzyl CH's, Mbh CH), 7.19 (4H, d, J AB  8.3 Hz, Mbh aromatic CH's), 6.87 (41-1, d, JAB 
8.3 Hz, Mbh aromatic CH's), 6.07 (1H, .d, J 8.5 Hz, urethane NH), 5.13 (2H, .s, benzyl 
CI-1 2), 4.26 (41-1, m Gin aCH, Fmoc CH,CH 2), 3.95 (21-1, m, Gly CI-1 2), 3.72, 3.71 (61-1, 2 x 
s, 2 x OMe), 2.34, 2.08 (41-1, m, Gin 8/yCH2's); ôc  (50 MHz, d 6-DMSO) 172.4, 170.8, 
169.7 (2 x amide C=O, ester C=O), 158.2 (Mbh quaternary aromatic C), 156.1 
(urethane C=O), 143.9, 140.8 (Fmoc quaternary aromatic C's), 135.9, 135.1 (Mbh 
quaternary aromatic C, benzyl quaternary aromatic C), 128.4-113.7 (aromatic CH's, 
Mbh CH), 65.9 (Fmoc CH 2, benzyl CH 2), 55.1, 54.6 (2 x OMe, Gin aCH), 46.8 (Fmoc 
CH), 43.2 (Giy CI-1 2), 32.0, 28.3 (Gin 8/yCH 2 's); m/z (FAB), 742 (M'), 617, 419, 325, 
307; hrms, found 742.31280, C44 1-1 44N 306 requires 742.3 1282 (< 1 ppm); hplc R 1 (83) 
14.4 minutes. 
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N a_(9Fiuorenyimethoxycarbonyi)-L-phenyiaianyj_L_jne 	benzyl 	ester 
(138) 
Fmoc-L-Phe-L-Ala-OBzi 
Fmoc-L-Phe-OH (0.458 g, 1.18 mmol) was dissolved in DMF (15 ml) at room 
temperature, and to this was added N- methyl morpholine (0.135 ml, 1.18 mmol) and 
diphenyiphosphinic anhydride (127) (0.506 g, 1.18 mmol). After stirring for 5 
minutes, TosOH 2 -Ala-OBzl (131) (0.414g, 1.18 mmol) and N -methylmorphol,ne 
(0.270 ml, - 2.36 mmol) were added, and the reaction mixture was stirred for 3 
hours. Ethyl acetate (150 ml) was added, and the resulting solution was washed 
with water (1 x 150 ml), a saturated aqueous solution of NaHCO 3 (2 x 150 ml), 
water (1 x 150 ml), an aqueous solution of 10% citric acid (2 x 150 ml), water (1 x 
150 ml), a saturated aqueous solution of NaHCO 3 (2 x 150 ml) and brine (1 x 150 
ml). After drying the organic solution over Na 2 SO 4, the solvent was removed in 
vacuo to afford a white solid. This material was purified by flash chromatography 
on silica (eluting with ethyl acetate) to give a white solid, which was recrystallised 
from ethyl acetate/light petroleum (b.p. 40-60 °C) to afford the title compound 
(0.374 g 58%) as a white solid: tic R f (A7) 0.71; m.p. 183-185°C; [ct] D 27  -19.5 ° (C = 
- 1, DMF); Found: C, 74.3; H, 5.96; N, 5.38 CaIc. for C 34 H 32 N20 5 C, 74.4; H, 5.88; N, 
5.11%; 'max. (bromoform mull) 1745, 1695, 1650 (C=O), 1540, 1260 cm 1 ; 6 m (200 
MHz, d 6-DMSO) 8.57 (1H, d, J 7.3 Hz, amide NH), 7.89-7.13 (18H, m, aromatic CH's), 
5.15 (2H, s, benzyl CH 2), 4.25 (5H, Phe otCH, Ala aLCH, Fmoc CH,CH 2), 3.95 (2H, m, 
Phe BCH 2), 1.36 (3H, d, J 7.1 Hz, Ala CH) ; 6 (50 MHz, d 6-DMSO) 172.4, 171.8 
(amide C=O, ester C=O), 155.9 (urethane C=O), 143.8, 140.7, 138.2, 136.0 (Fmoc 
quaternary aromatic C's, benzyl quaternary C, Phe quaternary aromatic C), 
129.2-120.1 (aromatic CH's), 66.0, 65.7 (benzyl CH 2, Fmoc CH 2), 55.8 (Phe CH), 47.8 
(Ala aCH), 46.6 (Fmoc CH), 37.5 (Phe 8CH 2 ), 16.9 (Ala CH 
3); 
m/z (FAB), 549 (MH), 
237, 179; hrms, found 549.23897, C 34 H 33 N20 5 requires 549.23893 (< 1 ppm); hplc R 





The compound (139) was prepared by repeating the above procedure for the 
synthesis of Fmoc-L-Phe-L-Ala-OBzl (138), but using Fmoc-D-Phe-OH instead of 
Fmoc-L-Phe-OH. 
The product was recrystallised from ethyl acetate/light petroleum (b.p. 40-60 ° C) 
to afford the title compound (0.400 g, 62%) as a white solid: tic R 1 (A7) 0.71; m.p. 
163-164°C; [cl]027 +13.30 (C = 1, DMF); Found: C, 74.4; H, 5.96; N, 5.25 Caic. for 
C 34 H 32 N 20 5 C, 74.4; H, 5.88; N, 5.11%; V max (bromoform mull) 1745, 1695, 1655 
(C0), 1540, 1260 cm1; 6H  (200 MHz, d 6-DMSO) 8.55 (1H, d, J 7.1 Hz, amide NH), 
7.90-7.15 (18H, m, aromatic CH's), 5.14 (2H, s, benzyl CH 2), 4.25 (5H, m, Phe aCH, 
Ala otCH, Fmoc CH,CH 2), 3.94 (2H, m, Phe BCH 2), 1.29 (3H, d, J 7.2 Hz, Ala CH) ; c 
(50 MHz, d 5-DMSO) 172.4, 171.6 (amide C=O, ester C=O), 155.8 (urethane C=O), 
143.9, 140.8, 138.1, 136.0 (Fmoc quaternary aromatic C's, benzyl quaternary C, Phe 
quaternary aromatic C), 129.4-120.2 (aromatic CH's), 66.0, 65.8 (benzyl CH 2 , Fmoc 
CH 2), 56.0 (Phe clCH), 47.9 (Ala clCH), 46.7 (Fmoc CH), 38.1 (Phe BCH 2), .17.2 (Ala / 
m/z (FAB), 549 (MW), 237, 179; hrms, found 549.23889, C 34 H 33 N 20 5 requires. 
549.23893 (< 1 ppm); hplc R 
t 
(B7) 34.3 minutes. 	 - 
Fmoc-L-Ala-O[(-)Men] 
Fmoc-L-Ala-OH (0.520 g, 1.67 mmol) was dissolved in DMF (10 ml) at room 
temperature, and to this was added N-methylmorpholine (0.190 ml, 1.67 mmol) and 
diphenyiphosphinic anhydride (127) (0.716 g, 1.67 mmoi). After stirring for 10 
minutes, 2-dimethylaminopyridine (0.010 g, 0.084 mmol), N-methylmorpholine 
(0.190 ml, 1.67 mmol) and (-)-menthol (0.261 g, 1.67 mmoi) were added, and the 
reaction mixture was stirred for 3 hours. Ethyl acetate (100 ml) was added, and the 
resulting solution was washed with water (1 x 100 ml), a saturated aqueous 
solution of NaHCO 3 (2 x 100 ml), water (1 x 100 ml), an aqueous solution of 10% 
citric acid (2 x 100 ml), water (1 x 100 ml), 0.1M NaOH 
(aq)  (2 x 100 ml) and brine (1 
x 100 ml). After drying the organic phase over Na 2 SO4, the solvent was removed in 
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vacuo to afford a white solid. This material was purified by flash chromatography 
on silica (eluting with ethyl acetate) to give a solid; which was recrystallised from 
ethyl acetate/light petroleum(b.p. 40-60 °C) to afford the title compound (0.323 g, 
43%) as a white solid: tic R (A7) 0.72; m.p. 120-121 °C; Ecu 027 - 26.3° (c = 1, DMF); 
Found: C, 74.7; H, 7.89; N, 3.17 Calc. for C 28 H 35N04  C, 74.8; H, 7.80; N, 3.12%; vmax.  
(CH 2 Cl 2) 3420 (NH), 1720 (C=O), 1510,. 1210 cm1; 6H (200 MHz, COd 3) 7.78-7.27 
(81-1, m, Fmoc aromatic CH's), 5.44 (11-1, bd, J 6.6 Hz, NH), 4.75 (11-1, m, Men CH), 4.35 
(31-1, m, Fmoc CH,CH 2), 4.25 (11-1, m, Ala cuCH), 2.00-1.25 (91-1, m, Ala CH 
3' 
Men 
signals), 1.20-0.83 (91-1, m, Men signals), 0.77 (3H, d, J 6.9 Hz, Men CH 
3 );  c (50 
MHz. CDCI 3) 172.5 (ester C=O), 155.4 (urethane C0), 143.8, 143.7, 141.2 (Fmoc 
quaternary aromatic C's), 127.5, 126.9,124.9, 119.8' (Fmoc aromatic CH's), 75.4 (Men 
CH), 66.8 (Fmoc CH 2), 49.6 (Men CH), 47.1, 46.8 (Fmoc CH, Ala cuCH), 40.5 (Men CH 
2)' 
34.0 (Men CH 2), 31.2 (Men CH), 26.2 (Men CH 3), 23.3 (Men CH), 21.8, 20.5, 18.8 (2 x 
Men CH, Ala CH 
3)' 16.2 (Men CH 3); m/z (FAB), 450 (MH'), 312, 179, 91; hrms, found 
450.26444, C 28 H 36 N04 requires 450.26442 (< 1 ppm); hpic R 
t 
(B8) 39.3 minutes. 
( 9 -D-alanjne ±rnenthyi ester (141) 
Fm oc -0-Ala - O[( - ) Men] 
The compound (141) was prepared by repeating the above procedure for the 
synthesis of Fmoc - L-Ala -O[(-)Men] (140) but using Fmoc-D-Ala-OH instead of 
Fmoc-L-Ala-OH. 
The product was purified by flash chromatography on silica (eluting with ethyl 
acetate) to afford the title compound (0.361 g, 48%) as a clear oil: tic R (A7) 0.72; 
[a] 27 -20.7 0 (c = 1, DMF); V max  (CH 2Cl 2) 3440 (NH), 1720 (C0), 1510, 1215 cm 1 ; 
6H (200 MHz, COd 3) 7.78-7.25 (81-1, m, Fmoc aromatic CH's), 5.39 (11-1, bs, NH), 4.75 
(1H, m, Men CH), 4.38 (31-1. m, Fmoc CH,CH 2), 4.23 (11-1, m, Ala cuCH), 2.05-1.34 (91-1, 
m, Ala CH 3'  Men signals), 1.11-0.83 (91-1, m, Men signals), 0.78 (31-1, d, J 6.9 Hz, Men 
CH 3);  m/z (FAB), 450 (MH'), 312, 215, 202, 179; /7rms, found 450.26444, C 28 H 36N04 
requires 450.26442 (< 1 ppm); hplc R 
t 
(88) 39.1 minutes. 
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n.mr monitored stability studies with diphenyiphosphinic anhydride 
(127) and Zn! 2 
(1) Dipheny!phospjin,c anhydride {127) and ZnI (Q1q 
Diphenylphosphinic anhydride (127) (0.075 g, 0.18 mmol) was dissolved in 
CID 2Cl 2JDMF (1:4) (0.5 ml) at room temperature, and to this was added Zn1 2 (0.006 
g, 0.018 mmol). The resulting solution was monitored by 31 P n.m.r. (36 MHz), 
acquiring a spectrum immediately on the addition of the Zn1 2, and subsequently at 
15 minute intervals for 30 minutes. A small signal (25.41 ppm) was shown to be 
present after the 30 minute period as well as the starting anhydride (127) (27.76 
ppm). 
To the above solution was added N-methylmorpholine (0.020 ml, 0.18 mmol) 
and again spectra were recorded at given time intervals for 75 minutes. 
Immediately on addition of the base, only one signal (27.80 ppm) (i.e. the starting 
anhydride (127)) was shown to be present, and this remained unchanged for the 
duration of the experiment. 
(a.Diphenyipho .phin,c anhydride (12.71 g9d Zn l, L1Q.g) 
The above experiment was repeated with Zn1 2  (1.0 eq.) (0.057 g, 0.18 mmol). 30 
minutes after the addition of the Znl 2 only one signal was shown to be present 
(26.90 ppm) - i.e. not the starting anhydride (127). 
The addition of the base resulted in a shift of this signal to 25.11 ppm. 
31 
 P n.m.r. monitored couplings with jej!p.ppphinjcanhydrideL1271pd 
(1) Coupling of Z-Phe-OH (108) and TosOTjj-Gly-OBziQ7) 
(A) Z-Phe-OH (108) (0.200 g, 0.67 mmol) was dissolved in CID 2 Cl 2/DMF (1:4) (3.0 
ml) at room temperature, and to this was added N-methylmorpholine (0.076 ml, 
0.67 mmol) and diphenylphosphinic anhydride (127) (0.284 g, 0.67 mmol). The 
solution was monitored by 31 P n.m.r. (36 MHz), acquiring spectra at given time 
intervals for 15 minutes. After the 15 minutes the activation was shown to be 
complete. 
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To the above solution was added Znl 2 (0.021 g, 0.067 mmol). 31 P n.m.r. revealed 
a change in the phosphinate anion signal i.e. what had been a sharp peak at 16.42 
ppm had become a broad hump at 17.6 ppm. 
After 10 minutes TosOH
2 +-GIy-QBzl (107) (0.224 g, 0.67 mmol) and 
N-methylmorpholine (0.152 ml, 1.34 mmol) were added, and again spectra were 
acquired for 10 minutes. The coupling was shown to be complete within 10 
minutes and mass spec. (FAB) confirmed the presence of a peak at 447 (MH). 
(B) Z-Phe-OH (108) (0.100 g, 0.33 mmol) and Zn1 2 (0.010 g, 0.033 mmol) were 
dissolved in CID 2 Cl 2IDMF (1:4) (1.5 ml), and to this was added N - methylmorpholine 
(0038ml, 0.33 mmol) and diphenyiphosphinic anhydride (127) (0.142 g, 0.33 mmol). 
Immediately on mixing, 31 P n.m.r. (36 MHz) revealed 3 signals: one corresponding 
to the activated mixed anhydride (27.53 ppm), one to the starting anhydride (127) 
(27.43 ppm) and a broad signal for the phosphinate anion (17.50 ppm). The ratio of 
the peak heights of these signals remained unchanged over 10 minutes. 
After the 10 minutes TosOH 2 -Gly-OBzI (107) (0.112 g, 0.33 mmol) and 
N- methylmorpholine (0.076 ml, 0.67 mmol) were added. 31 P n.m.r. revealed that the 
coupling was complete within 20 minutes and mass spec. (FAB) confirmed the 
presence of a peak at 447 (MH). 
M.Coyp[i,M of  EPMtiy:PH. and I 	IH 2 -Glv:Ql L17) 
(A) Fmoc-Met-Gly.-OH (0.143 g, 0.33 mmol) was dissolved in CD 2Cl 2/DMF (1:4) 
(2.0 ml) at room temperature, and to this was added N - methylmorpholine (0.038 
ml, 0.33 mmol) and diphenyiphosphinic anhydride (127) (0.142 g, 0.33 mmol). 
Immediately on mixing 31 P n.m.r.. (36 MHz) revealed 3 signals: the activated mixed 
anhydride, the starting anhydride (27.50, 27.41 ppm) and the phosphinate anion 
(17.26 ppm). Over a 20 minute period the signals at 27.50 and 27.41 ppm reduced 
substantially in height, while that of the anion signal increased. 
Zn1 2  (0.010 g, 0.033 mmol) was added to the above solution. 31 P n.m.r. revealed 
that immediately on mixing a large signal (27.43 ppm) and a broad signal (17.26 
ppm) were present. Over a 10 minute period the ratio of the peak heights of the 
signals remained unchanged. 
TosOH2 '-GIy-OBzl (107) (0.112 g, 0.33 mmol) and N -methylmorpholine (0.076 
ml, 0.67 mmol) were added, and again spectra were acquired at given time 
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intervals. The coupling was shown to be complete within 20 minutes and mass 
spec. (FAB) confirmed the presence of a peak at 576 (MH). 
(B) Fmoc-Met-Gly-OH (0.143 g, 0.33 mmol) and Zn1 2 (0.010 g, 0.033 mmol) were 
dissolved in CD 2 Cl 2/DMF (1:4) (2.0 ml) at room temperature, and to this was added 
N-methylmorpholine (0.038 ml, 0.33 mmol) and diphenylphosphinic anhydride (127) 
(0.142 g, 0.33 mmol). The solution was monitored by 31 P n.m.r. (36 MHz), acquiring 
spectra at 5 minute intervals for 15 minutes. After 5 minutes three signals were 
shown to be present: the activated mixed anhydride (27.56 ppm), the starting 
anhydride (27.23 ppm), and the phosphinate anion (broad signal). The ratio of the 
peak heights of these signals remained unchanged over the 15 minute period. 
To the above solution were added TosOH 2 -Gly-OBzl (107) (0.112 g, 0.33 
mmol) and N-méthylmorpholine (0.076 g, 0.67 mmol), and spectra were again 
acquired at given time intervals. The coupling was shown to be complete within 20 
minutes and mass spec. (FAB) confirmed the presence of a peak at 576 (MH). 
enzylocycarbonyl)phenlaiany!a!anine benyI ester (13) 
Z-Phe-Ala-OBzl 
Z-Phe-OH (108) (0.501 g, 1.67 mmol) and Znl 2 (0.053 g, 0.167 mmol) were dissolved 
in DMF (15 ml) at room temperature, and to this were added N-methylmorpholine 
(0.185 ml, 1.67 mmol) and diphenylphosphinic anhydride (127) (0.716 g, 1.67 mmol). 
After stirring the resulting solution for 5 minutes, TosOH 2 -Ala-OBzl (131) (0.586 
g, 1.67 mmol) and N-methylmorpho line(0.370 ml, 3.34 mmol) were added, and the 
reaction mixture was stirred for 3 hours. Ethyl acetate (150 ml) was added, and the 
organic solution was washed with water (1 x 150 ml), a saturated aqueous solution 
of NaHCO 3 (3 x 150 ml), water (1 x 150 ml), an aqueous solUtion of 10%  citric acid 
(3 x 150 ml) and brine (1 x 150 ml), and dried over Na 2 SO4. The removal of the 
solvent in vacuo gave a white solid which was purified by flash chromatography 
on silica (eluting with ethyl acetate). The resulting material was recrystallised from 
acetone/light petroleum (b.p. 40-60 °C) to afford the title compound (0.619 g, 81%) 
as a white solid: tIc R f (A4) 0.69; m.p. 124-126 °C; [] 27 -23.4 0 (c = 1, acetone); 
Found: C, 70.5; H, 6.20; N, 6.20 CaIc. for C 27 H 28 N 205 C, 70.4; H, 6.13; N, 6.08%; V max 
(CH 2Cl 2) 3420 (NH), 1740, 1670 (C=O), 1500, 1200 cm1; 6H (200 MHz, CD 3COCD 3 ) 
8.75 (1H, bd, amide NH), 7.30 (15H, m, aromatic CH's), 6.49 (1H, d, J.8.8 Hz, urethane 
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NH), 5.18, 5.00 (Z- CH 2'  benzvl CH 2), 4.55 (2H. m, Phe cLCH, Ala cCH), 3.08 (2H, m, 
Phe BCH 2), 1.38 (3H, d, J 7.2 Hz, Ala CH 3); 6C (50 MHz, CD 3 COCD 3) 171.3, 170.2 
(amide C=O, ester C=O), 155.1 (urethane C=O), 136.9, 136.4, 135.4 (quaternary 
aromatic C's), 128.5-125.5 (aromatic CH's), 65.4, 64.9 (Z- CH 
2, benzyl CH 2), 55.1 (Phe 
xCH), 47.2 (Ala aCH), 37.2 (Phe BCH 2), 16.0 (Ala CH); m/z (FAB), 461 (MH), 417, 
327, 210; hplc R (B2) 20.5 minutes. 
Regeneration of diphenylphosphinic acid (1) 
Ph 2 PO2 H 
A mixture of diphenyiphosphinic anhydride (127)/diphenyiphosphinic acid (125) 
(50.0 g) was suspended in a mixture of 1M NaOH (200 ml) and ethyl acetate (100 
ml), and was stirred for 60 minutes. The organic and aqueous layers were 
separated, and the aqueous layer was washed with further ethyl acetate (2 x 100 
ml), before the pH was adjusted to 2.0 by the addition of 1M HCI. The resulting 
white precipitate was extracted with ethyl acetate (3 x 100 ml), washed with water 
(1 x 100 ml), and dried over Na 2 SO 4 . The removal of the solvent in vacuo afforded 
the title compound (40.8 g) as a white solid: m.p. 193-195 °C (lit. 236 193-195 0 C); 
Found: C, 65.7; H, 5.12 CaIc. for C 12 H 11 0 2P C, 65.8; H, 5.02%; 'Sp (36 MHz, 
CDCI 3/DMF (1:1)) 24.90; m/z(FAB), 219 (MH), 141. 
Regeneration of dienylphospJylchIoridQj4 
Ph 2 POCI 
The compound was prepared by the method Kreutzkamp and Schindler 236 
DiphenylphosphiAic acid (125) (20.00 g, 0.092 mol) was suspended in thionyl 
chloride (40.0 ml, 0.548 mol) and warmed to 60 °C for 30 minutes. The reaction 
mixture was then heated to 90 °C at atmospheric pressure for 10 minutes, and at 
water pump pressure for 3 hours, before being distilled to afford the title 
compound (18.58 g, 86%) as a yellow oil: b.p. 144 °C at 0.5-0.7 mmHg (lit. 236 
135-140°C at 0.01 mmHg); 5H (60 MHz, CDCI 3) 8.70-6.95 (m, aromatic CH's); 5 p (36 
MHz, CDCI 3) 44.69; m/z(FAB), 237 (M), 219, 201, 141. 
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Loading first residue to pikybenzyl alcohol resin () 
(1) 	 colrm 
(1 4 2j 
Fm o c -G Iy-( 0-C H 2 C 5 H 4 - OR) 
(A) Fmoc-GlV-OH (2.497 g, 8.40 mmol) was dissolved in DMA (15 ml) at room 
temperature, and to this was added diisopropylcarbodiimicle (0.65 ml, 4.20 mmol). 
After stirring for 15 minutes, this was added to p - alkoxybenzyl alcohol resin (8) 
(Bachem, 1.05 mmol/g) (2.00 g, 2.10 mmol) which had been swollen in DMA (25 ml) 
in the presence of DMAP (0.013 g, 0.11 mmol). The reaction mixture was agitated 
for 3 hours in a ultrasonic bath at room temperature. The resin was filtered, 
washed with DCM (3 x 30 ml), DMA (3 x 30 ml) and DCM (3 x 30 ml), and dried. 
The coupling yield was found to be 54% (0.489 mmol/g) (by UV deprotection 
study 36). 
(B) Fmoc-Gly-OH (3.942 g, 13.3 mmol) was dissolved in DMF (30 ml) at room 
temperature, and to this was added N - methylmorpholine (1.47 ml, 13.3 mmol) and 
diphenylphosphinic anhydride (127) (5.548 g, 13.3 mmol). After stirring for 5 
minutes, this was added to p-alkoxybenzyl alcohol resin (8) (Bachem, 0.79 mmol/g) 
(4.20 g, 3.32 mmol) which had been swollen in DMF (30 ml) in the presence of 
DMAP (0.020 g, 0.17 mmol). The reaction mixture was agitated for 3 hours in a 
ultrasonic bath at room temperature, followed by washing and drying as above. 
The coupling yield was found to be 80% (0.537 mmol/g) (by UV deprotection 
study36 ). 
N('_[2.2-b/$ (4'-Nitrope nyl)et 	carff_gjyçj p-aIkoxybenyi aIcpiipi 
resin (11) 
Bnpeoc-Gly-(O-CH 2 C 6H-OR) 
Bnpeoc-Gly-OH (3.268 g, 8.40 mmol) was dissolved in DMA (15 ml) at room 
temperature, and to this was added diisopropylcarbodiimide (0.65 ml, 4.20 mmol). 
After stirring for 15 minutes, this was added to p-alkoxybenzylalcohol resin (8) 
(Bachem, 1.05 mmol/g) (2.00 g, 2.10 mmol) which had been swollen in DMA (25 ml) 
in the presence of DMAP (0.013 g, 0.11 mmol). The reaction mixture was agitated 
for 3 hours in a ultrasonic bath at room temperature, followed by washing and 
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drying as above. The coupling yield was found to be 52% (0.454 mmol/g) (by UV 
deprotection study 36 ). 
Na_(9_Fluorenyimethoxycarbonyl)aiaflYj fl-alkoxybenzvjcohoI resin (143) 
Fmoc-Ala-(O-CH 2 C 6H-QR) 
(A) Fmoc-Ala-OH (1.961 g, 6.30 mmol) was dissolved in DMF (23 ml) at room 
temperature, and to this was added diisopropylcarbodjjmjde (0.50 ml, 3.15 mmol). 
After stirring for 15 minutes, this was added to p-alkoxybenzyl alcohol resin (8) 
(Bachem, 1.05 mmol/g) (1.50 g, 1.58 mmol) which had been swollen in DMF (23 ml) 
in the presence of DMAP (0.010 g, 0.08 mmol). The reaction mixture was agitated 
and washed as above. The coupling yield was found to be 36% (0.340 mmol/g) (by 
UV deprotection study 36). A second coupling, performed exactly as the first, was 
therefore necessary. The coupling yield was then found to be 78% (0.660 mmol/g). 
Fmoc-Ala--OH (0.981 g, 3.15 mmol) was dissolved in DMF (15 ml) at room 
temperature, and to this was added N -methylmorpholine (0.35 ml, 3.15 mmol) and 
diphenyiphosphinic anhydride (127) (1.317 g, 3.15 mmol). After stirring for 5 
minutes, this was added to -alkoxybenzyl alcohol resin (8) (Bachem, 1.05 mmol/g) 
(1.50 g, 1.58 mmol) which had been swollen in DMF (15 ml) in the presence of 
DMAP (0.010 g, 0.08 mmol). The reaction mixture was agitated and washed as 
above. The coupling yield was found to be 56% (0.492 mmol/g) (by UV 
deprotection study 36). A second coupling, performed exactly as the first, was 
therefore necessary and resulted in an overall coupling yield of 79% (0.666 
mmol/g). 
Fmoc-Ala-OH (0.981 g, 3.15 mmol) was dissolved in DMF (15 ml) at room 
temperature, and to this was added N-methylmorpholine (0.35 ml, 3.15 mmol) and 
diphenylphosphinic anhydride (127) (1.317 g, 3.15 mmol). After stirring for 5 
minutes, this was added to p-alkoxybenzyl alcohol resin (8) (Bachem, 0.79 mmol/g) 
(1.00 g, 0.79 mmol) which had been swollen in DMF (15 ml) in the presence of 
DMAP (0.010 g, 0.08 mmol). The reaction mixture was agitated and washed as 
above. The coupling yield was found to be 78% (0.522 mmol/g) (by UV 
deprotection study36). 
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Automated Solid Phase Peje Synthesis 
General notes 
All peptides prepared in this section were done so using an Applied Biosystems 
430A automated solid phase peptide synthesiser. All solvents used were either 
freshly distilled (in the case of DCM) or used as commercially supplied by Applied 
Biosystems, Rathbone and Aldrich (DMF and DMA). 
The first residue of each sequence (i.e. the C - terminal residue) was coupled to 
the p-alkoxybenzyl alcohol resin (8) outside the synthésiser. 'The extent of the 
coupling was determined by deprotecting a small sample of the loaded resin and 
quantitatively checking the olefin produced by UV 36 . 
A number of programmed cycles were employed. The standard DIC (HOBt) 
activation and coupling cycles, used routinely on the 430A synthesiser, are 
summarised below. The diphenyiphosphinic anhydride (127) cycles are also 
introduced, with the relative changes and developments in the cycles discussed 
with the relevent peptide. 
All washings were transferred to a waste outlet, with the exception of the 
deprotection solutions. These were first passed through a UV cell (monitoring at 
313 nm) before being put to waste. This enabled the relative efficiency of the 
coupling/deprotection cycles to be determined. 
Tyro sylisoleucylphenylalanylalanylglycine (144) 
H-Tyr-lie-Phe-Ala-Gly-OH 
Fmoc/dipheopjhinic nhydridej12flmethodQjQgy 
The synthesis of (144) was accomplished using the functionalised resin, 
Fmoc-Gly-(O-CH 2 C 6H-OR) (142), on a 0.5 mmol scale, employing Fmoc 
N-protectecJ amino acid derivatives and diphenylphosphinic anhydride (127) 
activation. The side-chain hydroxyl function of the tyrosine residue was protected 
as a tBu  ether, and a 'double couple' cycle was employed which involved: 
(1) washing the functionalised resin - DCM, DMA (5 x, total time = 5 minutes), 
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(2) removal of the 0-protecting group - 20% piperidine in DMA (10.8 ml) (4 x, 3 + 
3 + 3 + 1 minutes), (3) washing - DCM. DMA (10 x, total time = 14 minutes), (4) 
activation - Fmoc-AA-OH (1.0 rnmoi) + diphenylphosphinic anhydride (127) (1.0 
mmol in DMA (4.0 ml)) + N -methylmorphoiine (1.0 mmoi in DMA (2.0 ml)) (2 
minutes), (5) coupling - activated mixed anhydride transferred to the reaction 
vessel + N -methylmorpholine (0.5 mmol)/2,6-lutidine (2.0 mmol) (in DMA (3.0 ml)) 
(40 minutes), (6) washing - 0CM, DMA (2 x, total time = 3 minutes), (7) repeat the 
activation and coupling steps, (8) washing - DCM, DMA (5 x, total time = 5 
minutes), (9) capping - acetic anhydride (1.0 ml of a 0.5M solution in DMA) + 
pyridine (1.0 ml of a 0.IM solution in DMA) (2 x, 2.5 + 3.5 minutes). 
The cycle was terminated with the removal of the N e -protecting group from 
the tyrosine residue and the subsequent washings. 
The cleavage of the peptide from the support (and the simultaneous removal of 
the tBu protecting group) was performed by trifluoroacetic acid/water/thioanisole 
(95:5:5) (33 ml). The reaction mixture was agitated in an ultrasonic bath for 90 
minutes at room temperature, before the resin was filtered off and washed with 
DMA (6 x 10 ml). The combined filtrates were concentrated in vacuo to give a 
yellow solid, which was washed with diethyl ether and filtered. This material was 
purified by preparative hplc, employing a Spherisorb C 18 reverse phase prep. 
column, with water/acetonitrile (+0.05% TFA) as eluent and monitoring at 254 nm. 
The removal of the hplc solvents by lyophilisation afforded the title compound 
(0.117 g, 41%) as a white solid: 6 (360 MHz, 0 20/CD 3CQCD 3) 7.24-7.10 (51-1, m, 
Phe aromatic CH's), 6.97 (21-1, d, J 8.5 Hz, Tyr aromatic CH's), 6.70 (21-1, d, J 8.5 Hz, 
Tyr aromatic CH's), 4.60 (11-1, q, Ala CH), 4.30, 4.23 (21-1, m, Phe aCH, Tyr cCH), 4.10 
(1H, d. J 8.0 Hz, Ile aCH), 3.82 (21-1, m, Gly CH 2), 3.05 (41-1, m, Phe BCH 2, Tyr BCH 2 ), 
1.62 (11-1, m, Ile BCH), 1.27 (31-1, d, J 7.2 Hz, Ala CH 
3)'  1.12 (11-1, m, lie yCH), 0.95 (11-1, 
m, lie yCH), 0.69 (6H, m, 2 x Ile CH 3);  m/z(FAB), 570 (MH), 323, 136; hrms, found 
570.29272, C29 H 40N 507  requires 570.29275 (< 1 ppm); amino acid analysis, 




(ALEmoc/DIC (HQt) methodology 
The synthesis of (14 5) was accomplished using the functionalised resin, 
Fmoc -Gly - (O-CH 2 C 6 H 4-OR) (142) on a 0.5 mmol scale, employing Fmoc 
N e-protected amino acid derivatives and a combination of DIC and HOBt 
activation. A 'double couple' cycle was employed which involved: 
(1) washing the functionalised resin - 0CM, DMF (5 x, total time = 5 minutes), 
(2) removal of the N a -protecting group - 20'/ piperidine in DMF (10.8 ml) (4 x, 3 + 
3 + 3 + 1 minutes), (3) washing 0CM, DMF (10 x, total time = 14 minutes), (4) 
activation - Fmoc-AA-OH (2.0 mmol) + DIG (1.0 mmoi in DMF (2.0 ml)) (15 
minutes), (5) coupling - activated symmetrical anhydride transferred to the reaction 
vessel (90 minutes), (6) washing - 0CM, DMF (2 x, total time = 3 minutes), (7) 
activation - Fmoc-AA-OH (1.0 mmol) + HOBt (1.0 mmol in DMF (2.0 ml)) + DIC (1.0 
mmoi in DMF (2.0 ml)) (30 minutes), (8) coupling - HOBt active ester transferred to 
the reaction vessel (90 minutes), (9) washing - 0CM, DMF (5 x, total time = 5 
minutes), (10) capping - acetic anhydride (1.0 ml of a 0.5M solution in DMF) + 
pyridine (1.0 ml of a 0.5M solution in DMF) (2 x, 2.5 + 3.5 minutes). 
The cycle was terminated with the removal of the N a -protecting group from 
the leucine residue and the subsequent washings. 
The cleavage of the peptide from the support was performed by trifluoroacetic 
acid/water (95:5) (30 ml). Agitation of the reaction mixture in an ultrasonic bath at 
room temperature for 90 minutes, followed by filtration of the resin and washing 
with DMF(6 x 10 ml), gave a white solid on removal of the solvents in vacua This 
material was purified by Sephadex LH20 gel filtration (eluting with DMF) to afford 
the title compound (0.189 g, 73%) as a white solid: 5H  (200 MHz, D 20/TFA) 6.15, m, 
Phe aromatic CH's), 3.52 (1H, t, J 7.4 Hz, Leu aCH), 3.23 (11-1, m, Ala aCH), 2.95 (2H, 
m, lie aCH, Phe aCH), 2.76 (21-1, d, J 3.8 Hz, Gly CH 
2)'  1.89 (21-1, m, Phe BCH 2), 0.47 
(41-1, m, Ile BCH, Lau BCH 2/yCH), 0.17 (51-1, m, Ala CH 
3'  Ile yCH 2), -0.31 (12H, m, 2 x 
Leu CH 3'  2 x Ile CH 3);  m/z (FAB), 520 (MH t), 294, 227, 199, 147; hrms, found 
520.31350, C26 H 42 N 50 6  requires 520.31349 (< 1 ppm); amino acid analysis, 
Gly 1 1.00, Ala 1 1.00, lle 1 0.97, Leu 1 O.99, Phe 1 1.04; hplc R 1 (139) 17.4 minutes. 
(L.PQc/P!C. (HOBt) methodo!ogy 
The synthesis of (145) was performed using the functionalised resin, 
Bnpeoc-Gly-(O-CH 2 C 6H-QR) (113) on a 0.5 mmol scale, employing Bnpeoc 
N e-protected amino acid derivatives and a combination of DIC and HOBt 
activation. A 'double couple' cycle was used as in method (A). 
The unprotected peptide was removed from the support and manipulated as 
above to yield a yellow solid. An analytical hplc (139) trace of this solid revealed 
two products: a major peak, R 17.5 minutes (the desired pentapeptide), and a 
minor peak, R t.  18.2 minutes (impurity). Amino acid analysis of the crude material 
(G1y 1 1.08, A1a 1 0.77, lle 1 11.05, Leu 1 1.03, Phe 1 l.06) suggested the impurity to be the 
tetrapeptide, H-Leu-lle-Phe-Gly-OH. 
An aliquot of this material was purified by preparative hplc, employing a 
Spherisorb C 18 reverse phase prep. column, eluting with water/acetonitrile (+0.05% 
TFA) and monitoring at 229 nm. The removal of the hplc solvents by lyophilisation 
afforded the title compound (0.076 g, calculated yield = 61%) as a white solid: 6H 
(360 MHz, D 20/TFA) 7.47-7.35 (5H, m, Phe aromatic CH's), 4.85 (1H, t, J 7.5 Hz, Leu 
CH), 4.55 (11-1, q, Ala aCH), 4.33 (1H, d, J 7.9 Hz, Ile cCH), 4.24 (11-1, m, Phe czCH), 
4.08 (2H, m, Gly .CH 2), 3.17 (2H, m, Phe BCH 2), 1.90-1.71 (4H, m, Ile BCH. Leu 
BCH 2/yCH), 1.56 (1H, m, Ile yCH), 1.50 (3H, d, J 7.1 Hz, Ala CH). 1.21 (1H, m, lie 
yCH), 1.09-0.92 (12H, m, 2 x Leu CH 3, 2 x Ile CH); m/z(FAB), 520 (MH), 294, 228, 
200, 147; hrms, found 520.31350, C 26H 42 N 506 requires 520.31349 (< 1 ppm); amino 
acid analysis, Gly 1 11.08, A1a 1 0.99, 11e 1 0.98, Leu 1 0.99, Phe 1 0.96; hplc R  (139) 17.6 
minutes. 
The removal of the hplc solvents of the fractions containing the 'impurity' by 
lyophilisation afforded a white solid (0.006g). Mass spec. (FAB) confirmed the 
presence of a peak at 449 (H-Leu- Ile- Phe-GIy-OH m.wt. 448). 
(C) Fmoc/diphenylphosphinic anhygde (127) methodology 
The synthesis of (145) was performed using the functionalised resin, 
Fmoc-Giy-(O-CH 2C 6 H 4-OR) (142) on a 0.5 mmol scale, employing Fmoc 
Na_protected amino acid derivatives and diphenylphosphinic anhydride (127) 
activation. A 'double couple' cycle was employed which involved: 
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(1) washing the functionalised resin - DCM, DMF (5 x, total time = 5 minutes), 
(2) removal of the Na_protecting group - 20% piperidine in DMF (10.8 ml) (4 x, 3 + 
3 + 3 + 1 minutes), (3) washing - DCM, DMF (10 x, total time = 14 minutes), (4) 
activation - Fmoc-AA-OH (1.0 mrnol) + diphenyiphosphinic anhydride (127) (1.0 
mmoll) + N -methylmorpholine (1.0 mmol in DMF (2.0 ml)), (5) coupling - activated 
mixed anhydride transferred to the reaction vessel + N - methylmorpholine (0.5 
mmol)/2,6-lutidjne (2.0 mmol) (in DMF (3.0 ml)), (6) washing - 0CM, DMF (2 x, total 
time = 3 minutes), (7) repeat activation and coupling steps, (8) washing - DCM, 
DMF (5 x, total time = 5 minutes), (9) capping - acetic anhydride (1.0 ml of a 0.5M 
solution in DMF) + pyridine (1.0 ml of a 0.5M solution in DMF) (2 x, 2.5 + 3.5 
minutes). 
The cycle was terminated with the removal of Na_protecting group from the 
leucine residue and the subsequent washings. 
The cleavage of the unprotected peptide from the support was performed as 
method (A), to give on filtration, a white solid. This material was purified by 
Sephadex LH20 gel filtration (eluting with DMF) to afford the title compound (0.204 
g, 78%) as a white solid: ô (200 MHz, 0 20/TFA) 6.12 (5H, m, Phe aromatic CH's), 
3.54 (1H, t, Leu aCH), 125 (1H, m, Ala aCH), 3.00 (2H, m, lie aCH, Phe ciCH), 2.77 
(2H, m, Gly CH 2)'  1.91 (2H, m, Phe BCH 2), 0.49 (4H, m, lie BCH, Leu BCH 2/yCH), 0.20 
(5H, m, Ala CH 3'  lie yCH 2), -0.33 (12H, m, 2 x Leu CH 3'  2 x lie CH 3);  m/z (FAB), 520 
(MH), 294, 227, 199, 147; hrms, found 520.31350, C 26 H 42 N 506 requires 520.31349 
(< 1 ppm); amino acid analysis, Gly 1 l.03, Ala 1 l.01, lle 1 0.98, Leu 1 0.99, Phe 1 l.00; hplc 
R 1 (89) 17.4 minutes. 
(0) BnpeocIdjhenylphosphinic anh ydr i de. jflrnethodoloq 
The synthesis of (145) was z performed using the functionaiised resin, 
Bnpeoc -Gly-(O-CI-1 2C6H-OR) (113) on a 0.5 mmol scale, employing Bnpeoc 
Na_protected amino acid derivatives and diphenyiphosphinic anhydride (127) 
activation. A 'double couple' cycle was used as in method (C). 
The unprotected peptide was removed from the support and manipulated as 
above to give a yellow solid. An analytical hplc (139) trace of this material revealed 
a major peak (R 
t 17.4 minutes) with an accompanying small shoulder. Amino acid 
analysis of this crude material (Gly 1 l.00, A1a 1 0.98, 11e 1 1.00, Leu 1 0.94, Phe 1 l.08) gave 
no obvious clue as to the identity of the impurity. 
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The solid was purified by preparative hpic, employing an Aquapore C 18 reverse 
phase prep. column, eluting with water/acetonitrile (+0.05% TFA) and monitoring at 
229 nm. The removal of the hplc solvents by lyophilisation afforded the title 
compound (0.151 g, 58%) as a white solid: 5H (360 MHz, D 2 0/TFA) 7.47-7.34 (5H, 
m, Phe aromatic CH's), 4.86 (1H, t, J 7.5 Hz, Leu czCH), 4.57 (1H, q, Ala cLCH), 4.34 
(1H, d, J 7.8 Hz, lie ciCH), 4.26 (11-1, m, Phe ciCH), 4.09 (2H, d, Gly CH 2), 3.23 (2H, m, 
Phe BCH 2), 1.89-1.74 (4H, m, lie BCH, Leu BCH 2/yCH), 1.54 (1H, m, lie yCH), 1.51 
(3H, d, J 7.1 Hz, Ala CH 3), 1.23 (11-1, m, lie yCH), 1.10-0.94 (12H, m, 2 x Leu CH 
3' 2 x 
Ile CH 3);  m/z (FAB), 520 (MH), 294. 227, 199, 147; hrms, found 520.31350. 
C 26 H 42 N 50 6  requires 520.31349 (< 1 ppm); amino acid analysis,. Gly 1 0.98, Ala 1 1.00, 
Ile 1 1.00, Leu 1 l.03, Phe 1 0.99 hplc R (139) 17.5 minutes. 
ProlvlQlvcvlprolyl - D-phenyjaianyJaIa nine i4 
H-Pro-Giy- Pro -D -phe-Ala-OH 
Fmoc/dipenylphoshjnjc anhydride 11 27). rnethodoIy 
The synthesis of (146) was accomplished using the functionaiised resin, 
Fmoc-Ala-(0-CH 2C 6H-OR) (143) on a 0.5 mmol scale, employing Fmoc 
N ot- protected amino acid derivatives and diphenylphosphinic anhydride (145) 
activation. A 'double couple' cycle (2 x 2 eq.), outlined above for the synthesis of 
H -Leu-Ile-Phe-Ala-Gly-OH (145) (method (C)), was used, with one exception - the 
glycine residue was incorporated in a single (1 x 4 eq.) coupling rather than the 
standard (2 x 2 eq.) double cycle. 
The unprotected peptide was removed from the support and manipulated as 
above to give a yellow oil. This material was purified by preparative hplc, 
employing an Aquapore C 8  reverse phase prep. column, eluting with 
water/acetonitrile (+0.05% TFA) and monitoring at 229 nm. The removal of the hplc 
solvents by lyophilisation afforded the title compound (0.192 g, 79%) as a white 
solid: 6H (360 MHz, 0 20) 7.36 (5H, m, Phe aromatic CH's), 4.77 (1H, m, Phe ciCH), 
4.46 (1H, m, Ala ciCH), 4.35 (2H, m, 2 x Pro aCH), 4.15 (2H, m, Pro CH 2), 3.83 (2H, m, 
Gly CH 2), 3.45 (2H, m, Pro CH 2). 3.10 (2H, m, Phe BCH 2), 2.45 (1H, m, Pro CH), 2.08 
(4H, m, 2 x Pro CH, Pro CH 
2)' 1.90 (2H, m, 2 x Pro CH), 1.50 (1H, m, Pro CH), 1.36 
(3H, d, J 7.3 Hz, Ala CH 
3); m/z (FAB). 488 (MH), 334, 155, 139; /7rms, found 
488.25091, C 24 H 34 N 506  requires 488.25089; amino acid analysis, Pro 2 l.94, G1y10.98, 
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Ala i  1.03, Phe 1 O.99; hplc R 1 (810) 14.7 minutes. 
Leucylvalylleucylarginyileucy(arglnyiglycylgiycjne(147) 
H-Leu-Val-Leu-Arg- Leu-Arg -Gly-G ly-OH 
Fmoc/diphe!ylphosphinic anhidride (1271 methodjgy 
The synthesis of (147) was accomplished using the functionalised resin, 
Fmoc -GIy-(O-CH 2 C 6 H 4-OR) (142) on a 0.5 mmol scale, employing Fmoc 
N a-protected amino acid derivatives and diphenylphosphinic anhydride (127) 
activation. A 'double couple' cycle (2 x 2 eq.); outlined above for the synthesis of 
H-Leu-lle-Phe-Ala-Gly-OH (145) (method (C)), was used for each of the residues, 
with the exception of glycine, which was incorporated in a single (1 x 4 eq.) 
coupling. Also, unlike the above cycles, which employed a mixture of DCM and 
DMA/DMF as the solvent, only DMA was used. The second couplings of both the 
first arginine and the valine residues were left overnight, rather than for the 
standard 40 minutes. The arginine side-chain function was protected with the Pmc 
group. 
The cleavage of the peptidè from the support (and the simultaneous removal of 
the Pmc protecting group) was performed by trifluoroacetic acid/water/thioanisole 
(95:5:5) (33 ml). The reaction mixture was agitated in an ultrasonic bath for 90 
minutes at room temperature, before the resin was filtered off and washed with 
DMA (6 x 10 ml). The combined filtrates were concentrated in vacuo to give an 
off-white solid, which was washed with diethyl ether and filtered. An aliquot of 
this material was purified by preparative hplc, employing an Aquapore C 18 reverse 
phase prep. column with water/acetonitrile (+0.05% TFA) as eluent and monitoring 
at 229 nm. The removal of the hplc solvents by lyophilisation afforded the title 
compound (0.030 9, calculated yield = 44%) as a white solid: 5H (360 MHz, D 20) 
4.38 (4H, m, 2 x Arg aCH, 2 x Leu CH), 4.17 (1H, d, J 8.7 Hz, Val CH), 4.09 (1H, m, 
Leu (xCH), 3.99 (4H, m, 2 x Gly CH 2). 3.24 (4H, m, 2 x Arg BCH 2), 2.05 (1H, m, Val 
BCH), 1.91-1.55 (17H, m, 3 x Leu BCH 2/yCH, 2 x Arg yCH 2/5CH 2), 1.00-0.87 (24H, m, 
6 x Lau CH 3'  2 x Val CH 3);  m/z (FAB), 883 (MH), 870, 213, 149; lirms, found 
883.584113, C 39 H 75 N 1409  requires 883.58411 (< 1 ppm); amino acid analysis, 
Gly22.13, Va1 1 0.92, Leu 33.17, Arg 22.09; hplc, R 
t (B12) 20.0 minutes. 
Thr!icy!rylisoleucyigiycine (14) 
H -Thr-Leu-Ser-1 le- Gly-OH 
(A) Fmoc/diphenylphosphinic 	hydride (127) methodology 
The synthesis of (148) was accomplished using the functionalised resin, 
Fmoc-Gly-(O-CH 2 C 5H-OR) (142) on a 0.5 mmol scale, employing Fmoc 
N ot- protected amino acid derivatives and diphenyiphosphinic anhydride (127) 
activation. The side-chain hydroxyl functions of the serine and threonine residues 
were protected as 'Bu ethers. A 'quadruple couple' cycle was employed which 
involved: 
(1) washing the functionalised resin - DMF (5 x, total time = 5 minutes), (2) 
removal of the N o- protecting group - 20% piperidine in DMF (10.8 ml) (4 x, 5 + 3 + 
3 + 1 minutes), (3) washing - DMF (10 x, total time = 14 minutes), (4) activation - 
Fmoc-AA-OH (0.5 mmol) + diphenyiphosphinic anhydride (127) (0.5 mmol) + 
N- methyl morpholine (0.5 mmol in DMF (1.0 ml)) (2 minutes), (5) coupling - 
activated mixed anhydride transferred to the reaction vessel + N -methylmorpholine 
(0.5 mmol)/2,6-luttdine (2.0 mmol) (in DMF (3.0 ml)) (20 minutes), (6) washing - 
DMF (2 x, total time = 3 minutes), (7) repeat the activation and coupling steps 
three times, (8) washing - DMF (5 x, total time = 5 minutes), (9) capping - acetic 
anhydride (1.0 ml of a 0.5M solution in DMF) + pyridine (1.0 ml of a 0.5M solution 
in DMF) (2 x, 2.5 + 3.5 minutes). 
The cycle was terminated with the removal of the Na_protecting group from 
the threonine residue and the subsequent washings. 
The cleavage of the peptide from the support (and the simultaneous removal of 
the t Bu side-chain protecting groups) was performed with trifluoroacetic 
acid/water/thioanisote (95:5:5) (33 ml). The reaction mixture was agitated in an 
ultrasonic bath for 90 minutes at room temperature, before the resin was filtered 
off and washed with DMF (6 x 10 ml). The combined filtrates were concentrated in 
vacuo to give a yellow solid, which was washed with diethyl ether and filtered. 
Amino acid analysis of the crude material gave the following: Thr 1 0.89, Ser 1 O.89, 
Gly 1 l.15, lle 1 l.01, Leu 1 1.05. An aliquot of this material was purified by preparative 
hplc, employing an Aquapore C 18 reverse phase prep. column, with 
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water/acetonitrile (+0.05% TFA) as eluent and monitoring at 229 nm. The removal 
of the hpic solvents by lyophilisation afforded the title compound (0.057 g, 
calculated yield = 60%) as a white solid: 6H (360 MHz, D 2 0) 4.50 (21-1, m, Leu aCH, 
Ser ctCH), 4.29 (1H, d, J 7.3 Hz, lie c&CH), 4.17 (1H, m, Thr BCH), 4.00 (2H, s, Gly 
CH 2), 3.91 (1H, d, J 6.4 Hz, Thr czCH), 3.85 (2H, m, Ser BCH 2), 1.94 (1H, m, lie BCH), 
1.67 (3H, m, Leu BCH 2/yCH), 1.50 (1H, m, lie yCH), 1.34 (3H, d, J 6.5 Hz, Thr CH 
3)' 
1.24 (1H, m, lie yCH), 0.98-0.88 (12H, m, 2 x Leu CH 
3' 2 x lie CH 3);  m/z (FAB), 490 
(MH'), 474, 446, 201, 173; hrms, found 490.28769, C 21 H 40 N 50 8 requires 490.28767 
(< 1 ppm); amino acid analysis, Thr 1 0.99, Ser 1 0.94, G1y 1 1.07, 11e 1 0.99, Leu 1 l.01; hplc 
R t (Bli) 23.5 minutes. 
(.Lipeoc/DiC (HOBt) methodology 
The synthesis of (148) was performed using the functionalised resin, 
Bnpeoc-Gly-(O-CH 2C 6 H 4 -OR) (113) on a 0.25 mmoi scale, employing Bnpeoc 
0-protected amino acid derivatives and a combination of DIC and HOBt 
activation. The side-chain - hydroxyl functions of the serine and threonine residues 
were protected as tBu ethers (see above for the preparation of 
Bnpeoc-Ser( t Bu)-OH (119) and Bnpeoc-Thr( t Bu)-OH (124)). A 'double couple' cycle 
was used as outlined above. 
The peptide was deprotected, removed from the support, and manipulated as 
above to give a yellow solid. This material was purified by preparative hplc, 
employing an Aquapore C 18 reverse phase prep. column, with water/acetonitrile 
(+0.05% TFA) as eluent and monitoring at 229 nm. The removal of the hpic 
solvents by iyophiiisation afforded the title compound (0.041 g, 33%) as a white 
solid: 6H (360 MHz, D 20) 4.54 (2H, m, Leu aCH, Ser aCH), 4.30 (1H, d, J 7.3 Hz, lie 
aCH), 4.18 (1H, m, Thr BCH), 3.99 (2H, s, Giy.CH 2), 3.91 (1H, d, J 6.4 Hz, Thr aCH), 
3.88 (2H, m, Ser 8CH 2), 1.95 (1H, m, lie BCH), 1.67 (3H, m Leu BCH 2/yCH), 1.51 (1H, 
m, lie yCH), 1.35 (3H, d, J 6.5 Hz, Thr CH 
3)'  1.24 (1H, m, lie yCH), 0.99-0.86 (12H, m, 
2 x Leu CH 3'  2 x lie CH 3); m/z (FAB), 490 (MH), 257, 234, 199; flrms, found 
490.28770, C 21 H 40 N50 8 requires 490.28767 (< 1 ppm); amino acid analysis, 
Thr 1 O.99, Ser 1 O.92, Giy 1 1.06, ile 1 l.02, Leu 1 l.01; hplc R t (Bil) 23.6 minutes. 
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